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RESUMO 
Esta tese é suportada por duas revisões sistemáticas da literatura com meta-
análise, que perspetivaram a sistematização e a quantificação da investigação 
produzida em animais, e por dois estudos experimentais com ratos Sprague-
Dawley que objetivaram a avaliação dos efeitos de 35 semanas de exercício 
físico regular de intensidade moderada, no desenvolvimento de neoplasias 
mamárias induzidas por carcinogénese química, no microambiente tumoral das 
lesões infiltrativas e no grau de atrofia muscular esquelética. As revisões 
sistemáticas com os respetivos procedimentos de meta-análise revelaram que 
a prática regular de exercício físico com caraterísticas específicas reduz a 
carga tumoral, a proliferação celular e a inflamação sistémica, aumentando as 
caraterísticas pro-apoptóticas das células tumorais e regulando o nível 
circulante das hormonas sexuais e dos fatores associados ao metabolismo da 
glicose. Não se encontraram evidências convincentes da associação entre 
exercício físico e angiogénese tumoral. Os resultados dos estudos 
experimentais revelaram, nos animais exercitados, uma redução no 
desenvolvimento dos tumores e no número de lesões infiltrativas. Nas lesões 
infiltrativas observou-se, também com o exercício físico regular, uma melhoria 
no equilíbrio entre a proliferação celular e a morte celular, bem como uma 
redução de tecido conjuntivo, o que sugere uma menor agressividade tumoral. 
Constatou-se ainda que o exercício físico regular inibiu a ativação de vias de 
sinalização associadas ao catabolismo proteico muscular esquelético, situação 
que conduziu a um aumento da área de secção transversal das fibras 
musculares e a uma melhoria do seu metabolismo oxidativo. Os resultados 
encontrados permitem concluir que, no modelo animal com cancro da mama 
induzido quimicamente, o exercício físico regular atenua a carga tumoral e 
favorece o estadio microscópico, limitando a agressividade infiltrativa e a 
progressão tumoral, reduzindo também as suas repercussões orgânicas 
sistémicas, particularmente a nível muscular esquelético. 
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ABSTRACT 
The research for this thesis involved two systematic reviews of the literature 
guided by meta-analyses, which intend to summarize and quantify the effects of 
exercise on breast tumor outcomes in animal research. It also entailed two 
experimental studies with Sprague–Dawley rats to evaluate the effects of 35 
weeks of regular physical exercise of moderate intensity not only on the 
development of chemically induced breast neoplasms, and in the tumor 
microenvironment of infiltrative lesions, but also on the degree of skeletal 
muscular atrophy. Guided by meta-analytic procedures, the systematic reviews 
revealed that regular physical exercise under specific conditions can reduce 
tumor burden, cell proliferation, and systemic inflammation, as well as increase 
the proapoptotic features of tumors, regulating the circulating levels of sex 
hormones and of glucose-related factors. By contrast, no convincing evidence 
was found to indicate a positive association between exercise and tumor 
angiogenesis. Moreover, the results of the experimental studies revealed a 
reduction in tumors development and in the number of infiltrative lesions in 
animals that exercised. In the infiltrative lesions of those animals, the improved 
balance of cell proliferation and cell death was observed, as was a reduction of 
connective tissue, which suggests lower tumor aggressiveness. Among other 
observations, regular physical exercise inhibited the activation of signaling 
pathways associated with catabolic effects in skeletal muscle proteins, which 
prompted increases in the cross-sectional area of muscle fibers, accompanied 
by improvements in their oxidative metabolism. Altogether, findings indicate that 
in animal models with chemically induced breast cancer, regular exercise 
training attenuates tumor burden and favorably affects tumor staging by limiting 
infiltrative aggressiveness and tumor progression, as well as by reducing 
systemic organic consequences in skeletal muscle. 
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1. GENERAL INTRODUCTION 
Cancer remains not only one of the most daunting diseases worldwide 
but also a major public health concern. Although extensive research has been 
conducted on cancer prevention, diagnosis, and treatment, statistics of cancer’s 
effects are disheartening. In 2012 alone, cancer killed roughly 8.2 million people 
worldwide [343]. Trends no doubt similar in more recent years clearly suggest 
that cancer continues to rank foremost among public health problems, one 
without any projected solutions in the near future [344].  
Among cancer’s various types, breast cancer is the second-most 
common and the most common among women. In 2012, an estimated 1.7 
million women had breast cancer, more than 520,000 women died from the 
disease, and breast cancer accounted for 25% of all cases of cancer and 15% 
of all cancer-related deaths among women. Cases of breast cancer in 
developed countries account for about half of all cases of breast cancer 
worldwide and 38% of all deaths due to breast cancer [371]. The greater 
incidence of breast cancer in such countries reflects not only the use of breast 
cancer screening but also the higher prevalence of risk factors of the disease 
[372]. 
The International Agency for Research on Cancer (IARC) has estimated 
that 1.97 million new cases of breast cancer will be diagnosed in 2020, which 
represents 25% of all cases of cancer in women. In Portugal, breast cancer is 
the leading cause of cancer-related death among women, and the IARC 
estimates that the country will experience 6,749 new cases of breast cancer in 
General introduction 
																																																																																																																																										  
4 
2020, 1,714 of which will be fatal [125]. Worldwide, it is assumed that one of 
every eight women will develop breast cancer at some point in their lives [214]. 
For that reason, cancer researchers have focused on seeking new preventive 
as well as therapeutic approaches that can reduce the number of new cases of 
breast cancer, more effectively treat cases that do occur, decrease the number 
of deaths related to breast cancer, improve the quality of life of individuals with 
breast cancer, and reduce the disease’s recurrence in breast cancer survivors 
[344].  
 
1.1 Breast cancer: Risk and prevention 
The multifactorial origin of breast cancer encompasses dietary factors, 
reproductive factors, hormonal factors, and factors of physical activity, among 
others. Breast cancer’s etiology begins in utero and, throughout life, is informed 
by various kinds of exposure that modulate risk at different times [124]. Several 
factors, including age, race, sex, estrogen exposure, reproductive factors, 
genetic alterations, and lifestyle, are associated with the risk of developing 
breast cancer [345, 381]. Dependent upon age, the development of breast 
cancer is nearly nonexistent before the age of 30 years and has far higher 
incidence in women older than 50. Once women enter their 70s, one in every 15 
will probably develop breast cancer [342, 343]. Also sex dependent, breast 
cancer is far more frequent in women than in men, who account for less than 
1% of all diagnosed cases [144]. By race, remarkable differences in the 
incidence and mortality of breast cancer have also been reported, with the 
General introduction 
																																																																																																																																										  
5 
highest rates among Caucasian women and the lowest among Asian women 
[251, 341].  
Evidence from epidemiologic and laboratory data indicate that the sex 
steroid hormones play a determining role in breast cancer etiology and that the 
greater the exposure to estrogens, the greater the risk of developing breast 
cancer [165]. Thus, the early onset of regular menstruation and late entry into 
menopause, both of which increase lifetime exposure to estrogens, expand the 
risk of developing breast cancer [353]. Indeed, a 2-years delay of menarche can 
reduce the risk by as much as 10%, and each year of menopause delays can 
increase the risk in 3% [30]. Consequently, another possible factor of increased 
estrogen exposure is the use of oral contraceptives and hormone replacement 
therapy, and indeed, the risk of breast cancer is greater following such therapy, 
especially when coupled with factors of density of breast tissue, body 
composition, and genetic mutations [63, 68, 244, 277]. Reproductive factors can 
also increase the risk of developing breast cancer. Women who have never 
given birth have an overall higher risk of breast cancer compared to parous 
women, and multiparous women reduce their risk by 7% with each additional 
birth [66, 67, 208, 238, 317]. Last, more than in other types of cancer, mammary 
neoplasms show familial clustering, and inherited mutations in tumor-
suppressing genes BRCA1 and BRCA2 are also well-documented risk factors 
of the disease, since both are involved in DNA repair to ensure the stability of 
genetic components. Even if only 5–10% of all cases of breast cancer are 
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dependent upon genetics, individuals carrying mutations in those genes have 
40–80% greater risk of developing the disease [74, 111, 145, 276, 278, 279]. 
Among lifestyle factors that increase the risk of breast cancer, alcohol 
consumption [73, 187, 234, 250], tobacco use [59, 87, 138, 275], unhealthy diet 
[260], and reduced levels of daily physical activity or exercise are rank among 
the most major [129]. Alcohol consumption and tobacco use, especially from 
initial menstruation to first full-term pregnancy, are consistently associated with 
the risk of breast cancer, for they are both considered to promote damage to 
deoxyribonucleic acid (DNA) [186, 193, 235]. Evidence of an association 
between alcohol consumption and smoking with reduced survival time following 
a diagnosis with breast cancer has also been reported [36, 153]. Due to 
increases in insulin and insulin-like growth factors (IGFs), increased body mass 
index (BMI), overweight or obesity, and especially visceral fat are also 
considered to be important risk factors for breast cancer [95, 96, 179, 205, 268, 
309, 356].  
By contrast, among lifestyle factors, higher daily levels of physical activity 
and exercise training are associated with a decreased risk of breast cancer. 
Unlike determined genetic factors, regular physical activity (RPA) and regular 
structured exercise training (REX) are modifiable risk factors that can contribute 
to reducing the risk of breast cancer, as convincing evidence suggests [128]. In 
general, RPA and/or REX (RPA/REX) can contribute to overall health, with 
undeniable benefits for cardiorespiratory fitness (CRF), muscle strength, insulin 
resistance, immune function, and BMI maintenance, which can particularly 
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extended to the prevention of several diseases, including breast cancer [131, 
334]. As highlighted by prevention studies, their benefits occur under both 
premenopausal and postmenopausal conditions [105, 133, 135, 249, 290, 373], 
in a dose-responsive manner [129, 367]. Other evidence has recently indicated 
that the benefits of the RPA/REX occur independently of race or ethnicity. 
Moreover, stronger protection against breast cancer has been reported in 
women who maintain consistently high levels of physical activity from menarche 
to adulthood [35, 247].  
Nevertheless, the biological mechanisms underlying the protective effect 
of RPA/REX on breast cancer remain poorly understood. Biomarkers proposed 
to support that association include the modulation of circulating levels of both 
metabolic hormones (e.g. insulin and IGFs) and sex steroid hormones (e.g. 
estradiol and progesterone), the reduction of proinflammatory factors (e.g. 
interleukins, IL-6 and IL-10; tumor necrosis factor-α, TNF-α; C-reactive protein, 
CRP), the enhancement of anti-inflammatory factors (e.g. adiponectin and IL-1) 
and immune function, by increasing the number and improving the function of 
innate and acquired immune cells (e.g., natural killer cells and leukocytes), and 
the reduction of oxidative stress (i.e. reactive oxygen species) [54, 134, 253]. 
Moreover, the benefits indicated by those biomarkers related to RPA/REX are 
closely associated with improved BMI [301]. However, it is unclear whether 
RPA/REX directly acts to modulate them or whether their modulation is 
indirectly achieved via improvements in BMI [270], even despite evidence 
suggesting the association of RPA/REX and the decreased risk of breast cancer 
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in women with normal BMI who perform exercise of moderate or vigorous 
intensity [129, 308]. 
 
1.2 Tumorigenesis and the hallmarks of cancer 
With the potential to progress over several years, tumorigenesis is a 
multistage process involving initiation, promotion, progression and 
metastization, during which a succession of genetic changes occurs that 
promote the alteration of normal cells into cancer cells [161, 285]. Initiation is 
characterized by DNA damage as normal cells are converted into initiated ones; 
whereas promotion is considered to be a relatively long, reversible phase, in 
which altered cells proliferate and consequently generate a cumulative 
population of preneoplastic cells. During progression, genetic and phenotypic 
alterations occur along with cell proliferation, all of which increase tumor size. 
Last, metastization involves the spread of malignant cells from the site of origin 
to other distant sites [381], meaning that to form tumors, incipient cancer cells 
have to break the barrier that normally limits their proliferative potential. By 
some means, they need to become able to multiply during an exceptionally 
large number of growth and division cycles, so that they can complete the 
multiple steps of tumor development [381]. 
In 2001 [161], Weinberg et al. proposed several hallmarks of cancer to 
identify essential alterations in cell physiology that collectively dictate malignant 
growth. In 2011 [162], they updated their list to include eight hallmarks: 
sustained proliferative signaling, the evasion of growth suppressors, resistance 
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to cell death, replicative immortality, angiogenesis, the activation of invasion 
and metastasis, the reprogramming of energy metabolism, and the evasion of 
immune destruction. A notable characteristic of tumor cells is their ability to 
sustained proliferation by producing growth factors (GFs) and by signaling 
normal cells within tumor-associated stroma, which supplies them with several 
GFs (e.g. transforming GF-β, TGF- β) [39, 40, 61]. Another feature of cancer 
cells is their capacity to inhibit cell death. Their apoptotic machinery is regulated 
by extrinsic (i.e. the extrinsic apoptotic program) and intrinsic signals (i.e. the 
intrinsic apoptotic program) both types of which are guided by the activation of 
normally latent proteases—namely caspase 8 and 9, respectively [162]. 
Mediated by mitochondria, the intrinsic pathway is initiated by countless signals 
that triggered the proapoptotic members of the B cell lymphoma 2 (BCL-2) 
family (e.g. Bax, BCL-2-associated x protein and Bak, BCL-2-associated k 
protein) and activate a cascade of events including the release of cytochrome C 
to cytoplasm and the activation of caspase 9, that culminate in cell death. By 
contrast, the extrinsic pathway, which involves death receptors (e.g. FAS-first 
apoptosis signal ligand, and the FAS receptor), culminates in cell death via the 
activation of caspase 8 [106].  
Another hallmark of cancer is angiogenesis, which tumors have to induce 
in order to growth. A compelling body of evidence indicates that the capacity of 
tumor-induced angiogenesis relies mostly on the upregulation of the vascular 
endothelial growth factor (VEGF) [211]. The best-characterized angiogenic 
factor, VEGF modulates vessel permeability and thereby promotes endothelial 
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cell survival, proliferation, and migration [85, 160]. Because those processes 
are typically overexpressed in cancer cells, VEGF is a common target of 
antitumor therapies [162, 337]. High levels of VEGF result in the formation of 
new vessels with abnormal and disorganized architectures that consequently 
hamper its function [239]. However, recent findings have suggested that the 
process of angiogenesis is far from fully understood. For patients with some 
types of cancer, including pancreatic cancer and breast cancer, the addition of 
an antiangiogenic component to chemotherapy has not produced meaningful 
improvement in overall survival [56]. Nevertheless, other evidence indicates that 
the antiangiogenic therapy has helped to normalize the tumor vasculature and 
thus affords an opportunity for the delivery of chemotherapy [240].  
Many of the mentioned hallmarks of cancer, including the abilities to 
induce proliferation, inhibit apoptosis, stimulate angiogenesis avoiding hypoxia 
and immune detection, and confiscate immune cells to their benefit via invasion 
and metastasis [58], relate to tumor microenvironment (TME). During the 
progression of cancer, intricate crosstalk develops between malignant cells and 
the TME, which consists of both stromal cells and the extracellular matrix 
(ECM). The TME cultivates different types of altered cells (e.g. fibroblasts, 
endothelial cells, and leucocytes) that demonstrate permanent interaction [210], 
and the interaction of tumor cells and their TMEs can determine the phenotype 
of tumors. Cancer cells can alter their surrounding stroma to promote support 
for tumor development [178], and in particular, the  subpopulation of cancer-
associated fibroblasts (CAFs) determines cancer growth and progression [267]. 
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The fibroblasts at the tumor site remain permanently activated, similar to their 
state when repairing of normal tissue [206]. In breast cancer, 80% of stromal 
fibroblasts, also known as myofibroblasts, are believed to have achieved the 
activated phenotype [206]. Such so-called “reactive stroma” is composed of a 
great many fibroblasts, type 1 collagen, and fibrin deposition, along with highly 
dense capillaries, epithelial cells, fat cells, and immune cells [225]; the ECM is 
also rich in type 1 collagen and fibronectin. Invasive carcinoma is often 
associated with the expansion of tumor stroma that corrupts the tumor 
basement membrane, together with increased deposition of the ECM (e.g. type 
1 collagen) [338]. Given the importance of the TME in the progression of 
mammary neoplasms, it stands to reason that the TME could represent a 
therapeutic target that can be manipulated to improve the antitumor immune 
response by stifling the potential of malignancy. 
 
1.3 Breast cancer-associated biomarkers 
Breast cancer is a highly heterogeneous disease that encompasses a 
great number of biologically distinct entities with specific pathologic features and 
biological behaviors that inevitably prompt the host systemic response [88]. 
Biological evidence suggests that glucose and other factors related to glucose 
metabolism, including insulin, the IGF family, and IGF-binding proteins 
(IGFBPs), may contribute to the development of breast cancer by promoting a 
more favorable environment for cancer cells to grow [84, 90, 149, 274, 302, 
307, 392]. Ample data highlight that cancer cells express insulin and IGF 
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receptors, whose active role in signaling specific networks in neoplastic tissue 
suggests their key role in the regulation of cellular proliferation and apoptosis 
[303]. Insulin may signal a cascade of proliferative and antiapoptotic event that, 
improve the cell cycle capacity in malignant tissue and decrease their 
proapoptotic properties, which could diminish the survival rate of patients with 
breast cancer [376]. Furthermore, mounting evidence suggests that insulin-
related factors increase the risk of breast cancer recurrence and death, and 
adverse prognoses have been reported in relation to the levels of fasting insulin 
[100, 150-152, 180, 288]. 
Compelling proof associating inflammation and the progression of breast 
cancer suggests another certainty [4]. Inflammation is a function of the immune 
system that aims to protect the organism from pathological aggressions by 
inducing chemical mediators to destroy infective agents and repair the damaged 
tissue [24]. In 1863, Virchow first detected the presence of leukocytes in tumors, 
which suggested a possible connection between inflammation and cancer (for 
refs see [25]). At present, a wide range of evidence from epidemiological and 
preclinical studies supports the consensus that inflammation and cancer are 
related [4, 86, 243]. More than likely, tumor-related inflammation plays a 
significant role in the development and progression of cancer by influencing the 
host immune response. Indeed, the interplay of inflammatory cells and immune 
cells is a determinant of tumor development [155]. In response to persistent 
inflammation amid breast cancer, innate immune cells (e.g. macrophages and 
natural killer cells) and adaptive immune cells (T and B lymphocytes) are 
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components of TME, along with cancer cells and their surrounding stroma (e.g. 
fibroblasts, endothelial cells, and mesenchymal cells) [26]. Consequently, 
crosstalk among those various cell types determines the direction of the path 
that will be done [156]. The host systemic milieu is clearly affected by such 
interactions in the TME, which reacts to continuous inflammation that resembles 
a wound that never heals with unceasing surveillance [83, 101]. The permanent 
state of inflammation and the host–tumor interplay promote deregulation in a 
considerable number of systemic biomarkers. Among them, the serum 
diminishing of albumin synthesis has been underscored as an independent 
predictor of worst prognoses, even in early stages of the disease, and mortality 
in several types of cancer including breast cancer [159, 166, 231, 233]. 
Furthermore, increased levels of lactate dehydrogenase (LDH) have been 
implicated as an independent predictor of breast tumor progression and 
mortality. Some studies have even shown that LDH can be used to estimate 
tumor size and thereby predict treatment responses and prognoses [48, 233]. 
Another marker of the development and progression of mammary 
neoplasms is the circulating levels of sex hormones [254]. Estrogens, of which 
17β-estradiol is the most common form in circulation, are steroid hormones 
once thought to be produced only by the ovaries but can be also produced by 
fat tissue, the liver and the adrenal glands [157]. Deriving from cholesterol, 
estrogens act at the cellular level by binding to specific nuclear estrogen 
receptors (ERs). In the breast tissue, estrogens stimulate the growth and 
differentiation of the ductal epithelium, which not only induce mitotic activity and 
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the growth of connective tissue but during breast cancer also stimulates the 
growth of breast cancer cells [282]. Of the two known subtypes of ERs—
namely, ERα and ERβ—the cells of some types of breast cancer express 
mostly ERα, which is responsible for many of estrogen effects in normal and in 
cancerous breast tissue [94, 157, 282]. As mentioned, the risk of the 
development and progression of breast cancer relates to the circulating levels of 
sex hormones and is greater in women with sustained exposure to estrogen 
[94, 163, 204].  
In contrast to estrogen, progesterone is believed to be antiproliferative, 
and to offer protection against the development and progression of breast 
cancer by reducing the estrogen-induced proliferation of breast cancer cells by 
way of progesterone receptors (PRs) [23]. However, whereas some studies 
have associated progesterone with the onset of breast tumors in response to 
carcinogens, others have suggested that progesterone reduces estrogen-
induced proliferation in breast epithelial cells [7, 8, 46, 52, 164, 165, 185, 220, 
228, 259, 326]. Such conflicting results have been observed in both human and 
preclinical studies. However, whereas the preclinical data can be explained, at 
least in part, by the use of different models for breast cancer, the divergence of 
results in human studies remains without explanation [46, 273]. 
 
1.4 Classification of mammary neoplasms 
In women, mammary glands contain two distinct types of cells: epithelial 
(i.e. luminal) and myoepithelial (i.e. basal) cells. Although most breast tumors 
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originate in epithelial cells, the 3–15% of all breast cancers arising from basal 
cells feature a more aggressive type of tumor [388]. The earliest changes in 
breast tissue are proliferative, due to either an imbalance of factors that 
promote proliferation with ones that inhibit it or decreased apoptosis [381]. 
About 95% of breast cancers are adenocarcinomas, which can be further 
divided into ones that have not penetrated the limiting basement membrane (i.e. 
noninvasive) and ones that have (i.e. invasive or infiltrative) [216, 219].  
The extraordinary diversity of histological types and subtypes of 
mammary tumors complicates the improvement of treatment strategies that 
target each one of them individually [10]. In the last decade, many efforts have 
focused on complementing the histological classification of breast tumors with 
molecular variables that could clarify their heterogeneity and thus their behavior, 
which would facilitate better decisions in strategizing therapies [339]. 
Based on similarities in gene expression profile, Perou et al.’s [295] 
classification of breast cancer into distinct subgroups has provided new insights 
into the biology of breast tumors. In their molecular approach, breast tumors are 
divided into four major classes—luminal A, luminal B, HER2-overexpressing, 
and basal-like—according to the tumors hormonal status, namely the 
expression of ERs and PRs, and the expression of a proto-oncogene, namely 
human epidermal GF receptor-type 2 (HER2/neu), also known as Erbb2 in 
rodents and ERBB2 in humans [295]. Luminal B tumors differ from luminal A 
tumors given the lower quantitative content of hormone receptors in the former; 
by contrast basal-like tumors are triple negative (ER-/PR-/HER2-), and HER2-
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overexpressing tumors cluster near them [295, 348, 349]. Hormonal status 
(ER+/ER-; PR+/PR-) and the expression of HER2 (+/-) determine the 
aggressiveness of a given subtype [347]. Studies have shown that basal-like 
and HER2-overexpressing tumors have a more aggressive character, which 
results in less favorable outcome for patients than either luminal tumor type 
does [109]. Luminal A tumors account for 50% of invasive breast cancer 
tumors, luminal B tumors for 20 %, HER2 overexpressed tumors for 15% of all 
invasive breast neoplasms, and the basal-like tumors for 15% of all invasive 
breast cancer tumors [347]. Currently, the choice of adjuvant systemic therapy 
is based on the patient’s age, the tumor size, the histological grade, lymph node 
involvement, the hormone receptor status, and HER2 status [9, 47, 219]. 
However, the only predictive markers with an associated targeted therapy are 
the ER and HER2 [57]. 
The plethora of histological types and subtypes of mammary neoplasms 
makes breast cancer a complex, heterogeneous disease, for which successful 
treatment options depend upon knowledge of the biological and molecular 
features of each phenotype. Accordingly, animal models are considered to be 
useful for investigating the mentioned phases and for understanding the biology 
of such an intricate disease in order to promote the development of new 
therapeutic targets [375]. The chief forms of carcinoma of the breast are briefly 
classified in Table 1 [216, 219, 318].  
In both humans and animals, carcinoma in situ refers to a neoplastic 
proliferation limited to the ducts or lobes by the basement membrane that does 
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not invade the stroma or lymphovascular channels. Different histologic types 
and subtypes of mammary tumors presenting different histological patterns can 
be found in humans and rats, and a single tumor may comprise either a single 
histologic pattern or a set of different ones [216, 219, 318].  
Table 1: Histological classification of mammary tumors in humans and in rats 
Humans mammary gland tumors Rats mammary gland tumors 
I. Epithelial tumors I. Epithelial tumors 
A. Benign epithelial proliferations 
1. Sclerosing adenosis 
2. Apocrine adenosis 
3. Microglandular adenosis 
4. Radical scar/complex sclerosing lesion 
5. Adenomas 
(a) Tubular 
(b) Lactating 
(c) Apocrine 
6. Papillary lesions 
(a) Intraductal papilloma - Intraductal papilloma with 
atypical hyperplasia 
B. Intraductal proliferative lesions 
1. Usual ductal hyperplasia 
2. Columnar cell lesions 
3. Atypical ductal hyperplasia 
A. Benign lesions  
 
 
 
 
1. Adenoma 
(a) Tubular  
(b) Lactating 
 
2. Papillary lesions 
(a) Intraductal papilloma 
(b) Papillary cystadenoma  
B. Premalignant lesions 
1. Intraductal proliferation 
C. Precursor lesions 
1. Ductal carcinoma in situ (DCIS) 
C. Malignant lesions 
1. Ductal carcinoma in situ 
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2. Lobular neoplasia (LCIS) 
3. Papillary lesions  
(b) Intraductal papillary carcinoma  
(c) Encapsulated papillary carcinoma  
(e) Solid papillary carcinoma In situ 
2. Papillary lesions 
(a) Ductal papillary carcinoma 
(b) Ductal solid and cribriform carcinoma 
(c) Ductal comedo carcinoma 
D. Invasive breast carcinoma 
1. Invasive ductal carcinoma, no special type (NST)  
2. Invasive lobular carcinoma  
3. Tubular carcinoma 
4. Cribriform carcinoma 
5. Mucinous carcinoma 
6. Carcinoma with medullary features  
7. Carcinoma with apocrine differentiation 
8. Carcinoma with signet-ring-cell differentiation 
9. Invasive micropapillary carcinoma  
10. Metaplastic carcinoma NST  
11. Papillary lesions  
D. Invasive breast carcinoma 
1. Tubular carcinoma 
2. Cribriform carcinoma 
3. Papillary carcinoma 
4. Comedo carcinoma 
 
 
 
 
 
 
II. Mesenchymal tumors II. Stromal neoplasms 
A. Benign 
1. Nodular fasciitis 
2. Myofibroblastoma 
3. Benign vascular lesions 
4. Pseudoangiomatous stromal hyperplasia 
5. Granular cell tumor  
6. Benign peripheral nerve-sheath tumors 
7. Lipoma  
8. Leyomioma 
A. Benign  
1. Fibroma 
 
B. Premalignant lesions  
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1. Desmoid-type fibromatosis  
2. Inflammatory myofibroblastic tumor  
C. Malignant 
1. Liposarcoma 
2. Angiosarcoma  
3. Rhabdomyosarcoma  
4. Osteosarcoma  
5. Leiomyosarcoma  
B. Malignant 
1. Fibrosarcoma 
III. Fibroepithelial tumors III. Epithelial stromal neoplasms 
A. Benign 
1. Fibroadenoma  
2. Phyllodes tumor  
3. Hamartoma 
A. Benign 
1. Fibroadenoma 
B. Preneoplastic lesions 
1. Phyllodes tumor  
 
C. Malignant 
1. Phyllodes tumor  
2. Periductal stromal tumor, low grade  
B. Malignant 
1. Carcinosarcoma 
  
Accounting for 55% of breast cancer, invasive ductal carcinoma (IDC) is 
the most common form of invasive breast cancer, while ductal carcinoma in situ 
(DCIS) is the most frequent noninvasive breast neoplasms, which accounts for 
20–25% of all newly diagnosed cases [103, 212]. Two thirds of all cases of 
breast cancer show hormone dependency upon and express hormone 
receptors for both estrogen ER+ and for progesterone PR+ [147], have better 
prognoses, and are linked with longer survival times as well as lower rates of 
recurrence [115, 177, 350]. 
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Rodent models of breast cancer have shown intratumoral heterogeneity 
that can align with that of human subtypes at the molecular level [171]. Although 
no individual model can be expected to fully illustrate a disease as complex as 
breast cancer [375], mammary cancer in female rats resembles that in women 
in its hormone responsiveness, histological patterns, biochemical properties, 
and molecular and genetic characteristics [316, 318]. Consequently, rat models 
represent a fundamental tool for testing new therapeutic, pharmacological, and 
nonpharmacological approaches as well as their systemic and organic 
repercussions [375]. Although several models are suitable to mimic human 
cancer, cell-line derived models (i.e. subcutaneous or orthotropic allografts, and 
xenografts), genetically engineered models, and chemical models, have 
singular peculiarities, and the choice of any of them depends on both the goals 
of research and the availability of resources [139].  
Among them, the chemically induced tumors pose certain advantages, 
particularly their short latency period and high reproducibility. Given their 
similarities with carcinogenesis in humans, including tumor development via a 
series of progressive steps (i.e. initiation, promotion, progression, and 
metastasis), such in vivo animal models provide highly relevant information 
about carcinogenesis in a target organ and the possibility of evaluating new 
preventive and therapeutic agents [209]. Therefore, chemically induced animal 
models of breast tumors have been extensively used to evaluate preventive and 
therapeutic agents for human breast cancer. Two such models, both involving 
Sprague–Dawley rats, are the most frequently used to study the rat mammary 
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tumorigenesis: tumors induced with either 7,2-dimethylbenz[a]-anthracene 
(DMBA) or with N-methyl-N-nitrosourea (MNU) [319]. MNU is a specific 
carcinogenic that, unlike DMBA does not require metabolic activation but acts 
directly to induce irreversible changes in DNA and thereby promotes tumors 
that are locally aggressive and can metastasized [271]. In general chemically 
induced mammary tumors are hormone-dependent adenocarcinomas [232].  
Breast cancer is typically described in stages, and the most widely used 
system for staging breast carcinomas is the TMN system, which accounts for 
the size of the tumor and its metastasis in the axillary lymph nodes [219]. In the 
system’s name, T refers to the tumor size (i.e. >2 cm alters the T stage), N 
refers to nodus status, which changes as the tumor spreads into lymph nodes, 
and M refers to metastasis, which indicates whether the cancer has spread to 
other sites. [219]. Histological grading is also considered to be an effective 
prognostic factor, and invasive breast carcinomas are routinely graded based 
on an assessment of tubular and glandular formation, nuclear pleomorphism 
and mitotic count [107, 108]. Many studies have demonstrated a significant 
association between those histological grades and the survival of patients with 
invasive breast carcinoma [41].  
 
1.5 Cancer-induced muscle wasting  
The loss of skeletal muscle in cancer is a well-documented process that 
affects most cancer patients, albeit to different degrees [6]. The most abundant 
organic system in human body, the musculoskeletal system affords the basic 
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functions of locomotion, strength generation, and respiration. For that reason, 
maintenance of muscle mass whether in health or with disease is crucial [17]. 
The preservation of muscle mass and muscle fiber size depends on protein 
turnover, in which the balance between protein synthesis and protein 
breakdown should be preserved. A network of signaling pathways regulates that 
balance, and under pathological conditions, such regulation can be 
compromised and result in muscle atrophy [321]. In oncology, interest in muscle 
function relies on the study of cancer-associated cachexia. Systemic 
inflammation and metabolic disorder caused by tumors seem to affect protein 
turnover by promoting wasting in muscle mass involving reduced protein 
content, muscle fiber diameter, force production, and fatigue resistance [98].  
Although the understanding of the mechanisms that can underlie cancer-
related cachexia remains incomplete, cachexia is considered to be a 
multifactorial syndrome characterized by the continuous waste of skeletal 
muscle, with or without loss of fat mass, primarily via the ubiquitin–proteasome 
system, often associated with inflammation and insulin resistance [13, 110, 
120]. Cachexia can occur even in the absence of anorexia and cannot be 
completely reversed by nutritional support, both of which seem to suggest the 
presence of catabolic promoters perhaps driven through the tumor or the host, if 
not both [43, 346]. One possible explanation focuses on metabolic 
abnormalities caused by the disease that elevate the resting energy expenditure 
in cancer patients as a result of the high, constant demands of glucose from 
tumors, which prompts a negative energy balance that promotes muscle 
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wasting. In short, the greater the tumor mass the greater the energy demand 
[136, 169]. 
 Mounting evidence suggests that the decline in muscle mass in cancer 
patients is an inherent condition regardless of the disease’s stage. The loss of 
more than 5–10% of body weight is generally held as the basis of a cachectic 
state, although the physiological changes might emerge before that threshold is 
reached [102, 118, 121]. Some researchers have viewed diagnostic criteria for 
cancer cachexia based on weight loss as arbitrary measures that should take 
into account other criteria. In response to those concerns, in 2011 a panel of 
experts reached a consensus about the parameters for staging cachexia in 
cancer patients according to three levels: precachexia, cachexia and refractory 
cachexia. Other than weight loss, the presence of systemic inflammation, 
reduced muscle strength, and altered body composition, especially regarding 
muscle mass, should also be measured [120]. Moreover, to facilitate the 
classification of patients according to the severity of cachexia, Argilés et al have 
constructed the Cachexia Score (CASCO) to categorize patients according to 
degree of cachexia, ranging from mild to terminal, by taking the mentioned 
parameters (i.e., weight loss, systemic inflammation, body composition and 
muscle strength) into account during diagnoses [19]. However, despite all 
efforts it seems that weight loss continues to be the major reference for the 
diagnosis of a cachectic state [245].  
As the physiological condition of patients with cancer deteriorates, their 
functional status to cope with possible pharmacological treatments deteriorates 
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as well. Patients with such altered body composition are highly prone to 
treatment-related toxic effects, even when drugs are administrated in relation to 
body mass or surface area [18]. Ultimately, cachectic conditions are estimated 
to account for 20% of all cancer deaths [368], and although certain cancers are 
more associated with cachexia than others, variation in the prevalence of 
cachexia detected among patients seems to indicate that some individuals are 
more susceptible to the development of cachexia than others, which suggests a 
genotypic dependency regardless of cancer site [192]. 
Skeletal muscle atrophy in cancer-related cachexia is regulated by 
signaling pathways that are activated via cytokines produced by tumors and 
stromal cells within the TME, and by cells of the host immune system [191]. As 
mentioned, cancer cells depend on inflammatory mediators to grow, receive 
protection from apoptosis, and promote angiogenesis, all of which allow them to 
initiate a cascade of events that has several consequences, including the 
triggering of the degradation of muscular proteins [190]. Studies in animals and 
humans have consistently shown that the ubiquitin–proteasome system is the 
chief regulator of protein breakdown under cancer conditions [369]. The 
activation of the system prompts the destruction of myofibrillar proteins that 
consequently impairs the contractile function of skeletal muscles and promotes 
atrophy [136]. Thus, the production of proinflammatory cytokines by the host 
and tumors, including IL-1, IL-6, TNF-α, interferon-gamma (INF-γ), TNF-like 
weak inducer of apoptosis (TWEAK), and myostatin, can serve to activate 
intracellular signals that precipitate protein degradation via nuclear factor–κB 
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(NF–κB) pathways [297, 298]. The presence of those proinflammatory cytokines 
increases the expression of muscle-specific ubiquitin ligases E3, muscle 
atrophy F-box protein (MAFBx), also known as atrogin 1, and muscle RING 
finger-containing protein 1 (MuRF1), all of which promote the ubiquitylation of 
myofibrillar proteins [16, 28, 29, 141]. By contrast, the activation of the 
phosphatidylinositol-3 kinase/Akt signaling pathway prevents muscle atrophy by 
inhibiting Forkhead box class O (FOXO) activity transcription factors, which 
augments protein synthesis [328, 395].  
TWEAK and its receptor fibroblast GF inducible 14 (Fn14), in the so-
called TWEAK–Fn14 system, are major regulators of skeletal muscle mass in 
many catabolic conditions [322, 359]. Additionally, peroxisome proliferator-
activated receptor γ coactivator 1α (PGC-1α) is key in regulating skeletal 
muscle fiber composition, mitochondrial content, and oxidative metabolism [11]. 
Mitochondrial biogenesis is essential to prevent muscle loss under pathological 
conditions such as cancer [222, 314]. 
Skeletal muscles are composed of muscle fibers classified according to 
their speed of contraction and predominant type of energy metabolism. The 
phenotype and functional capacity of any given muscle depends of the quantity 
of the different types of fibers that compose it [329]. As mentioned, during 
atrophic processes, a reduction in fiber size should be expected that inevitably 
reduces functionality [327]. A particularity of cancer-associated muscle waste is 
that muscles seem to be selectively targeted [2]. Indeed, cancer stimuli seem to 
preferentially affect the myosin heavy chain (MyHC) of type 2 fibers with the 
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relative preservation of the MyHC of type 1 fibers [2, 65, 393]. Available data 
regarding humans and rodents seem to confirm the loss of MyHC and the 
consequent reduction in cross sectional area (CSA) driven by cancer stimuli [1, 
21, 104, 119, 330, 379, 380, 394]. 
 
1.6 Exercise training along the breast cancer continuum 
As mentioned, the risk of developing breast cancer relies upon several 
factors. However, unlike other risk factors such as age, family history, early 
menarche, and late menopause, RPA/REX is a modifiable one [308]. A 
considerable number of reviews have reported epidemiological evidence that 
establishes a connection between RPA/REX and cancer prevention by 
associating the amount of exercise performed with a decreased risk of 
developing cancer [134, 263, 312, 387]. Although the role of RPA/REX following 
the diagnosis of cancer has received less attention from researchers, its 
importance in controlling and reducing the side effects of cancer therapy is 
evident [79, 80, 194, 195, 199, 229]. Such evidence encourages health 
professionals to recommend RPA/REX as an adjuvant in treatment conditions to 
improve cardiorespiratory fitness that, in turn, can increase the rate of 
completion of pharmacologic therapies, reduce cancer-related fatigue, and 
improve the quality of life (QoL) of patients [78, 126, 197, 229, 272, 289, 293, 
331, 334, 340, 357].  
Early detection and improved treatments are vital to promoting the 
survival of patients with breast cancer [305]. However, better prognoses relate 
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not only to earlier detection but also to tumor phenotype and lifestyle behaviors 
[182, 347]. In recent years, researchers in exercise oncology have begun to 
investigate the association between active behaviors and the cellular and 
molecular mechanisms underlying that association [237]. Research in that field 
has several concerns regarding therapies that best suit specific cases, minimize 
the number of deaths, and reduce recurrence [60, 76, 218, 312].  
Literature provides sufficient evidence to suggest that RPA/REX, when 
performed at moderate to vigorous intensity for at least 30 min/day, is safe and 
well tolerated by patients both during and after therapy [50, 182, 198, 311]. After 
a diagnosis of breast cancer, the American College of Sport Medicine (ACSM) 
recommends that patients avoid inactivity. Patients should be as active as 
allowed by their conditions and, if possible, follow the guidelines for healthy 
individuals that recommend 150 min/week of exercise training at moderate 
intensity or 70 min/week of exercise training at vigorous intensity, either of 
which should combined endurance and resistance exercises [137, 333]. 
Moreover, the guidelines of the American Cancer Society (ACS) support that 
recommendation [311]. However, the patient’s overall status should always be 
taken into account to ensure an individually adjusted amount of activity by 
defining individual thresholds of activity established on a symptom-based 
approach [200, 284, 389].  
Several studies provide evidence supporting those recommendations. 
Among them, a meta-analysis with 14 randomized controlled trials (RCTs) 
involving 715 patients with breast cancer showed that aerobic exercise training 
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(AET) and resistance exercise training (RET) improved self-esteem, physical 
fitness, body composition, and the rate of chemotherapy completion [252]. A 
few years later, a prospective study with more than 4,000 patients revealed that 
being active during and after treatment for breast cancer can reduce mortality 
among women regardless of age, state of the disease, and the BMI [170], while 
another one involving more than 14,000 women demonstrated that high levels 
of cardiorespiratory fitness were strongly associated with a decreased number 
of deaths [294]. Similar results were found in another meta-analysis of six 
prospective cohort studies involving more than 12,000 breast cancer survivors; 
those findings showed that physical activity after the diagnosis of breast cancer 
reduced death and recurrence by 34% and 24%, respectively, regardless of 
BMI, while pre-diagnosis physical activity reduced the risk of mortality only 
among women with a BMI <25 kg/m2 [176].  
More recently, Lahart et al. [218] and Lipsett et al. [229] conducted two 
meta-analyses to quantify the effects of exercise training on breast cancer 
outcomes during adjuvant therapy. Both meta-analyses revealed that patients 
with breast cancer benefited by engaging in exercise training activities. Lahart 
et al. [218] concluded that a combination of AET and RET affords significant 
benefits by reducing fatigue among women with breast cancer, while Lipsett et 
al. [229] reported an inverse relationship between RPA levels and breast 
cancer-related deaths and recurrence. Nevertheless, results observed in human 
populations, most of which have stemmed from epidemiological evidence, have 
highlighted a positive relationship between RPA/REX and breast tumor-
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associated deaths and recurrence, that seems to be dose-dependent—that is, 
the more activity, the more protection. Yet, confusion remains about the ideal 
amount of exercise in response to breast cancer-associated mechanisms that 
can prompt the best outcomes.  
However, if studies in clinical contexts have provided extensive evidence 
showing that RPA/REX promotes breast tumor survival and reduced recurrence, 
then such linearity in animal studies has not been found. In fact, divergent 
results have been reported regarding the development and progression of 
breast tumors amid RPA/REX. Furthermore, although evidence showing a 
positive relationship between RPA/REX and the development of mammary 
tumors [69, 70, 116, 188, 189, 221, 241, 242, 264, 364-366, 385, 396-398] 
exists, the opposite have also been reported by several researchers [71, 241, 
363, 390].  
 Given all of the above, it is clear that interest in understanding whether 
RPA/REX plays a major role in tumorigenesis-related outcomes by modulating 
tumor behavior has increased [82, 176]. Researchers have sought to confirm a 
link between RPA/REX and concurrent biological changes in order to establish 
better outcomes. That association addresses the type, intensity, and duration of 
exercise training bouts, potential pathophysiological pathways, and breast 
cancer-associated mechanisms within the context of the beneficial effects of 
exercise [77].  
As mentioned, the modulation of metabolic hormones, including markers 
of glucose–insulin homeostasis (e.g. glucocorticoids, IGFs, and insulin), sex 
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steroid hormones (e.g. progesterone and estrogens), systemic inflammation 
(e.g. IL-6, TNF-α, CRP and INF-γ), and improvements in immune response are 
reported to be connected to exercise [27, 97, 162, 312, 315]. Tumors are 
recognized to have an altered cellular metabolism that favors aerobic glycolysis 
in order to support high-energy turnover and rapid cell proliferation [246]. The 
markedly increased consumption of glucose by some tumors, such as those in 
the breast, which result in enhanced lactate production (i.e. the Warburg effect), 
is a well-described mechanism [374, 377]. Thus, limiting glucose availability 
should restrict the capacity of GFs to maintain cellular viability, thereby leading 
to cell death, in a process in which RPA/REX might be pivotal. In other 
research, RPA/REX has been hypothesized as an inducer of perturbations in 
the insulin–glucose axis, improved insulin sensitivity, and, consequently, a 
reduction in the circulating levels of insulin and glucose [42, 183].  
Several studies, mostly RCTs, conducted in the past few years have 
sought to elucidate whether RPA/REX has an active role in the modulation of 
glucose-related factors of improved outcome projections in women diagnosed 
with breast cancer. Fairey et al. [112] conducted a RCT to determine the effects 
of REX in glucose-related markers of 53 postmenopausal breast cancer 
survivors. The exercise group trained on cycle ergometers for 15 weeks (3 
days/week for 35 min) at a moderate intensity. Although no significant changes 
occurred in fasting insulin, glucose, insulin resistance, or IGFPB-1, REX 
markedly improved the levels of IGF-1 and IGFBP-3. Theoretically, increases in 
in IGF-1 imply improvements in cell division and the inhibition of cell death [54, 
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302, 325]; however, also theoretically, because IGFBP-3 is responsible for 
binding the majority of IGF-1, increased levels of IGFBP-3 should be a good 
sign [392]. Nevertheless, in the authors’ opinion, the clinical implications of the 
results remain to be clarified [112]. In a different exercise paradigm, Schmitz et 
al. [332] also conducted a RCT involving 85 postmenopausal breast cancer 
survivors who underwent a twice-weekly (60 min/session) weight training 
program for 12 months. Training sessions were supervised for 6 months during 
which participants learned how to work and how to increase their workload. 
Thereafter, they continued to work unsupervised for another 6 months. Although 
positive results were found regarding IGF-2 levels, no evidence was detected 
concerning improvements in insulin sensitivity and glucose levels [332]. Those 
results, which are both discouraging and challenging, also do not indicate 
whatsoever that REX can effectively improve insulin levels, glucose levels, or 
insulin resistance. Some evidence of a positive relationship was revealed 
regarding IGF-2 levels that could related to the different lengths of exercise 
exposure in the studies, differences in the types of exercise performed, or 
reductions in women’s BMI, as reported in the latter but not in the former study. 
A few years later, Ligibel et al. [226] randomly assigned 101 sedentary 
and overweight breast cancer survivors to either a 16-week program of 
unsupervised AET combined with RET (2 days/week for 50 min with 
supervision) or to a control group in an attempt to analyze the influence of REX 
on insulin concentrations. The intervention group was asked to complete 90 
min/week of AET. Positive changes were reported for fasting insulin with some 
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evidence for improvement in insulin resistance but not for fasting glucose [226]. 
Similarly, Irwin et al. [183] studied 75 postmenopausal breast cancer survivors 
who were subjected to an exercise program involving three weekly supervised 
sessions and twice-weekly unsupervised sessions, both lasting 30 min, of 
moderate AET for 6 months. Findings underscored decreased insulin, IGF-1 
and IGFBP-3, in women with higher exercise levels. Intriguingly, albeit despite 
other evidence [320], the authors concluded that the decrease in IGFBP-3 
probably related to similarly reduced levels of IGF-1.  
Along similar lines, another RCT conducted by Guinan et al. [158] involve 
a group of 26 breast cancer survivors to verify the effects of a light-to-moderate 
AET program on the levels of glucose and insulin. However, the combined 
supervised and home-based program twice weekly for 60 min in either case 
produced no changes after 8 weeks [158]. Likewise, Thomas et al. [360] 
submitted 65 postmenopausal breast cancer survivors to an intervention 
program that combined supervised (3 days/week) and unsupervised (2 
days/week) 30-min training sessions of moderate exercise with the goal of 
reaching 150 min/week during a 6-month period. They observed a significant, 
seemingly dose-dependent reduction in fasting glucose among women in the 
intervention, and more active women (>120 min/week) achieved better 
outcomes [360]. Again however, differences in their results and the results of 
other studies could have derived from the different exercise designs used, 
which casts doubts on which type and amount of exercise are best to prescribe 
to patients with breast cancer in order to achieve the best outcomes.  
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Two recently published meta-analyses did not shed any clarifying light on 
the discrepancies, either. Although their results demonstrated that exercise 
reduced fasting insulin levels [207] and IGFs [257] in the breast cancer 
survivors, differences in the exercise programs prevent attempting strength 
subgroup analysis in one of the meta-analysis [257], whereas in the other, the 
heterogeneity in exercise designs was mentioned as a limitation, and no 
subgroup analysis was performed [207]. Clearly, upholding the ethical principles 
that should guide any research in the field and harmonizing those concerns with 
results sought rank among the greatest challenges in research in exercise 
oncology. 
Similarly to trends in human studies, contrasting results also characterize 
preclinical data. Several reports have associated RPA/REX with improvements 
in the levels of glucose-related factors [116, 398], whereas others have reported 
the opposite [140]. Moreover, the use of different exercise programs precludes 
any clear understanding of the amount of exercise desirable to enhance the 
glucose-related markers [366, 397].  
As mentioned, chronic inflammation is a key factor of the development 
and progression of breast cancer [299]. RPA/REX could counteract that 
permanent state of inflammation by promoting a systemic anti-inflammatory 
environment. Among the mechanisms by which exercise can reduces cancer-
induced inflammation, the working skeletal muscles by increasing the 
production of anti-inflammatory myokines is one of them [248, 296]. Such 
reductions in cancer-induced systemic inflammation could relate to the type, 
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intensity, duration and frequency of the exercise performed [143, 367]. Indeed, it 
seems that higher levels of RPA/REX intensity (i. e. moderate or vigorous) can 
induce the reduction of the circulating levels of proinflammatory cytokines, and 
improve immune function [143, 270, 281, 292, 300]. 
Data correlating cancer-induced inflammation with exercise in human 
patients is relevant to illustrate the need for more studies. In a RCT with 52 
breast cancer survivors exposed to 15 weeks of moderate cycle ergometer 
exercise, Fairey et al. [114] observed significant improvements in immune 
function expressed by exercise-induced natural killer cell activity but did not 
detected any association between REX and the expression of either 
proinflammatory (i.e. IL-1, IL-6 and TNF-α) or anti-inflammatory (i.e. IL-4 and IL-
10) cytokines [113]. In another article published a few months later with the 
same intervention group, the authors reported positive associations between 
REX and the CRP levels [114]. Similarly, in a study involving 28 breast cancer 
survivors exposed to moderate treadmill exercise training combined with 
resistance training for 6 months, Hutnick et al. [175] reported no association 
between REX and levels of plasma IL-6 and IFN-γ, although the improved 
activation of lymphocyte in women who exercised showcased a positive 
association between exercise and immune function. Gómez et al. [148] 
conducted another RCT that involved subjecting 16 breast cancer survivors to 
an 8-week, three-times-weekly combined aerobic and resistance exercise 
program but found no significant changes in their inflammation-related systemic 
markers (e.g. IL-6, IL-10 and TNF-α). In still another RCT Jones et al. [202] had 
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75 breast cancer survivors complete a 6-month exercise program of three 
weekly supervised and twice-weekly unsupervised sessions of moderate AET 
(i.e. running or use of different ergometers, if not both); although they observed 
beneficial outcomes in plasma IL-6 concentrations they detected no effects in 
CRP and TNF-α levels. Following a highly similar approach, Scott et al. [335] 
randomly assigned 90 breast cancer survivors to a control group or to three 
weekly 30-min supervised sessions of moderate exercise with different 
ergometers, accompanied by 15 minutes of RET (intervention group) for 24 
weeks, accompanied also by individualized nutritional information about healthy 
diets. Although in the intervention group they detected improvements in levels of 
leptin, another protein with proinflammatory functions [283], they observed no 
changes in CRP. Likewise, Rogers et al. [313] found a positive relationship 
between REX and leptin levels, along with evidence of the benefits induced by 
REX in some proinflammatory cytokines (i.e. IL-6 and TNF-α) in a 3-month 
training program combining AET and RET in breast cancer survivors.  
Despite several additional studies that have collectively addressed the 
spectrum of RPA and breast cancer, no associations in the levels of 
inflammatory parameters measured (e.g. IL-6, IL-1 and CRP) have been 
observed. Payne et al. [291] assessed the levels of RPA measured by 
pedometers in 20 postmenopausal women with breast cancer for 14 weeks, 
while Demark–Wahnefried et al. [95] evaluated RPA plus resistance training in 
a home-based program among 90 premenopausal patients for 6 months. The 
lack of association between RPA and inflammation parameters in both studies 
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likely related to the interventions implemented, which were based on patients’ 
adherence without supervision, as well as to nonadherence of participants, as 
the researchers acknowledge. Similarly, Campbell et al. [55] did not find any 
association between a 24-week home-based program of moderate exercise and 
the outcomes of CPR as an inflammatory marker in 37 postmenopausal breast 
cancer survivors. However, their exceptionally small sample size, which limited 
the power to detect causal relationships, likely influenced their results. 
Even given the considerable amount of research performed in the last 
decade, the relative importance of RPA/REX to changes in the systemic 
repercussions of breast cancer currently remains unknown. Again, differences 
among studies complicate discerning whether RPA/REX programs truly benefit 
inflammation-related markers or enhances immune response. In response to 
that uncertainty, researchers highlighted the positive effects of chronic exercise 
training in low-grade inflammation among women with breast cancer in a recent 
meta-analysis of different types of exercise and inflammatory mediators in 
breast cancer survivors. They also reported that the benefits related to 
intervention length (>11 weeks) and duration (>45 minutes/session) and that 
significant decrease in TNF- α levels were associated with decreased levels of 
adiposity [256]. Although such results are encouraging, they should be 
interpreted with caution given the number of correlations performed, which in 
some cases were quiet few. 
 In like manner and regarding preclinical data the benefits of RPA/REX to 
modulate inflammation are also diverse, including the improved expression of 
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several inflammation markers (e.g. TNF-α, CRP, INF-γ, IL-6, monocyte 
chemoattractant protein 1 [MCP1], serum amyloid P [SAP], leptin and spleen 
weight) [116, 146, 184, 269, 366, 397, 398], although other data has reported 
the opposite, primarily regarding in IL-6 regulation [366, 398]. In that case, the 
considerable variety of exercise designs and breast tumor models might have 
significantly influenced the outcomes. 
In response to breast cancer, RPA/REX has been linked to lower levels 
of circulating estrogen, which could explain its favorable association with breast 
cancer [255]. Circulating levels of estrogen have been linked to increased cell 
proliferation and to the inhibition of apoptosis via ER-mediated mechanisms 
[224]. Lower estrogen levels among physically active women with breast cancer 
improve survival, particularly for ones with tumors overexpressing ER+ and PR+, 
although few data from human studies exist to support that hypothesis [176]. 
Irwin et al. [182] conducted a prospective observational study with 933 breast 
cancer survivors stratified by levels of self-reported physical gathered with 
questionnaires. They concluded that higher levels of RPAREX correlated 
significantly with a lower risk of death, although only among women who 
presented ER+ tumors. Also using participants’ physical activity self-reported via 
questionnaire, Dal Maso et al. [89] verified that the levels of RPA/REX did not 
relate to mortality levels regardless of the hormonal type of tumor. Similarly, 
Sternfeld et al. [352] used the data of 1970 women from a previous cohort study 
to assess levels of RPA/REX self-reported on a questionnaire; however, they 
found no differences in levels of RPA/REX, the number of breast cancer deaths, 
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or tumors’ hormonal status. Interestingly, the number of all-cause deaths was 
significantly lower among women who presented ER+ and PR+ tumors and had 
engaged in RPA/REX of moderate intensity. In 2011, Irwin et al. [181] assessed 
the self-reported data of 2,910 women with breast cancer regarding their 
RPA/REX behaviors to determine whether such behaviors influenced mortality 
but found inconsistent evidence of any positive relationship between the 
RPA/REX levels and mortality in women with ER+ and HER- tumors. Conversely 
Chen et al. [60] observed that levels of RPA/REX were associated with reduced 
total mortality only among women with ER- or PR- tumors, but not with ER+ or 
PR+ ones. Although the methodological approach was identical, the results 
differed starkly. Referring also to self-reported levels of RPA/REX Bradshaw et 
al. [45] used the data of 1,423 women with breast cancer to gauge the 
relationship between those levels and the mortality index. The positive 
association of RPA/REX with mortality was more pronounced among women 
with ER+ or PR+ tumors than ones with ER- or PR-. 
Altogether human studies have also presented divergent evidence even 
though most have used the same methodological approach. Notably lacking are 
studies on the relationship between circulating levels of estrogen and RPA/REX 
in the development and progression of breast cancer, particularly because 
those levels are associated with the growth of tumor cells [62, 254].  
In preclinical studies, the lack of data also hampers any sure 
understanding of the role of RPA/REX in regulating the circulating levels of 
estrogen and progesterone. Indeed, RPA/REX has been shown to have a 
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positive association with sex hormone circulating levels in some studies [184, 
366, 397, 398], although the opposite can be also found [116].  
Overall, such findings suggest that methodological limitations, including 
small sample sizes, heterogeneous cohorts, and randomized characteristics, 
could explain conflicting results regarding the impact of RPA/REX on breast 
cancer-associated biomarkers. Moreover, the lack of data concerning some 
biomarkers consistently associated with the progression of mammary tumors in 
which improvements have been linked to RPA/REX is remarkable. And if this is 
true for breast cancer-associated systemic markers, then it is even more 
marked regarding intratumoral markers.  
As mentioned, the highly adaptable architecture and integrity of TME are 
susceptible to permanent reshuffle in response to host signaling [213]. Host 
exposure to different stimuli, including exercise, can alter the systemic milieu 
and thereby impose a reaction of the TME [213]. However, despite of the 
mentioned findings linking RPA/REX with breast cancer and reflecting the 
epidemiological associations, to the best of our knowledge no studies with 
humans have involved analyzing that association with TME. Although some 
evidence from animal studies indicates that RPA/REX can alter the TME, such 
evidence is sparse and refers only to some of TME milestones, namely 
angiogenesis [37, 117, 184, 201, 396], apoptosis [37, 188, 189, 396] and 
proliferation [184, 188, 189, 396]. Notably, results of the mentioned research 
have also revealed divergences that mark a clear limitation to understanding the 
benefits of RPA/REX in the TME. Moreover, they seem to conflict regarding 
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angiogenesis. In fact, exercise may increase VEGF levels and at once promote 
a shift towards a more normalized TME by improving intratumoral perfusion and 
vascularization [201]. 
Knowing the role of physical exercise in the muscle atrophy associated 
with cancer is paramount. To reiterate, the loss of muscle mass throughout the 
disease process of cancer undoubtedly reduces the functional capacity of 
patients. In response, considerable efforts has been made in the past few years 
to find an effective anticachectic agent, and exercise has been proposed as a 
possible measure to mitigate or reverse muscle wasting and dysfunction, if not 
both [14, 15, 44, 120, 223, 230]. Several studies with humans with different 
types of cancer have reached conclusions that, though varied, generally favor 
exercise. Unfortunately, regarding breast cancer, results are scarce due to the 
lower incidence of breast cancer patients who suffer from cachexia [53]. As 
mentioned, Schmitz et al. [332] conducted a RCT with 85 postmenopausal 
breast cancer survivors divided in either an immediate treatment or delayed 
treatment group, which underwent a twice-weekly (60 min/session) weight 
training program for 12 and 6 months, respectively. Although both groups 
ultimately exhibited increased lean mass, the finding was more expressed in the 
immediate treatment group, whereas the delayed treatment group did not show 
variations in lean mass across the study period [332]. Courneya et al. [81] 
obtained similar results after randomizing 242 patients with breast cancer 
receiving ongoing treatments into three groups: a control group, a group that 
received AET with different ergometers of moderate-to-vigorous intensity 45 
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min/day three times weekly, and another that received RET involving two sets 
of 8/12 repetitions in different muscle groups three times weekly. The study 
lasted approximately 17 weeks in order to follow the entire treatment period. 
Both exercise groups ultimately demonstrated increased lean mass, although 
the result was more expressed in women who received RET, whereas the 
control group did not show any variation in lean mass during the study period 
[81]. Such lack of variation in lean mass observed between the groups 
prompted the underestimation of the results in a published review [6]; however, 
given the limited number of studies on the topic, definite conclusions about the 
effectiveness of REX in people with breast cancer cannot be made.  
Similar to human studies research conducted with animals has also 
highlighted the benefits of exercise against the depletion of muscle mass in 
cancer context. Al-Majid et al. [5] reported the benefits of REX in the muscles of 
the lower limb of tumor-bearing animals subjected to eight sessions of electrical 
stimulation modeling RET. Puppa et al. [306] additionally reported the beneficial 
effects of REX on muscle mass in cancer-induced cachectic animals 
overexpressing systemic IL-6. REX involving moderate treadmill exercise of 55 
min/day 6 days/week for 11 weeks, blocked the reduction in the quadriceps 
mass. Using the same animals, White et al. [386] observed that similar to the 
quadriceps, the gastrocnemius also suffered a reduction under the action of 
elevated systemic IL-6 that was completely reversed by exercise training. By 
contrast, after measuring 11 days of daily physical activity along with skeletal 
muscle strength, Toledo et al. observed the reduced physical activity and 
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contractile functionality of upper limb skeletal muscles, both of which effects 
were associated with increased tumor burden [370]. However, none of those 
studies were conducted with breast tumor models.  
In one of two recent studies with mammary neoplasm models [127, 286], 
Franjacomo et al. [127] sought to determine whether their model of mammary 
neoplasms could be adequate to pursue the aims of studying cachexia in 
mammary models of cancer. They concluded that the model, involving Ehrlich 
carcinoma cells inoculation could feature systemic inflammation and the muscle 
wasting of cachexia in a less aggressive manner suitable for studying new 
pharmacological approaches. Padilha et al. [286], using an inoculation model of 
Walker-256 cancer cells subjected rats to a 6-week RET program commenced 
before inoculation and continued for 12 days afterward. RET performed prior to 
tumor implantation prevented the development of cachexia by attenuating 
tumor-induced systemic proinflammatory conditions, oxidative stress in the 
muscles, and muscle damage, which seems to suggest the benefits of exercise 
training prior to tumor onset. 
Considering the reported findings, the heterogeneity of research designs 
in clinical and animal models seems to be a pivotal shortcoming in research on 
cancer-induced muscle wasting. The incidence and severity of cachexia 
depends on a reasonable range of factors and can vary according to the type, 
site and mass of the tumor, interindividual variations in susceptibility to 
cachexia, and reductions in food intake or abnormal metabolism [14, 31, 32, 34, 
191, 192]. Clearly, additional studies are needed in the context of cancer-
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induced muscle wasting. In a recently published systematic review and meta-
analysis of RCTs involving exercise for patients with cancer cachexia, 
insufficient data in published literature precluded the possibility of determining 
whether the patients met precachexia or cachexia criteria [154]. To date, no 
medical intervention has completely reversed cachexia, and no approved drug 
therapies are available [31, 33].  
However, promising results, though currently scarce, considering more 
local approaches have been reported. Indeed, evidence from animal studies 
demonstrates that RPA/REX might play an important role in attenuating cancer-
induced muscle wasting by regulating or inhibition, if not both, of several factors 
at the molecular level [321]. As mentioned earlier, the TWEAK– Fn14 system, is 
the major regulator of skeletal muscle mass in many catabolic conditions [322, 
359]; whereas the system’s activation causes skeletal muscle wasting, PGC-1α 
preserves muscle mass [167]. As Hindi et al. [167] have shown TWEAK can 
significantly reduce the expression of PGC-1α along with mitochondrial content 
(≈ 50%), while levels of PGC-1α can be significantly increased in TWEAK-
knockout and Fn14-knockout mice. Furthermore, the transgenic overexpression 
of PGC-1α can inhibit muscle wasting in TWEAK-transgenic mice, and TWEAK-
induced activation of NF–κB (≈ 50%) can considerably reduce (≈ 90%) the 
expression of the atrogenes MAFBx and MuRF1. Similarly, Sato et al. [323] 
reported that TWEAK- knockout mice presented a higher expression of PGC-1α 
and other molecules involved in oxidative metabolism in the muscles, which 
consequently enhanced the muscles’ mitochondrial biogenesis, oxidative 
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capacity, and tolerance to exercise (i.e. treadmill running at a speed of 15 
m/min for 90 min). Additionally, levels of VEGF and angiogenesis also 
improved. In another study conducted by the same research team in TWEAK-
transgenic mice, a reduction in voluntary physical activity was observed 
together with several other metabolic abnormalities, including glucose 
intolerance and insulin insensitivity [324]. Apparently, exercise activates a 
network of transcription factors, kinases, and coregulator proteins that cap 
change in gene expression and prompt increases in mitochondrial biogenesis, 
which in turn cause metabolic reprogramming in skeletal muscle. The 
neutralization of TWEAK therefore seems to be a potential approach to prevent 
skeletal muscle wasting [322]. In the past few years, several studies in rodents 
have been conducted to understand the active role of exercise in modulating 
transcription factors that could influence muscle metabolism and, in turn, alter 
the fiber phenotype in cancer [11]. Consistent evidences shows that endurance 
training induces mitochondrial biogenesis and a fast-to-slow fiber-type switch in 
skeletal muscles, in which PGC-1α is highly expressed in either type 1 and type 
2A fibers [12, 227]. 
Taken together, the results demonstrate that a range of discrepancies in 
the field need clarification and that several lines of evidence need to be 
supported by more powerful studies in human populations. Regarding animal 
studies, such divergence could be overcome with protocols that realistically 
mimic the human contexts. In general, considering the diversity of exercise 
protocols of published research and the lack of consensus, we believe that if 
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such diversity affords the possibility of establishing whether the variables under 
study changed amid various degrees of exposure to exercise, then it also limits 
perceiving characteristics arguably essential to prescribe exercise in patients 
with breast cancer. Clearly, the dynamic of that diversity poses major 
challenges to research in exercise oncology, both with humans and animals. 
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2. AIMS
Considering all of the above, particularly the divergence found in 
published research, the specific objectives of the research conducted for this 
thesis were: 
1. To summarize and quantify knowledge in preclinical data about the
effects of regular exercise training and regular physical activity in
breast cancer outcomes, specifically concerning tumor burden and
tumor microenvironment, as well as on circulating levels of cancer-
associated biomarkers;
2. To verify whether long-term moderate exercise training can
attenuate breast cancer progression and malignancy in rats
exposed to MNU;
3. To assess the influence of moderate exercise training on the rate of
cell proliferation and death within tumors, as well as on the amount
of connective tissue; and
4. To analyze the contribution of TWEAK signaling to cancer-induced
muscle wasting and evaluate whether long-term exercise training
alters such signaling and prevents such muscle waste.
This thesis is structured according to the Scandinavian model and is 
divided into five chapters. Chapter 1 includes a general, enlarged introduction to 
breast cancer, including its classification, etiology and prevention, that analyzes 
Aims 
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the role of regular exercise in instances of breast cancer along the disease’s 
continuum and in cancer-associated muscle wasting. Chapter 1 ends by stating 
the objectives of the thesis and its research. Chapter 2 constitutes the 
experimental part of the thesis and includes a systematic review and meta-
analysis of the efficacy of exercise training in breast cancer outcomes in animal 
studies; a systematic review and meta-analysis of the effects of exercise 
training in breast cancer-related systemic biomarkers; an experimental study on 
the efficiency of exercise training in modulating the infiltrative neoplasm 
microenvironment; and an experimental work regarding the attenuation of 
muscle wasting under the influence of exercise training. Next, Chapter 3 is 
dedicated to a general discussion of methods and results obtained in the 
original studies reported in the previous chapter. Chapter 4 details the major 
conclusions along with the implications of the studies. Last, Chapter 5 presents 
a bibliography of work that supports Chapter 1 and 3.  
48
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1. Study 1
Figueira, ACC; Cortinhas, A; Soares, JP; Leitão, JC; Ferreira, R and Duarte, JA. 
(2018). Efficacy of exercise on breast cancer outcomes: a systematic review 
and meta-analysis of preclinical data. International Journal of Sports Medicine. 
39: 1–16. doi.org/10.1055/s-0044-101149. Reprinted here with the kind 
permission of George Thieme Verlag KG. 
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Introduction
Breast cancer is one of the most commonly diagnosed malignancies 
among women, and it is the leading cause of death by cancer in 
women in several countries. As a result, breast cancer is also an in-
creasingl\ common field oI stud\ >1@. In recent \ears researcKers 
in tKe field oI exercise oncolog\ KaYe Eegun to inYestigate tKe asso-
ciation between active behaviors and cancer, as well as the cellular 
and molecular mecKanisms underl\ing tKat association >43 2@.
7Ke Eeneficial e̥ects oI regular pK\sical actiYit\ and structured 
exercise training considered Kere to Ee exercise on Ereast cancer 
preYention and surYiYorsKip are noZ Zidel\ recogni]ed 
>11 17 18 20 41@. FurtKermore altKougK a IeZ aspects oI tKe 
Eeneficial association EetZeen exercise and tumor outcomes re-
main uncertain, being active is highly recommended during and 
aIter cancer treatment >3 4 7@. Exercise is important to control 
and reduce tKe side e̥ects oI cancer tKerap\ >10 3 38  8 9@ 
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AbStR ACt
7Ke use oI preclinical models to inYestigate antitumor e̥ects 
oI exercise on Ereast tumor B7 deYelopment and progression 
are critical. +oZeYer puElisKed results KaYe not Eeen Tuanti-
tatiYel\ summari]ed or examined Ior potential exercise-mod-
erating YariaEles. :e conducted tKis reYieZ to summari]e and 
TuantiI\ tKe e̥ect-si]e oI exercise on B7 outcomes in preclini-
cal studies. A literature searcK Zas perIormed in ME'/I1E
3uEMed :eE oI Science and S\stem Ior InIormation on *re\ 
/iterature in Europe SI*/E dataEases. 5isN oI Eias Zas assessed 
using S<5C/E·s 5oB tool. A total oI 11 correlations Zere per-
Iormed to anal\]e 28 preclinical studies puElisKed tKrougK
'ecemEer 201 ZKicK included 208 animals and 1 exercise 
programs. 3ositiYe e̥ects oI small medium and large magni-
tude Zere oEserYed in tumor incidence groZtK and multiplic-
it\ respectiYel\. In tKe tumor microenYironment positiYe eI-
Iects oI large magnitude Zere also oEserYed in proliIeration 
and apoptosis Eut not in angiogenesis. Moderator YariaEles 
correlated with higher intervention effects were identified
along ZitK a consideraEle Keterogeneit\ in exercise protocols 
tKat precluded us Irom clearl\ perceiYing tKe Eenefits oI exer-
cise exposure. In conclusion exercise perIormed under spe-
cific conditions Eenefits B7 outcomes. 3reclinical studies ZitK 
exercise designs mimicNing exercise exposure tKat can Ee used 
in clinical contexts are needed.
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and Eeing actiYe during and aIter treatment appears to reduce 
mortalit\ among Zomen >2 29 30 48@.
3uElisKed studies KaYe sougKt to confirm a linN EetZeen exer-
cise and Eiological cKanges tKat promote Eetter tumor outcomes 
possiEl\ acKieYed Yia tKe modulation oI tumor EeKaYior >49@. In-
deed NnoZledge oI cell proliIeration tKe cellular apoptosis rate 
and proangiogenic and antiangiogenic eYents are important Ior 
predicting tKe EeKaYior oI tumors and tKeir metastatic potential 
and tKere is eYidence tKat exercise ma\ exert a Eeneficial e̥ect E\ 
altering tKese processes >13 4 4@.
7Ke current literature suggests tKat exercise ZKen perIormed 
at a moderate to Yigorous intensit\ Ior 7–10 min per ZeeN is 
saIe and Zell tolerated E\ patients during and aIter tKerap\ >3 7@. 
+oZeYer tKe maMorit\ oI inYestigations Iocusing on Kumans KaYe 
ascertained an appropriate actiYit\ leYel using suEMectiYe i. e. selI-
reported measures ZKicK oEscure NnoZledge aEout tKe t\pe in-
tensit\ duration and IreTuenc\ oI exercise tKat conIers optimal 
Eenefits >19@.
5esearcK on tKe topic using animal models to mimic tKe disease 
in humans is essential to reveal the biological mechanisms by which 
exercise exerts its Eeneficial e̥ects identiI\ tKe amounts oI exer-
cise tKat \ield Eetter outcomes and proYide inIormation aEout 
tumor pK\siolog\ >4@. +oZeYer tKe results oI preclinical researcK 
are still Keterogeneous liNel\ due to tKe diYersit\ oI exercise ex-
perimental protocols tKat preclude a clear understanding oI tKe 
strengtK oI exercise e̥ects as Zell as tKe t\pe duration intensit\ 
and IreTuenc\ oI exercise tKat most e̥ectiYel\ preYent and con-
trol Ereast cancer in animals >3@.
AltKougK seYeral reYieZs addressing tKe e̥ects oI exercise on 
breast cancer in animal models have been conducted, the results 
oI sucK reYieZs KaYe not Eeen assessed TuantitatiYel\; no meta-
anal\tic procedures Zere used to report e̥ect si]es or to scrutini]e
potential moderators oI interYention e̥ects.
Our stud\ addressed tKis suEstantial gap in tKe literature E\ 
TuantiI\ing tKe e̥ects oI exercise on Ereast cancer outcomes in 
animals. 7Kis meta-anal\sis Iocuses primaril\ on tKe e̥ect si]e oI 
exercise on tumor outcomes as assessed E\ cKanges in incidence 
i. e. tKe total oI tumors per group oI animals actiYe Ys. sedentar\ 
multiplicit\ i. e. tKe numEer oI tumors per animal actiYe Ys. sed-
entar\ tumor ZeigKt tumor Yolume and cKanges in tKe tumoral 
microenYironment i. e. marNers oI cellular proliIeration and ap-
optosis and marNers oI angiogenesis. 7Kis TuantitatiYe assessment 
also examines Ieatures oI exercise designs tKat inÁuence tKe exer-
cise-cancer relation in di̥erent Za\s E\ anal\]ing ZKicK ones are 
associated ZitK Eetter interYention e̥ects.
MetKods
7Kis meta-anal\sis Zas conducted according to tKe 3reIerred 5e-
porting Items Ior S\stematic 5eYieZs and Meta-Anal\ses statement 
>0@. 7Kis article does not contain an\ studies ZitK Kuman partici-
pants or animals >24@.
Search strategy
A literature searcK conducted once in April 201 and again in 'e-
cemEer 201 Zas perIormed on tKe IolloZing dataEases: ME'-
/I1E 3uEMed :eE oI Science :eE oI Science; Current Contents 
Connect and S\stem Ior InIormation on *re\ /iterature in Europe 
SI*/E and in tKe searcK Ze used MeS+ terms and Ne\Zords re-
lated to Ereast cancer exercise and animals >Electronic supplemen-
tar\ material ESM table S1@. Booleans Zere also used ZKen pos-
siEle to Iorm searcK expressions comEining tKe MeS+ terms ESM 
Fig. S1. :e also conducted an additional manual searcK oI tKe reI-
erences in tKe manuscripts retrieYed.
Inclusion criteria
:e included studies iI tKe\ satisfied tKe IolloZing criteria: 1 tKe\ 
Zere perIormed on animals and Zritten in EnglisK; 2 tKe\ com-
pared tKe e̥ects oI an actiYe and a sedentar\ liIest\le on tumor 
outcomes; 3 tKe\ inYestigated tKe e̥ects oI exercise IolloZing 
tumor induction. :e excluded studies iI: 1 tKe\ addressed tKe 
cancer-preYentiYe e̥ects oI exercise; 2 tKe\ endeaYored to de-
termine tKe acute e̥ects oI exercise; 3 tKe\ comEined exercise 
exposure ZitK cKemical tKerap\ exposure; 4 tKe\ descriEed data 
tKat made it impossiEle to calculate e̥ect si]es.
7Zo sources Zere excluded Eecause Iull-text Yersions Zere un-
aYailaEle Ior purcKase and could not Ee oEtained; tKe autKors oI 
tKose sources Zere contacted and tKe manuscripts reTuested Eut 
no response Zas receiYed.
Data collection process
7Kree autKors ACCF 5F and JA' independentl\ assessed tKe eli-
giEilit\ oI tKe studies and graded tKeir metKodological Tualit\ 
using tKe S<stematic 5eYieZ Centre Ior /aEorator\ animal Experi-
mentation S<5C/E·s 5isN oI Bias 5oB tool CocKrane 5oB tool 
adapted Ior animals. 7Kis Tualit\ assessment tool rates tKe stud-
ies· procedures as ´KigK.µ ´unclearµ or ´loZµ risN oI Eias in six di-
mensions selection perIormance detection attrition reporting 
and otKer Eias adapted Ior aspects oI Eias tKat pla\ a specific role 
in animal studies ESM Fig. S2 >28 74@. An\ disagreements Zere 
resolYed E\ consensus or E\ inYolYing a IourtK reYieZer J3S. 7Kree 
reYieZers ACCF AC JC/ extracted and interpreted tKe data and 
ZKen necessar\ contacted tKe autKors to reTuest additional inIor-
mation.
7Ke IolloZing inIormation Zas extracted Irom eacK manuscript: 
name oI tKe first autKor \ear oI puElication sample si]e and t\pe 
oI animals used as Zell as tumor induction protocol tumor out-
come data and exercise design Ieatures.
Statistical analysis
:e perIormed tKe statistical anal\sis using CompreKensiYe Meta-
Anal\sis CMA soItZare Yersion 2.2.07 Biostat Inc EngleZood 
1eZ Jerse\ 8SA.
7o estimate tKe e̥ect si]e oI tKe exercise-cancer relation Ze 
used tKe correlation coe̦cient r ZKen aYailaEle. :Ken r Zas una-
YailaEle Ze used aYerages standard deYiations and percentages 
and conYerted tKese statistics into r Yalues. In comparatiYe stud-
ies Ze conYerted to r Yalues using exact p Yalues >@. Considering 
tKe diIIerent metKodologies adopted in eacK stud\ a random- 
eIIects model Zas used and CoKen·s 1988 criteria Ior small 
r  0.10 medium r  0.30 and large r  0.0 e̥ects Zere con-
sidered to TuantiI\ tKe magnitude oI tKe results >@.
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+eterogeneit\ and risN oI Eias
:e used CocKran·s 4 and I2 tests to gauge Keterogeneit\ and per-
formed a sensitivity analysis omitting one study at a time from the 
initial meta-anal\sis. :e also scrutini]ed potential moderators oI 
interYention e̥ects e. g. Yoluntar\ or Iorced exercise intensit\ 
distance coYered duration and IreTuenc\ selected Eased on tKe-
or\ and prior findings >4@. :e tKen accordingl\ coded interYen-
tion Ieatures ̂table 1.
7o test Ior Eias Ze examined Iunnel plots and used Egger·s re-
gression and Begg·s ranN correlation.
5esults
Study characteristics
As shown in ̂ Fig. 1 Ze identified 271 articles in tKe aEoYe-men-
tioned dataEases plus 90 in searcKes oI gre\ literature. AIter an 
 initial anal\sis fiIt\-one articles remained and Zere examined in 
detail; KoZeYer onl\ 28 oI tKe articles >2 7–9 14 1 21 23 31 33 
34 39 42 4 47 1 3 0 –70 72 73 7–77@ Iulfilled all oI 
the inclusion criteria.
'escriptiYe data regarding tKe selected studies are presented 
in ̂ table 2.
In total Ze eYaluated 1 programs 18 oI ZKicK used Yoluntar\ 
exercise 1.0  11 used a Iree ZKeel 27.4  >7–9 23 39 47 
0 9 70 7 7@ and 7 a motori]ed ZKeel 21.  >33 34 42 47 
1 9 77@. Forced exercise on a treadmill Zas used in 13 studies 
49.0  >2 9 14 1 21 31 4 3 –8 72 73@.
Exercise intensit\ Zas measured in 33 protocols 4.7 . Mod-
erate-intensit\ exercise Zas tKe most IreTuentl\ used 4.  Iol-
loZed E\ loZ-intensit\ exercise 30.3  and Yigorous-intensit\ ex-
ercise 24.2 . Onl\ 4.4  oI tKe experimental protocols KaYe de-
Iined exercise Eout durations Yer\ long: 3. ; long: 2.0 ; 
medium: 3. ; sKort: 17.9 .
7Ke duration oI tKe experiments Yaried Irom 2 to 3 ZeeNs and 
27 oI tKese lasted more tKan one montK >2 7–9 14 1 21 23 
31 33 34 39 42 4 47 1 3 0 –70 72 7–77@ ZitK 17 
lasting more tKan tZo montKs >7–9 14 1 21 23 33 42 4 
1 3 0 –8 77@.
CKemical models Ior Ereast cancer Zere tKe most IreTuentl\ 
used 7.8  >7 8 14 1 21 33 34 42 4 47 1 –
9 72 7–77@ IolloZed E\ transgenic models 14.29  
>9 23 3 0@.
7Zent\ studies anal\]ed tumor incidence >7–9 14 21 33 34 42 
4 47 1 –9 72 73 7–77@ and fiYe oI tKose studies 2  
reported adYerse e̥ects oI exercise >9 21 4  73@. OI tKe 14 
studies tKat anal\]ed tumor multiplicit\ >8 9 14 23 33 34 4 
47 3 0 9 7–77@ tZo 14.3  reported negatiYe data associ-
ated ZitK exercise >9 0@. 7umor ZeigKt Zas oEserYed in nine stud-
ies >2 14 33 34 0 72 73 7 77@ and tumor Yolume Zas oE-
serYed in 11 studies >2 7 9 14 23 31 4 3 0 70 72@. 1egatiYe 
e̥ects oI exercise Zere reported E\ one stud\ in tumor ZeigKt 
11.1  >14@ and E\ tKree studies in tumor Yolume 27.3  
>7 14 4@.
7Ke tumor microenYironment Zas anal\]ed in onl\ six studies 
>1 31 33 34 39 7@ and negatiYe data Zere reported in tZo 
studies Eut onl\ in tumor angiogenesis >1 39@.
Risk of bias and quality evidence
:e anal\]ed tKe proportion oI ´loZµ ´unclearµ or ´KigKµ risN oI 
Eias among studies Ior eacK item in tKe tool >2@. In 89.29  
n  2 oI tKe studies tKe randomi]ation tKe Easeline cKaracter-
istics and tKe allocation concealment Zere adeTuate. 7Ke Kousing 
conditions Zere similar EetZeen groups in 8.71  oI tKe cases 
n  24 and in 9.43  n  27 oI tKe studies all tKe animals Zere 
used in reported outcomes. 7Ke outcomes Zere completel\ re-
ported in 71.43  n  20 oI tKe cases. +igK risN oI Eias 4.29  
n  18 Zas oEserYed in tKe ´detection Eiasµ dimension mainl\ 
due to tKe unreported conditions in ZKicK tKe animals oI tKe 
 di̥erent experimental groups Zere sacrificed. IndiYiduall\ onl\ 
one stud\ >1@ Zas rated ZitK KigK .7  and unclear 22.22  
risN oI Eias. 7Ke remaining studies Zere rated ZitK loZ risN oI Eias 
ESM table S3.
Effect size of exercise on tumor outcomes
AIter meta-anal\tic procedures tKe results sKoZed tKat exercise 
significantl\ reduces tumor Eurden in animals. :e perIormed a 
total oI 11 correlations 37 Ior incidence ̂Fig. 2a 20 Ior multi-
plicit\ ̂Fig. 2b 14 Ior tumor ZeigKt ̂Fig. 2c and 1 Ior Yol-
ume ̂Fig. 2d and releYant correlations Zere noted. 5egarding 
tumor microenYironment ten correlations Zere made Ior proliI-
eration ̂Fig. 3a ten Ior angiogenesis ̂Fig. 3b and 12 Ior ap-
optosis ̂Fig. 3c. :e also Iound significant and positiYe results 
in proliIeration and apoptosis Eut not in angiogenesis.
7Ke positiYe impact oI exercise Zas noted in incidence ZitK a 
small magnitude r  ï0.202 p  0.000; 9  CI  ï0.29; ï0.10; 
̂table 1 Codification oI moderators.
Moderator Values Coding Description
Exercise t\pe 0  7readmill; 1  Free-ZKeel; 
2  Motori]ed-ZKeel
7\pe oI exercise perIormed. 3rotocols in treadmill Zere considered as Iorced exercise. 
For Yoluntar\ exercise protocols in Iree-ZKeel or in motori]ed-ZKeel Zere considered.
Exercise intensit\ 0  1'; 1  /oZ; 2  Moderate; 
3  9igorous
0: 1ot defined; 1: 8ntil 0  oI maximum speed; 2: 0 -70  oI maximum speed; 3: 
AEoYe 70  oI maximum speed.
'istance coYered 0  15; 1  SKort distance; 2  /ong 
distance
'istance coYered during tKe entire program 0: 1ot registered; 1: *roup oI animals 
ZKo coYered sKorter distances; 2: *roup oI animals ZKo coYered longer distances.
Exercise duration 0  15; 1  SKort duration; 
2  Medium duration; 3  /ong 
duration; 4  9er\ long 'uration
'ail\ exercise duration. 0: 1ot registered; 1: 8nder 30 min; 2: BetZeen 30 and 4 min; 
3: BetZeen 4 and 0 min; 4: AEoYe 0 min.
Exercise IreTuenc\ 0   dZeeN; 1   dZeeN; 2  7 d
ZeeN
:eeNl\ IreTuenc\. In Yoluntar\ exercise protocols iI IreTuenc\ Zas not defined E\ tKe 
autKors a IreTuenc\ oI 7 da\s is alZa\s assumed.
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n  1871; N  37 and ZitK a large magnitude in multiplicit\ 
r  ï0.32 p  0.000; 9  CI  ï0.7; ï0.44; n  1034; N  20. 
Medium-leYel Eenefits Zere oEserYed in tumor ZeigKt r  ï0.3 
p  0.002; 9  CI  ï0.7; ï0.139; n  39; N  14 and tumor Yol-
ume r  ï0.443 p  0.00; 9  CI  ï0.8; ï0.143; n  08; N  1.
Significant large-magnitude Eenefits Zere oEserYed in tumor 
proliIeration r  ï0.794 p  0.000; 9  CI  ï0.881; ï0.; 
n   280; N   10 and apoptosis r   ï0.798 p   0.000; 9  
CI  ï0.872; ï0.90; n  24; N  12. In tumor angiogenesis 
r  ï0.2 p  0.448; 9  CI  ï0.734;0.392; n  110; N  10 small 
positiYe Eenefits Zere oEserYed Eut tKe\ Zere not statisticall\ sig-
nificant.
We noticed s igni f icant  heterogeneit y  in  inc idence 
>43  82.9 p  0.000 I2  7 @ multiplicit\ >420  30.844 
p  0.000 I2  9 @ tumor ZeigKt >413  191.797 p  0.000 
I2  93 @ tumor Yolume >414  284.087 p  0.000 I2  9 @ 
proliIeration >49  1.840 p  0.000 I2  83 @ apoptosis 
>411   3.09 p   0.000 I2   79 @ and angiogenesis 
>47  14.379 p  0.000 I2  9 @.
Sensitivity analysis
For incidence remoYing tKe stud\ Mudge at KigK risN oI Eias did not 
reYeal diIIerent results r  ï0.193 p  0.000; 9  CI  ï0.28; 
ï0.097 in exercise e̥ects ESM Fig. S2a. MoreoYer in tKe remain-
ing variables, removing one study at a time for the analysis did not 
suEstantiall\ alter our results ESM Fig. S2b, c, d and S3a, b, c.
Moderator variables analysis
Because suEstantial YariaEilit\ in e̥ect si]es can relate to exercise 
Ieatures Ze also anal\]ed moderator YariaEles. Moderation in-
duced E\ exercise Ieatures Zas oEserYed in tKe maMorit\ oI tKe Yar-
iaEles tKat Ze anal\]ed ̂table 3.
9oluntar\ exercise and Iorced exercise
7Ke t\pe oI exercise perIormed is a moderating YariaEle oI exercise 
e̥ects tKat acts on tumor Eurden E\ decreasing it. In Iact tumor 
Eurden exKiEited Eenefits irrespectiYe oI ZKetKer tKe t\pe oI ex-
Reports after database 
searching
(n=271)
Remaining after a first 
selection (n=73)
Articles excluded (n=20)
Studies:
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tif
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n
Remaining for review 
(n=48)
Manuscripts included
(n=28)
Sc
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en
in
g
El
ig
ib
ili
ty
In
cl
ud
ed
Note: In some cases, exclusions were made due to the impossibility of calculating effect sizes from the
described data. The authors of such literature were contacted and additional statistics requested.
Reports after manual 
searching
(n=3)
Identified after duplicates 
removed
(n=138)
Excluded after a first selection 
(n=65)
Excluded after reading 
abstracts (n=25)
Grey literature search
(n=90)
3*('*,#&!(*.&,#'&  ,+' 0*#+&,
3*('*,#&!-,  ,+' 0*#+&,
3*('*,#&!,"&'*%$%%%*1!$&&,
3/#,"'%#&0('+-*+&
,
3with data unsuitable for calculate effect size
    (n=3),
3/#,"&',#&&$12.*#$+&.
̂Fig. 1 FloZcKart depicting tKe selection oI studies Ior meta-anal\sis.
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ercise perIormed Zas Iorced or Yoluntar\. In incidence 34.8  Ys. 
2.9  and multiplicit\ 87.0  Ys. 73.1  motori]ed-ZKeel exer-
cises appeared to Ee more adYantageous tKan Iree-ZKeel or tread-
mill exercise 34.8  Ys. 9.  and 87.0 Ys. 27.  respectiYel\. In 
terms oI tumor ZeigKt running in a Iree ZKeel 79.4  Zas more 
Eeneficial tKan motori]ed-ZKeel 48.  or treadmill 44.  ex-
ercise. 7umor Yolume Zas significantl\ decreased ZitK treadmill 
exercise 70.7  compared ZitK Iree-ZKeel exercise 33.8 . 1o 
research has been conducted about tumor volume under motor-
i]ed-ZKeel conditions.
Exercise perIormed on a motori]ed ZKeel IaYored an antiangi-
ogenic enYironment 8  and tKe positiYe e̥ects KigKligKted in 
proliIeration and apoptosis Zere not inÁuenced E\ tKe modalit\ oI 
tKe exercise perIormed. MoreoYer no studies KaYe Eeen conduct-
ed to assess marNers oI apoptosis ZitK Iorced exercise.
Intensity
7umor Eurden appears to accumulate Eenefits Irom all leYels oI in-
tensit\ oI training Eut to di̥ering degrees. Increased Eenefits to 
incidence 39.8  and multiplicit\ 88.1  Zere associated ZitK 
Yigorous exercise training and moderate-intensit\ exercise exert-
ed a stronger inÁuence on tumor ZeigKt 0.7 . 5eductions in 
tumor Yolume Zere KigKer Ior loZ-intensit\ exercise 84.7 .
3ositiYe and large e̥ects Zere Iound EetZeen moderate-inten-
sit\ exercise and tumor proliIeration 88. ; apoptosis 8.  
and angiogenesis 80.7  exKiEited Eetter results ZitK loZ-inten-
sit\ exercise. 1o studies KaYe tKorougKl\ examined proliIeration 
and angiogenesis marNers under Yigorous exercise conditions.
'istance coYered
7Ke proliIeration and apoptosis outcomes Zere not moderated E\ 
tKe distance tKe animals coYered. CoYering long distances appears 
to conIer moderate Eenefits in cancer incidence 3.8  tumor 
Yolume 4.1  and angiogenesis 4.3 ; tKe e̥ects Zere more 
pronounced Ior tumor multiplicit\ 8.0  and tumor ZeigKt 
8. . Additionall\ coYering sKort distances also significantl\ 
ḁected tumor multiplicit\ 89.0  tumor ZeigKt 3.1  and 
tumor Yolume 79.2 .
'uration
7Ke positiYe Eenefits Iound in tumor microenYironment marNers 
oI proliIeration and apoptosis Zere not moderated E\ tKe duration
oI exercise Eouts.
3erIorming exercise Ior 30–4 min Kas a small positiYe inÁuence
on tumor incidence 1.9  and multiplicit\ 27.  and a large 
positiYe inÁuence on tumor ZeigKt .3  and tumor Yolume 
9.0 . In addition sKort Eouts oI exercise conIer large Eenefits 
on tumor Yolume 98.7  and angiogenesis 80.7 . Surprisingl\ 
Eeing actiYe Ior more tKan 4 min appears to Ee unIaYoraEle in 
terms oI tumor incidence 17.8  tumor ZeigKt 37.1  and an-
giogenesis 7. .
FreTuenc\
Exercise perIormed ZeeNl\ is meaningIull\ correlated ZitK inci-
dence multiplicit\ tumor Yolume and angiogenesis. +oZeYer 
ZeeNl\ exercise does not moderate tKe exercise-tumor ZeigKt re-
lationsKip or an\ oI tKe otKer EiomarNers Iamilies tKat Zere stud-̂
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0.049
0.000
0.029
0.022
0.019
0.423
0.253
0.412
0.025
0.035
0.008
0.666
0.550
0.141
0.330
0.465
0.240
– 1.346
1.988
– 1.079
– 1.687
– 0.162
0.160
– 1.177
– 0.922
– 3.098
– 2.687
– 2.495
2.179
– 0.534
– 0.917
– 1.595
– 1.420
– 2.669
– 2.791
– 2.384
– 3.088
– 2.595
– 1.973
– 4.084
– 2.187
– 2.292
– 2.347
0.801
1.143
– 0.820
– 2.242
– 2.113
2.644
0.432
– 0.598
1.472
0.973
– 0.730
– 1.174
0.091
0.870
0.145
0.042
0.242
0.448
0.173
0.244
– 0.210
– 0.140
– 0.170
0.874
0.204
0.150
0.053
0.079
– 0.140
– 0.162
– 0.077
– 0.165
– 0.077
– 0.003
– 0.106
– 0.061
– 0.084
– 0.080
0.522
0.629
0.220
– 0.081
– 0.040
0.722
0.366
0.316
0.853
0.727
0.234
0.297
– 0.455
0.009
– 0.464
– 0.508
– 0.283
– 0.388
– 0.606
– 0.598
– 0.738
– 0.718
– 0.892
0.071
– 0.346
– 0.393
– 0.478
– 0.457
– 0.727
– 0.734
– 0.656
– 0.632
– 0.505
– 0.798
– 0.295
– 0.807
– 0.794
– 0.712
– 0.238
– 0.192
– 0.497
– 0.835
– 0.787
0.135
– 0.241
– 0.547
– 0.178
– 0.301
– 0.478
– 0.840
– 1.00 – 0.50 0.00 0.50 1.00
Statistics for each study Correlation and 95 % CI
Lower
limit
Upper
limit Z-Value p-ValueCorrelation
Study name Statistics for each study Correlation and 95 % CI
Lower
limit
Upper
limit Z-Value p-ValueCorrelation
Cohen, Kendall, Meschter et al, 1993 a
Zhu, Jiang, Thompson et al, 2012 b
Zhu, Jiang, Thompson et al, 2012 a
Zhu, Jiang, Thompson et al, 2008
Zhu, Jiang, Thompson et al, 2009
Thompson, Wolfe, Mctiernan et al, 2010 b
Thompson, Wolfe, Mctiernan et al, 2010 a
Steiner, Davis, Murphy et al, 2013
Murphy, Davis, Barrileaux et al, 2011
Mann, Jiang, Thompson et al, 2010 b
Mann, Jiang, Thompson et al, 2010 a
Malicka et al, 2015 c
Malicka et al, 2015 b
Malicka et al, 2015 a
Jiang, Zhu and Thompson, 2013
Jiang, Zhu and Thompson, 2009
Goh, Tsai, Bammier et al, 2013
Faustino-Rocha et al, 2016
Colbert, Westerlind, Hursting et al, 2009
Cohen, Kendall, Meschter et al, 1993 b
– 0.389
– 0.442
– 0.632
– 0.505
– 0.868
– 0.916
– 0.902
– 0.953
0.342
– 0.400
– 0.825
– 0.899
– 0.322
– 0.355
– 0.154
– 0.881
– 0.845
– 0.600
– 0.087
0.301
– 0.195
– 3.307
– 3.875
– 5.514
– 4.611
– 17.099
– 15.092
– 18.056
– 22.182
1.910
– 2.254
– 12.347
– 16.698
– 1.570
– 1.880
– 0.794
– 19.310
– 14.662
– 3.251
– 0.400
2.037
– 1.545
0.001
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.056
0.024
0.000
0.000
0.116
0.060
0.427
0.000
0.000
0.001
0.689
0.042
0.122
– 0.166
– 0.231
– 0.446
– 0.309
– 0.825
– 0.877
– 0.867
– 0.936
0.619
– 0.055
– 0.756
– 0.861
0.083
0.016
0.223
– 0.845
– 0.791
– 0.269
0.327
0.544
0.053
– 0.574
– 0.614
– 0.766
– 0.660
– 0.901
– 0.943
– 0.928
– 0.966
– 0.009
– 0.660
– 0.876
– 0.928
– 0.635
– 0.640
– 0.491
– 0.909
– 0.886
– 0.804
– 0.473
0.012
– 0.420
– 1.00 – 0.50 0.00 0.50 1.00
̂Fig. 2 a Forest plot oI tKe meta-anal\sis depicting tKe inÁuence oI exercise on tumor incidence. Correlation: e̥ect si]e r Ior eacK stud\. CI  con-
fidence interYal. a, b, c, d: di̥erent measures in di̥erent exercise protocols ZitKin tKe same stud\. b: Forest plot oI tKe meta-anal\sis depicting tKe 
inÁuence oI exercise on tumor multiplicit\. Correlation: e̥ect si]e r Ior eacK stud\. CI  confidence interYal. a, b: di̥erent measures in di̥erent 
exercise protocols ZitKin tKe same stud\.
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ied. 7umor incidence 2.8  multiplicit\ 84.7  and angiogen-
esis 4.3  Eenefit Irom KigKer IreTuencies oI exercise. +oZeYer 
exercising fiYe da\s per ZeeN appears to Ee su̦cient Ior conIerring 
Eenefits to tumor Yolume 72 .
AIter oEserYing Iunnel plots and considering Egger·s regression 
and Begg·s ranN correlation Ze Yerified tKe aEsence oI stud\ Eias 
in tumor incidence p  0.41712 multiplicit\ p  0.009 tumor 
ZeigKt p  0.01240 tumor Yolume p  0.14913 angiogenesis 
p  0.0000 and apoptosis p  0.2742. +oZeYer Eias Zas Iound 
in proliIeration p  0.00037.
'iscussion
7Ke impact oI exercise Zas oEserYed in tKe reduction oI tKe total 
numEer oI tumors in tKe actiYe animals 20.2 . :e also noted a 
reduction in tKe numEer oI tumors per animal 3.2  a decrease 
in tumor ZeigKt 3.  and a decrease in tumor Yolume 44.3 .
Study name
Aveseh et al, 2015
Zhu, Jiang, Thompson et al, 2012 b
Zhu, Jiang, Thompson et al, 2012 a
Zhu, Jiang, Thompson et al, 2008
Woods, Davis, Pate et al, 1994 a
Woods, Davis, Pate et al, 1994 b
Westerlind, McCarty, Strange et al, 2003 a
Westerlind, McCarty, Strange et al, 2003 d
Westerlind, McCarty, Strange et al, 2003 c
Westerlind, McCarty, Strange et al, 2003 b
Steiner, Davis Murphy et al, 2013
Jiang, Zhu and Thompson, 2013
Faustino-Rocha et al, 2016 b
Faustino-Rocha et al, 2016 a
– 0.233
– 0.345
– 0.366
– 0.378
– 0.834
– 0.078
– 0.053
– 0.254
– 0.763
– 0.271
– 0.705
– 0.404
– 0.581
0.135
0.543
– 0.585
– 0.540
– 0.557
– 0.566
– 0.876
– 0.318
– 0.302
– 0.463
– 0.827
– 0.519
– 0.782
– 0.658
– 0.679
– 0.282
0.210
0.192
– 0.113
– 0.139
– 0.152
– 0.781
0.170
0.204
– 0.019
– 0.679
0.019
– 0.607
– 0.067
– 0.462
0.509
0.763
– 1.078
– 2.870
– 3.083
– 3.193
– 15.179
– 0.615
– 0.397
– 2.113
– 11.227
– 1.835
– 9.962
– 2.322
– 7.967
0.625
3.019
0.281
0.004
0.002
– 1.00 – 0.50 0.00 0.50 1.00
0.001
0.000
0.539
0.691
0.035
0.000
0.066
0.000
0.020
0.000
0.532
0.003
c
d
Statistics for each study Correlation and 95 % CI
Lower
limit
Upper
limit Z-Value p-ValueCorrelation
Study name Statistics for each study Correlation and 95 % CI
Lower
limit
Upper
limit Z-Value p-ValueCorrelation
Aveseh et al, 2015
Westerlind, McCarty, Strange et al, 2003 b
Westerlind, McCarty, Strange et al, 2003 a
Welsch M., Cohen and Welsch C., 1995
Steiner, Davis, Murphy et al, 2013
Murphy, Davis Barrilleaux et al, 2011
Malicka et al, 2015 c
Malicka et al, 2015 b
Malicka et al, 2015 a
Isanejad et al, 2016
Goh Tsai, Bammier et al, 2013 b
Goh, Tsai, Bammier et al, 2013 a
Faustino-Rocha et al, 2016
Colbert, Westerlind, Hursting et al, 2009
Cohen, Choi and Wang, 1988
– 0.233
– 0.629
– 0.443
– 0.834
– 0.437
– 0.371
– 0.359
– 0.202
– 0.155
0.233
– 0.987
– 0.499
– 0.570
0.540
– 0.254
– 0.130
– 1.078
– 8.701
– 2.812
– 18.879
– 3.346
– 2.095
– 1.980
– 0.949
– 0.771
1.226
– 14.049
– 2.867
– 2.967
2.924
– 1.694
– 1.070
0.281
0.000
0.005
0.000
0.001
0.036
0.048
0.342
0.441
0.220
0.000
0.004
0.003
0.003
0.090
0.284
0.192
– 0.518
– 0.143
– 0.792
– 0.192
– 0.025
– 0.004
0.215
0.237
0.549
– 0.974
– 0.172
– 0.216
0.765
0.041
0.109
– 0.585
– 0.719
– 0.668
– 0.868
– 0.631
– 0.637
– 0.634
– 0.557
– 0.504
– 0.141
– 0.994
– 0.727
– 0.791
0.197
– 0.509
– 0.355
– 1.00 – 0.50 0.00 0.50 1.00
̂Fig. 2 Continued. c: Forest plot oI tKe meta-anal\sis depicting tKe inÁuence oI exercise on tumor ZeigKt. Correlation: e̥ect si]e r Ior eacK 
stud\. CI  confidence interYal. a, b, c, d: di̥erent measures in di̥erent exercise protocols ZitKin tKe same stud\. d: Forest plot oI tKe meta-anal\sis 
depicting tKe inÁuence oI exercise on tumor Yolume. Correlation: e̥ect si]e r Ior eacK stud\. CI  confidence interYal. a, b: di̥erent measures in 
di̥erent exercise protocols ZitKin tKe same stud\.
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Study name
a
b
c
Isanejad et al, 2016
Jiang, Zhu and Thompson, 2009 a
Zhu, Jiang, Thompson et al, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2013
Jiang, Zhu and Thompson, 2013
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Apaf-1
CASP 3
XIAP
BAX
BCL-2
BCL-2
BAX
Apaf-1
BAX
BCL-2
CASP 3
XIAP
0.000
0.000
0.000
0.000
0.001
0.000
0.000
0.000
0.000
0.140
0.000
0.000
0.041
– 4.589
– 7.423
– 8.677
– 8.895
– 3.471
– 3.726
– 7.270
– 6.144
– 3.582
– 1.477
– 4.316
– 9.030
– 2.046
– 0.529
– 0.663
– 0.872
– 0.753
– 0.244
– 0.690
– 0.797
– 0.710
– 0.362
0.124
– 0.438
– 0.836
– 0.022
– 0.899
– 0.879
– 0.972
– 0.911
– 0.713
– 0.872
– 0.958
– 0.937
– 0.861
– 0.710
– 0.890
– 0.975
– 0.765
– 0.773
– 0.795
– 0.939
– 0.850
– 0.516
– 0.798
– 0.904
– 0.862
– 0.685
– 0.384
– 0.752
– 0.946
– 0.474
Jiang, Zhu and Thompson, 2009 a
Jiang, Zhu and Thompson, 2009 b
Jiang, Zhu and Thompson, 2009 c
Jiang, Zhu and Thompson, 2013
Jiang, Zhu and Thompson, 2013
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
ki67
CYCLIN D1
E2F-1
p27kip1
p27kip1
CYCLIN D1
p27
CYCLIN D1
p27kip1
E2F-1
– 6.608
– 6.472
– 2.466
– 2.013
– 2.838
– 13.780
– 10.010
– 4.783
– 1.620
– 7.132
– 6.603
0.000
0.000
0.014
0.044
0.005
0.000
0.000
0.000
0.105
0.000
– 1.00 – 0.50 0.00 0.50 1.00
– 1.00 – 0.50 0.00 0.50 1.00
– 1.00 – 0.50 0.00 0.50 1.00
0.000
– 0.726
– 0.738
– 0.124
– 0.013
– 0.209
– 0.914
– 0.805
– 0.556
– 0.087
– 0.655
– 0.749
– 0.935
– 0.944
– 0.798
– 0.762
– 0.822
– 0.968
– 0.929
– 0.905
– 0.725
– 0.881
– 0.946
– 0.864
– 0.876
– 0.543
– 0.468
– 0.596
– 0.948
– 0.882
– 0.787
– 0.393
– 0.794
– 0.881
Biomarkers Statistics for each study
Lower
limitCorrelation p-ValueZ-Value
Upper
limit
Study name Biomarkers Statistics for each study Correlation and 95 % CI
Correlation and 95 % CI
Lower
limitCorrelation p-ValueZ-Value
Upper
limit
Study name Biomarkers Statistics for each study Correlation and 95 % CI
Lower
limitCorrelation p-ValueZ-Value
Upper
limit
Faustino-Rocha et al, 2016 a
Faustino-Rocha et al, 2016 b
Isanejad et al, 2016 a
Isanejad et al, 2016 b
Zhu, Jiang, Thompson et al, 2009
Jones, Viglianti, Tashjian et al, 2010
Jones, Viglianti, Tashjian et al, 2010
Jones, Viglianti, Tashjian et al, 2010
PER VESS
VEGF
VEGF
CD31
VEGF
VEGF
PER VESS
CD31
0.833
0.616
– 0.703
– 0.867
– 0.850
– 0.258
0.041
– 0.477
– 0.102
0.913
0.802
– 0.420
– 0.732
– 0.684
0.392
0.455
– 0.096
0.333
0.000
0.000
0.000
0.000
0.000
0.448
0.858
0.016
– 0.654
6.793
3.657
– 4.025
– 6.686
– 5.877
– 0.759
0.179
– 2.406
– 0.448
0.692
0.322
– 0.861
– 0.936
– 0.932
– 0.734
– 0.387
– 0.737
– 0.501
̂Fig. 3 a: Forest plot oI tKe meta-anal\sis depicting tKe inÁuence oI exercise on EiomarNers oI proliIeration. Correlation: e̥ect si]e r Ior eacK 
stud\ in proliIeration. CI  confidence interYal. a, b, c: di̥erent measures ZitKin tKe same stud\. Abbreviations: E2F-1 transcription Iactor; p27 and 
p27Nip1 c\clin Ninases inKiEitors Iamil\ memEers and .i7. b: Forest plot oI tKe meta-anal\sis depicting tKe inÁuence oI exercise on EiomarNers oI 
apoptosis. Correlation: e̥ect si]e r Ior eacK stud\ in. CI  confidence interYal. Abbreviations: ApaI-1 apoptotic peptidase actiYating Iactor-1; BA; 
BC/-2-associated ; protein; CAS3 3 caspase 3; ;IA3 ;-linNed inKiEitor oI apoptosis. c: Forest plot oI tKe meta-anal\sis depicting tKe inÁuence oI 
exercise on EiomarNers oI angiogenesis. Correlation: e̥ect si]e r Ior eacK stud\ in. CI  confidence interYal. Abbreviations: C'31 cluster; 3E5 9ESS 
numEer oI perIused Yessels; 9E*F Yascular endotKelial groZtK Iactor.
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In contrast to some preclinical researcK linNing an increased 
tumor Eurden to exercise >7 9 14 21 4 0  73@ tKese data 
proYide a step IorZard E\ TuantiI\ing tKe Eenefits KigKligKted in 
tKe maMorit\ oI preYious preclinical data >2 7–9 14 23 31 33 34 
42 4 47 1 3 0 7–70 72 73 7–77@. 7umor incidence Zas 
tKe onl\ YariaEle associated ZitK small Eenefits ZKicK can Ee part-
ly related to the breast cancer models used. The negative results 
Iound in tKis YariaEle Zere reported in IiYe studies >9 21 4 
 73@. EacK oI tKem used a di̥erent tumor model tKat ma\ KaYe 
resulted in di̥erences in tumor pKenot\pes and conseTuentl\ in 
di̥erent EeKaYiors ZKen exposed to exercise >22 27 37@. +oZeY-
er no data Zere aYailaEle regarding tKe di̥erent Kistological t\pes 
oI tKe deYeloped tumors and so Ze cannot NnoZ Ior sure ZKetKer
tKis could Ee tKe case. <et tKree oI tKe fiYe studies tKat KaYe re-
ported negatiYe results in tumor incidence also reported a Eenefi-
cial e̥ect oI exercise in tumor Eurden namel\ in tumor ZeigKt
>73@ and in tumor Yolume >9 4@. Additionall\ tKe cKaracteristics
oI exercise protocols and tKe total duration oI tKe experiments can
also Ee a Iactor tKat migKt explain tKis negatiYe data. Indeed tKe
negatiYe data reported Ior tumor incidence in one oI tKe experi-
ments onl\ occurred in animals tKat Zere exposed to exercise oI
loZ intensit\ >4@. 1eYertKeless seYeral reports KaYe noted a re-
duction oI malignant and inYasiYe t\pes oI tumor in actiYe rodents
compared ZitK sedentar\ ones >14 1@. Our results confirm tKe
eYidence oI a strong association EetZeen exercise and cancer out-
comes in Kuman patients >3 29 9 1@.
Exercise improYed tKe deregulation oI tumor proliIeration 
79.4  and apoptosis 79.8 . FurtKermore tKere is some eYi-
dence alEeit inconsistent Ior positiYe e̥ects in tumor angiogen-
esis 2.  ZKicK is consistent ZitK some preYious researcK >33 
34 49 3 4 4  71 7 77@. 1eYertKeless onl\ a IeZ preclin-
ical studies KaYe examined cKanges in tumor Eiolog\ regarding 
proliIeration >33 34 7@ angiogenesis >1 31 39 7@ and apop-
tosis >33 34 7@. MoreoYer experimental protocols ZitK Yoluntar\ 
exercise Zere tKe most oIten used; considering tKe intermittent 
Ieatures oI Yoluntar\ exercise in animals tKis situation is a clear 
limitation to speculating aEout similar results in a clinical context.
It is clear tKat increased proliIeration is a KallmarN oI malignant 
tumors and a Ne\ Ieature oI tumor progression tKat is associated 
ZitK a KigKer risN oI recurrence and a sKorter surYiYal duration >2@. 
Additionall\ suppression oI apoptosis is EelieYed to pla\ a central 
role in tKe deYelopment and progression oI Ereast cancer 
> 12 13@. 7Ke present data strongl\ support tKe recommenda-
tion Ior exercise in order to modulate tKe proliIeratiYe and tKe ap-
optotic rate in a tumor enYironment.
7Ke present results do not alloZ us to confirm a consistent rela-
tion EetZeen exercise and angiogenesis. +oZeYer in spite oI tKe 
undouEtedl\ important role tKat angiogenesis pla\s in tKe groZtK 
progression and metastasis oI a tumor >4 4@ recent researcK Kas 
sKoZn tKat tKe process oI tumor angiogenesis is Iar Irom clearl\ 
understood >32@. In Iact it seems tKat tKe antiangiogenic tKerap\ 
more tKan reduced tumor Yessels normali]ed tumor Yasculature 
reducing tumor Yessel permeaEilit\ and as a result ma\ improYe 
cKemotKerapeutic deliYer\ ZindoZ oI opportunit\ >44@. Could 
exercise create a ZindoZ oI opportunit\ Ior estaElisKing optimal 
conditions Ior cKemical tKerap\" 7Kis migKt explain some oI tKe 
results in the studies used in this review in which the active animals 
sKoZed KigK leYels oI 9E*F Yascular endotKelial groZtK Iactor ex-
pression Eut at tKe same time deYeloped tumors Kistologicall\ 
less aggressiYe >1@.
AnotKer finding oI tKis reYieZ is tKat tKe diYersit\ oI exercise 
protocols used in tKe selected studies migKt Ee an oEstacle to cre-
ating an accurate definition oI tKe t\pe and amount oI exercise nec-
essary to induce better tumor outcomes.
9oluntar\ exercise appears to exert more inÁuence on tKe inci-
dence multiplicit\ and ZeigKt oI tumors tKan Iorced exercise. 
+oZeYer Iorced exercise exKiEited Eetter tumor Yolume results. 
FaYoraEle inÁuences Zere also confirmed in multiplicit\ and tumor 
ZeigKt under Iorced-exercise conditions. 1eYertKeless it is ZortK 
noting tKat eYen tKougK Yoluntar\ exercise more strongl\ inÁu-
enced tumor outcomes tKis situation persisted in motori]ed-ZKeel 
exercise ZKicK appears to Ee an argument in IaYor oI protocols 
tKat can manipulate exercise intensit\. Forced exercise also proYed 
to Ee e̥ectiYe at inKiEiting tumors >3 7 8 72@ and it ma\ Ee 
ZortKZKile to gatKering inIormation aEout exercise prescriptions 
in a clinical context.
Moderate- or Yigorous-intensit\ exercise IaYoraEl\ ḁected all 
tKe YariaEles tKat Ze considered. For tumor Yolume angiogenesis 
and proliIeration tKe Eenefits Zere eYen more pronounced Ior loZ-
intensit\ exercise. Similar results can Ee Iound in tKe preYiousl\ 
puElisKed literature: a reduction in cancer recurrence and surYiYal 
are associated ZitK moderate and Yigorous exercise. +oZeYer in 
general tKe results oI tKe maMorit\ oI tKe studies mostl\ meta-
anal\ses Iailed to present signiIicant results aEout tKe ideal 
amount oI exercise i. e. intensit\ duration and IreTuenc\ to 
acKieYe Eenefits. 7Ke Yast maMorit\ oI cases used studies tKat poor-
l\ reported tKe amount oI exercise perIormed or onl\ reported leY-
els oI pK\sical actiYit\ estimated E\ selI-response >17 19 2 29 
48 9@.
Interestingl\ in tKis stud\ Ze Iound Eenefits associated ZitK 
loZ-intensit\ exercise a leYel oI intensit\ tKat is not usuall\ asso-
ciated ZitK large e̥ects and is tKereIore not usuall\ recommend-
ed in international guidelines >41@. Again tKis ma\ Ee due to tKe 
small number of studies that evaluated the microenvironment of 
tKe tumor. 1eYertKeless intensit\ appears to Ee a determining Iac-
tor in modulating tumor outcomes >8 9 4 7 8 73 77@. 7Kere 
sKould accordingl\ Ee a preIerence Ior stud\ designs in ZKicK tKe 
intensit\ can Ee controlled. SucK studies are most liNel\ to \ield im-
portant inIormation tKat adYances tKis field oI researcK >1@.
In contrast to some preclinical results >23 70@ tKe distances 
coYered during exercise do not appear to ḁect tumor outcomes. 
In Iact Eased on tKe present results it appears tKat intensit\ in-
stead oI distance ma\ KaYe more oI an inÁuence on tumor out-
comes.
7umor Eurden accrues more EeneIits ZKen exercise is per-
Iormed Ior 30–4 min. Onl\ tumor Yolume and angiogenesis >31@ 
Eenefitted Irom sKort periods oI exercise. 8nexpectedl\ Eouts oI 
exercise longer tKan 4 min adYersel\ impacted tumor incidence 
tumor ZeigKt and angiogenesis >14 1 73@.
+igKer exercise IreTuencies  or 7 da\s per ZeeN are correlat-
ed ZitK Eetter tumor outcomes in incidence multiplicit\ and an-
giogenesis; Ior tumor Yolume running  da\s per ZeeN is preIerred 
>7–9 23 33 34 39 47 1 3 0 9 70 73 7–77@.
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Curiousl\ tKe Eenefits KigKligKted E\ tKese TuantitatiYe proliI-
eration and apoptosis data do not appear to Ee inÁuenced E\ an\ 
oI tKe moderating YariaEles ZitK tKe exception oI intensit\. 7Kis
finding ma\ Ee related to tKe limited numEer oI studies tKat used
Iorced exercise protocols to examine tKe tumor microenYironment 
>14 1 31@. +oZeYer a Ne\ Tuestion still remains: does onl\ inten-
sit\ matter"
7Ke present results KigKligKt tKe importance oI neZ researcK 
tKat maNes use oI mecKanisms to assess tKe intensit\ IreTuenc\ 
and duration oI perIormed exercise. It Zill tKen Ee possiEle to test 
tKe amount oI exercise necessar\ to improYe eitKer tumor out-
comes or an aggressive intratumoral environment.
*iYen tKe diYersit\ oI exercise protocols used in tKe studies in-
cluded in tKis reYieZ accompanied E\ tKe Iact tKat onl\ a minorit\ 
oI studies clearl\ defined tKe exercise model in Kumans tKat tKe\
ZisKed to reproduce it is impossiEle to extrapolate specific and ac-
curate recommendations to a clinical context.
In general additional researcK is necessar\ tKat taNes into ac-
count a metKodological approacK mimicNing tKe exercises tKat can 
Ee perIormed E\ Kumans ZitK Ereast cancer. 8nderstanding tKe 
e̥ects oI specific intensit\ duration and IreTuenc\ exercise pre-
scriptions on pK\siological outcomes across di̥erent stages oI can-
cer Zill alloZ researcKers to personali]e exercise prescriptions.
Study limitations
7Kere are seYeral limitations to tKis stud\. First tKere Zas signifi-
cant Keterogeneit\ among tKe studies tKat Ze attempted to meas-
ure perIorming a sensitiYit\ anal\sis and anal\]ing exercise-related 
moderators. FurtKermore puElication Eias Zas Iound in one oI tKe 
YariaEles studied i. e. proliIeration. +oZeYer aIter perIorming 
tKe sensitiYit\ anal\sis Ze Yerified tKat tKe oYerall e̥ect Kad a small 
Yariation 3.3  Ys. 2.  in tKis YariaEle.
Finall\ studies puElisKed in languages otKer tKan EnglisK Zere 
not considered. AltKougK tKe exclusion oI non-EnglisK-language 
studies migKt KaYe resulted in smaller interYention e̥ects tKe lan-
guage Eias is generall\ small >40@.
Conclusions
7o tKe Eest oI our NnoZledge tKis meta-anal\sis is tKe first attempt 
to TuantiI\ tKe results oI preclinical researcK addressing tKe exer-
cise-Ereast cancer relationsKip. Our primar\ findings Zere: 1 tKere 
is conYincing eYidence Irom tKe preclinical data tKat exercise is as-
sociated ZitK tumor Eurden reduction; 2 tKere is eYidence sug-
gesting tKat exercise ma\ result in Eeneficial cKanges in tKe leYels 
oI proliIeration and apoptotic EiomarNers in tKe tumoral microen-
Yironment; and 3 tKere is insu̦cient eYidence regarding tKe as-
sociation EetZeen exercise and a positiYe modulation oI tKe angi-
ogenic events in the tumoral environment.
Finall\ tKere is eYidence tKat tKe intensit\ duration and Ire-
Tuenc\ oI exercise are important determinants oI tumor outcomes. 
1eYertKeless uniIorm preclinical exercise designs are necessar\ to 
Iacilitate comparisons oI results Irom di̥erent studies and define 
tKe amounts oI exercise reTuired to alter carcinogenesis.
Future researcK directions include tKe need Ior more preclinical 
studies particularl\ in tumor Eiolog\ and Ior exercise conditions tKat 
maNe it possiEle to manipulate tKe amount oI exercise perIormed.
AcNnoZledgements
7Kis stud\ Zas Iunded E\ CIAFE/ – 5esearcK Center in 3K\sical 
 ActiYit\ +ealtK and /eisure Facult\ oI Sport 8niYersit\ oI 3orto 
3orto 3ortugal.
ConIlict oI Interest
7Ke autKors declare tKat tKe\ KaYe no conÁict oI interest.
5eIerences
>1@ AsKcraIt .A 3eace 5M BetoI AS 'eZKirst M: Jones /:. E̦cac\ and 
mecKanisms oI aeroEic exercise on cancer initiation progression and 
metastasis: A critical s\stematic reYieZ oI in YiYo preclinical data. 
Cancer 5es 201; 7: 4032–400
>2@ AYeseK M 1iNooie 5 Aminaie M. Exercise-induced cKanges in tumour 
/'+-B and MC71 expression are modulated E\ oestrogen-related 
receptor alpKa in Ereast cancer-Eearing BA/Bc mice. J 3K\siol 201; 
93: 23–248
>3@ Ballard-BarEasK 5 FriedenreicK CM Courne\a .S SiddiTi SM 
Mc7iernan A AlIano CM. 3K\sical actiYit\ EiomarNers and disease 
outcomes in cancer surYiYors: A s\stematic reYieZ. J 1atl Cancer Inst 
2012; 104: 81–840
>4@ BetoI AS 'eZKirst M: Jones /:. E̥ects and potential mecKanisms oI 
exercise training on cancer progression: A translational perspectiYe. 
Brain BeKaY Immun 2013; 30 Suppl: S7–S87
>@ BucKKol] 7A 'aYis ': McConNe\ 'J S\mmans :F 9alero 9 JKingran 
A 7ucNer S/ 3us]tai / CristoIanilli M EsteYa FJ +ortoEag\i *1 SaKin 
AA. CKemotKerap\-induced apoptosis and Bcl-2 leYels correlate ZitK 
Ereast cancer response to cKemotKerap\. Cancer J 2003; 9: 33–41
>@ CoKen J. Statistical poZer anal\sis Ior tKe EeKaYioral sciences. 1eZ 
<orN: /. ErlEaum Associates; 1988: 400
>7@ CoKen /A CKoi .: :ang C;. InÁuence oI dietar\ Iat caloric 
restriction and Yoluntar\ exercise on 1-nitrosometK\lurea-induced 
mammar\ tumorigenesis in rats. Cancer 5es 1988; 48: 427–4283
>8@ CoKen /A .endall ME MescKter C Epstein MA 5einKardt J =ang E. 
InKiEition oI rat mammar\ tumorigenesis E\ Yoluntar\ exercise. In 
9iYo 1993; 7: 11–18
>9@ ColEert /+ :esterlind .C 3erNins S1 +aines 'C Berrigan ' 
'oneKoZer /A FucKs-<oung 5 +ursting S'. Exercise e̥ects on 
tumorigenesis in a p3-deficient mouse model oI Ereast cancer. Med 
Sci Sports Exerc 2009; 41: 197–10
>10@ Courne\a .S Segal 5J Mc.en]ie 'C 'ong + *elmon . FriedenreicK 
CM <asui < 5eid 5' CraZIord JJ MacNe\ J5. E̥ects oI exercise during 
adMuYant cKemotKerap\ on Ereast cancer outcomes. Med Sci Sports 
Exerc 2014; 4: 1744–171
>11@ Courne\a .S 7amEurrini A/ :oolcott C* Mc1eel\ M/ .arYinen .+ 
CampEell ./ Mc7iernan A FriedenreicK CM. 7Ke alEerta pK\sical 
actiYit\ and Ereast cancer preYention trial: 4ualit\ oI liIe outcomes. 
3reY Med 2011; 2: 2–32
>12@ 'aYis ': BucKKol] 7A +ess .5 SaKin AA 9alero 9 McConNe\ 'J. 
Automated Tuantification oI apoptosis aIter neoadMuYant cKemotKera-
p\ Ior Ereast cancer: Earl\ assessment predicts clinical response. Clin 
Cancer 5es 2003; 9: 9–90
>13@ Elmore S. Apoptosis: A reYieZ oI programmed cell deatK. 7oxicol 
3atKol 2007; 3: 49–1
>14@ Faustino-5ocKa AI *ama A OliYeira 3A AlYarado A 1eupartK MJ 
Ferreira 5 *inMa M. E̥ects oI liIelong exercise training on mammar\ 
tumorigenesis induced E\ M18 in Iemale Sprague-'aZle\ rats. Clin 
Exp Med 201; 17: 11–10
340
68
Figueira ACC et al. Exercise-induced Benefits in Breast Cancer Outcomes in Animals. Int J Sports Med 2018; 39: 327–342
>1@ Faustino-5ocKa AI SilYa A *aEriel J *il da Costa 5M MoutinKo M 
OliYeira 3A *ama A Ferreira 5 *inMa M. /ong-term exercise training 
as a modulator oI mammar\ cancer Yasculari]ation. Biomed 
3KarmacotKer 201; 81: 273–280
>1@ Ferla\ J SoerMomataram I 'iNsKit 5 Eser S MatKers C 5eEelo M 
3arNin 'M Forman ' Bra\ F. Cancer incidence and mortalit\ 
ZorldZide: Sources metKods and maMor patterns in */OBOCA1 2012. 
Int J Cancer 201; 13: E39–E38
>17@ Fong '< +o J: +ui B3 /ee AM MacIarlane 'J /eung SS Cerin E 
CKan :< /eung I3 /am S+ 7a\lor AJ CKeng ... 3K\sical actiYit\ Ior 
cancer surYiYors: Meta-anal\sis oI randomised controlled trials. BMJ 
2012; 344: e70
>18@ FriedenreicK CM. 7Ke role oI pK\sical actiYit\ in Ereast cancer etiolog\. 
Semin Oncol 2010; 37: 297–302
>19@ FriedenreicK CM Cust AE. 3K\sical actiYit\ and Ereast cancer risN: 
Impact oI timing t\pe and dose oI actiYit\ and population suEgroup 
e̥ects. Br J Sports Med 2008; 42: 3–47
>20@ FriedenreicK CM 1eilson +. /\ncK BM. State oI tKe epidemiological 
eYidence on pK\sical actiYit\ and cancer preYention. Eur J Cancer 
2010; 4: 293–204
>21@ *illette CA =Ku = :esterlind .C MelE\ C/ :olIe 3 7Kompson +J. 
Energ\ aYailaEilit\ and mammar\ carcinogenesis: E̥ects oI calorie 
restriction and exercise. Carcinogenesis 1997; 18: 1183–1188
>22@ *lass O. BoZie M Fuller J 'arr ' 8sar\ J Boss . CKoudKur\ .5 /iu 
; =Kang = /ocasale J: :illiams C 'eZKirst M: Jones /: SeeZaldt 
9. 'i̥erential response to exercise in claudin-loZ Ereast cancer. 
Oncotarget 2017; 8: 100989–101004
>23@ *oK J 7sai J Bammler 7. Farin FM Endicott E /adiges :C. Exercise 
training in transgenic mice is associated with attenuation of early 
Ereast cancer groZtK in a dose-dependent manner. 3/oS One 2013; 8: 
e80123
>24@ +arriss 'J MacsZeen A AtNinson *. Standards Ior etKics in sport and 
exercise science researcK: 2018 8pdate. Int J Sports Med 2017; 3814: 
112–1131
>2@ +iggins J3 Altman '* *ot]scKe 3C Juni 3 MoKer ' Oxman A' 
SaYoYic J ScKul] .F :eeNs / Sterne JA. CocKrane Bias MetKods * 
CocKrane Statistical MetKods *. 7Ke cocKrane collaEoration·s tool Ior 
assessing risN oI Eias in randomised trials. BMJ 2011; 343: d928
>2@ +olicN C1 1eZcomE 3A 7rentKam-'iet] A 7itus-Ernsto̥ / BerscK AJ 
StampIer MJ Baron JA Egan .M :illett :C. 3K\sical actiYit\ and 
surYiYal aIter diagnosis oI inYasiYe Ereast cancer. Cancer Epidemiol 
BiomarNers 3reY 2008; 17: 379–38
>27@ +olmes M' CKen :< FesNanicK ' .roenNe C+ Coldit] *A. 3K\sical 
actiYit\ and surYiYal aIter Ereast cancer diagnosis. JAMA 200; 293: 
2479–248
>28@ +ooiMmans C5 5oYers MM de 9ries 5B /eenaars M 5itsNes-+oitinga 
M /angendam M:. S<5C/E
s risN oI Eias tool Ior animal studies. BMC 
Med 5es MetKodol 2014; 14: 43
>29@ IEraKim EM Al-+omaidK A. 3K\sical actiYit\ and surYiYal aIter Ereast 
cancer diagnosis: Meta-anal\sis oI puElisKed studies. Med Oncol 2011; 
28: 73–7
>30@ IrZin M/ SmitK A: Mc7iernan A Ballard-BarEasK 5 Cronin . 
*illiland F' Baumgartner 51 Baumgartner .B Bernstein /. InÁuence 
oI pre- and postdiagnosis pK\sical actiYit\ on mortalit\ in Ereast 
cancer surYiYors: 7Ke KealtK eating actiYit\ and liIest\le stud\. J Clin 
Oncol 2008; 2: 398–394
>31@ IsaneMad A Ali]adeK AM Amani SKalam]ari S .Koda\ari + .Koda\ari 
S .Kori 9 .KoMasteKnMad 1. Micro51A-20 let-7a and micro51A-21 
patKZa\s inYolYed in tKe anti-angiogenesis e̥ects oI tKe interYal 
exercise training and Kormone tKerap\ in Ereast cancer. /iIe Sci 201; 
11: 30–40
>32@ Ja\son *C +icNlin 'J Ellis /M. Antiangiogenic tKerap\--eYolYing YieZ 
Eased on clinical trial results. 1at 5eY Clin Oncol 2012; 9: 297–303
>33@ Jiang : =Ku = 7Kompson +J. E̥ects oI limiting energ\ aYailaEilit\ Yia 
diet and pK\sical actiYit\ on mammalian target oI rapam\cin-related 
signaling in rat mammar\ carcinomas. Carcinogenesis 2013; 34: 
378–387
>34@ Jiang : =Ku = 7Kompson +J. E̥ects oI pK\sical actiYit\ and restricted 
energ\ intaNe on cKemicall\ induced mammar\ carcinogenesis. 
Cancer 3reY 5es 2009; 2: 338–344
>3@ Jones /: AlIano CM. Exercise-oncolog\ researcK: past present and 
Iuture. Acta Oncol 2013; 2: 19–21
>3@ Jones /: EYes 1' Courne\a .S CKiu B. Baracos 9E +anson J 
JoKnson / MacNe\ J5. E̥ects oI exercise training on antitumor e̦cac\ 
oI doxoruEicin in M'A-MB-231 Ereast cancer xenograIts. Clin Cancer 
5es 200; 11: 9–98
>37@ Jones /: .Zan M/ :elt]ien E CKandarlapat\ S SternIeld B SZeene\ 
C Bernard 3S Castillo A +aEel /A .roenNe C+ /angKol] BM 
4ueensEerr\ C3 Jr. 'ang C :eigelt B .usKi /+ Caan BJ. Exercise and 
prognosis on tKe Easis oI clinicopatKologic and molecular Ieatures in 
earl\-stage Ereast cancer: 7Ke /ACE and patKZa\s studies. Cancer 5es 
201; 7: 41–422
>38@ Jones /: 3eppercom J Scott JM Battaglini C. Exercise tKerap\ in tKe 
management oI solid tumors. Curr 7reat Options Oncol 2010; 11: 
4–8
>39@ Jones /: 9iglianti B/ 7asKMian JA .otKadia SM .eir S7 Freedland SJ 
3otter M4 Moon EJ ScKroeder 7 +erndon JE 'eZKirst M:. E̥ect oI
aeroEic exercise on tumor pK\siolog\ in an animal model oI Kuman 
Ereast cancer. J Appl 3K\siol 2010; 108: 343–348
>40@ Juni 3 +olenstein F Sterne J Bartlett C Egger M. 'irection and impact 
oI language Eias in meta-anal\ses oI controlled trials: Empirical stud\. 
Int J Epidemiol 2002; 31: 11–123
>41@ .usKi /+ 'o\le C McCullougK M 5ocN C/ 'emarN-:aKneIried : 
Bandera E9 *apstur S 3atel A9 AndreZs . *ansler 7.7Ke American 
Cancer Societ\ 1 3K\sical ActiYit\ *uidelines AdYisor\ C. American 
Cancer Societ\ guidelines on nutrition and pK\sical actiYit\ Ior cancer 
preYention. CA Cancer J Clin 2012; 2: 30–7
>42@ /ane +: 7eer 3 .eitK 5E :Kite M7 StraKan S. 5educed energ\ intaNe 
and moderate exercise reduce mammar\ tumor incidence in Yirgin 
Iemale BA/Bc mice treated ZitK 712-dimetK\lEen]aantKracene.  
J 1utr 1991; 121: 1883–1888
>43@ /\ncK BM 1eilson +. FriedenreicK CM. 3K\sical actiYit\ and Ereast 
cancer preYention. 5ecent 5esults Cancer 5es 2011; 18: 13–42
>44@ MaM E 3apierniN ' :ietr]\N J. Antiangiogenic cancer treatment: 7Ke 
great discoYer\ and greater complexit\ 5eYieZ. Int J Oncol 201; 49: 
1773–1784
>4@ MaNrilia 1 /appa 7 ;\la 9 1iNolaidis I S\rigos .. 7Ke role oI 
angiogenesis in solid tumours: an oYerYieZ. Eur J Intern Med 2009; 20: 
3–71
>4@ MalicNa I SieZiersNa . 3ula B .oEier]\cNi C +aus ' 3aslaZsNa 8 
CegielsNi M ']iegiel 3 3odKorsNa-ONoloZ M :o]nieZsNi M. 7Ke 
e̥ect oI pK\sical training on tKe 1-metK\l-1-nitrosourea-induced 
mammar\ carcinogenesis oI Sprague-'aZle\ rats. Exp Biol Med 201; 
240: 1408–141
>47@ Mann 3B Jiang : =Ku = :olIe 3 Mc7iernan A 7Kompson +J. :Keel 
running sNeletal muscle aeroEic capacit\ and 1-metK\l-1-nitrosourea 
induced mammar\ carcinogenesis in tKe rat. Carcinogenesis 2010; 31: 
1279–1283
>48@ Mc1eel\ M/ CampEell ./ 5oZe B+ .lassen 73 MacNe\ J5 Courne\a 
.S. E̥ects oI exercise on Ereast cancer patients and surYiYors:  
A s\stematic reYieZ and meta-anal\sis. CMAJ 200; 17: 34–41
>49@ Mc7iernan A. MecKanisms linNing pK\sical actiYit\ ZitK cancer. 1at 
5eY Cancer 2008; 8: 20–211
>0@ MoKer ' /iEerati A 7et]lḁ J Altman '*.*roup 3. 3reIerred 
reporting items Ior s\stematic reYieZs and meta-anal\ses: 7Ke 35ISMA 
statement. BMJ 2009; 339: E23
341
69
Figueira ACC et al. Exercise-induced Benefits in Breast Cancer Outcomes in Animals. Int J Sports Med 2018; 39: 327–342
Review Thieme
>1@ Moore C 7ittle 3:. Muscle actiYit\ Eod\ Iat and induced rat 
mammar\ tumors. Surger\ 1973; 73: 329–332
>2@ Moore SC /ee IM :eiderpass E CampEell 37 Sampson J1 .itaKara 
CM .eadle S. Arem + Berrington de *on]ale] A +artge 3 Adami 
+O Blair C. BorcK .B Bo\d E CKecN '3 Fournier A Freedman 1' 
*unter M JoKannson M .KaZ .7 /inet MS Orsini 1 3arN < 5iEoli E 
5oEien . ScKairer C Sesso + Spriggs M 9an 'usen 5 :olN A 
MattKeZs CE 3atel A9. Association oI leisure-time pK\sical actiYit\ 
ZitK risN oI 2 t\pes oI cancer in 1.44 million adults. JAMA Intern Med 
201; 17: 81–82
>3@ MurpK\ EA 'aYis JM Barrilleaux 7/ McClellan J/ Steiner J/ Carmi-
cKael M' 3ena MM +eEert J5 *reen JE. Benefits oI exercise training 
on Ereast cancer progression and inÁammation in C31S9407ag mice. 
C\toNine 2011; : 274–279
>4@ 5ogers CJ ColEert /+ *reiner J: 3erNins S1 +ursting S'. 3K\sical 
actiYit\ and cancer preYention: patKZa\s and targets Ior interYention. 
Sports Med 2008; 38: 271–29
>@ 5osentKal 5. Meta-anal\tic procedures Ior social researcK. CaliIornia: 
SA*E 3uElications; 1991: 1
>@ ScKmit] .+. Exercise Ior secondar\ preYention oI Ereast cancer: 
moYing Irom eYidence to cKanging clinical practice. Cancer 3reY 5es 
2011; 4: 47–480
>7@ ScKmit] .+ Courne\a .S MattKeZs C 'emarN-:aKneIried : *alYao 
'A 3into BM IrZin M/ :olin .< Segal 5J /ucia A ScKneider CM Yon 
*ruenigen 9E ScKZart] A/.American College oI Sports M. American 
College oI Sports Medicine roundtaEle on exercise guidelines Ior 
cancer surYiYors. Med Sci Sports Exerc 2010; 42: 1409–142
>8@ ScKmit] .+ +olt]man J Courne\a .S Masse /C 'uYal S .ane 5. 
Controlled pK\sical actiYit\ trials in cancer surYiYors: A s\stematic 
reYieZ and meta-anal\sis. Cancer Epidemiol BiomarNers 3reY 200; 14: 
188–19
>9@ SpecN 5M Courne\a .S Masse /C 'uYal S ScKmit] .+. An update oI 
controlled pK\sical actiYit\ trials in cancer surYiYors: A s\stematic 
reYieZ and meta-anal\sis. J Cancer SurYiY 2010; 4: 87–100
>0@ Steiner J/ 'aYis JM McClellan J/ Enos 57 MurpK\ EA. E̥ects oI 
Yoluntar\ exercise on tumorigenesis in tKe C31S9407ag transgenic 
mouse model oI Ereast cancer. Int J Oncol 2013; 42: 14–1472
>1@ Strasser B SteindorI . :isNemann J 8lricK CM. Impact oI resistance 
training in cancer surYiYors: A meta-anal\sis. Med Sci Sports Exerc 
2013; 4: 2080–2090
>2@ Stuart-+arris 5 Caldas C 3inder SE 3KaroaK 3. 3roliIeration marNers 
and surYiYal in earl\ Ereast cancer: A s\stematic reYieZ and meta-
anal\sis oI 8 studies in 3282 patients. Breast 2008; 17: 323–334
>3@ 7Kompson A Brennan . Cox A *ee J +arcourt ' +arris A +arYie M 
+olen I +oZell A 1icKolson 5 Steel M Streuli C. EYaluation oI tKe 
current NnoZledge limitations in Ereast cancer researcK: A gap 
anal\sis. Breast Cancer 5es 2008; 10: 52
>4@ 7Kompson +J. 3re-clinical inYestigations oI pK\sical actiYit\ and 
cancer: A ErieI reYieZ and anal\sis. Carcinogenesis 200; 27: 
194–1949
>@ 7Kompson +J Jiang : =Ku =. Candidate mecKanisms accounting Ior 
e̥ects oI pK\sical actiYit\ on Ereast carcinogenesis. I8BMB /iIe 2009; 
1: 89–901
>@ 7Kompson +J 5onan AM 5itacco .A 7agliaIerro A5 MeeNer /'. E̥ect 
oI exercise on tKe induction oI mammar\ carcinogenesis. Cancer 5es 
1988; 48: 2720–2723
>7@ 7Kompson +J :esterlind .C Snedden J Briggs S SingK M. Exercise 
intensit\ dependent inKiEition oI 1-metK\l-1-nitrosourea induced 
mammar\ carcinogenesis in Iemale F-344 rats. Carcinogenesis 199; 
1: 1783–178
>8@ 7Kompson +J :esterlind .C Snedden J5 Briggs S SingK M. InKiEition 
oI mammar\ carcinogenesis E\ treadmill exercise. J 1atl Cancer Inst 
199; 87: 43–4
>9@ 7Kompson +J :olIe 3 Mc7iernan A Jiang : =Ku =. :Keel running-
induced cKanges in plasma EiomarNers and carcinogenic response in 
tKe 1-metK\l-1-nitrosourea-induced rat model Ior Ereast cancer. 
Cancer 3reY 5es 2010; 3: 1484–1492
>70@ :elscK MA CoKen /A :elscK C:. InKiEition oI groZtK oI Kuman 
Ereast carcinoma xenograIts E\ energ\ expenditure Yia Yoluntar\ 
exercise in atK\mic mice Ied a KigK-Iat diet. 1utr Cancer 199; 23: 
309–318
>71@ :esterlind .C McCart\ +/ *iEson .J Strange 5. E̥ect oI exercise on 
tKe rat mammar\ gland: Implications Ior carcinogenesis. Acta 3K\siol 
Scand 2002; 17: 147–1
>72@ :esterlind .C McCart\ +/ ScKultKeiss 3C Stor\ 5 5eed A+ Baier 
M/ Strange 5. Moderate exercise training sloZs mammar\ tumour 
groZtK in adolescent rats. Eur J Cancer 3reY 2003; 12: 281–287
>73@ :oods JA 'aYis JM .oKut M/ *Kḁar A Ma\er E3 3ate 55. E̥ects oI 
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̂table S1 SearcK strateg\.
Search strategy ´Exerciseµ ´Breast cancerµ ´Animalsµ
MeSH terms Exercise
5unning
Breast neoplasms Animals
text words 3K\sical 
activity
9oluntar\ 
running
Treadmill 
running
Breast tumor
Mammar\ cancer
̂table S2  S<5C/E·s 5oB tool Ior assessing risN oI Eias.
Item bias domain Source of bias Support for judgments Review author’s judgment
1 Selection 
bias
SeTuence 
generation
'escriEe tKe metKods used iI an\ to 
generate tKe allocation seTuence in 
su̦cient detail to alloZ an assessment 
ZKetKer it sKould produce comparaEle 
groups.
<  7Ke inYestigators descriEed a random component.
8  7Ke inYestigators mention tKe randomi]ation Eut its 
not clear how.
1  1o randomi]ation Zere used or is not reported.
2 Selection 
bias
Baseline 
characteristics
'escriEe all tKe possiEle prognostic 
factors or animal characteristics, if any, 
tKat are compared in order to Mudge 
whether or not intervention and 
control groups Zere similar at tKe start 
oI tKe experiment.
<  Similarit\ in Easeline cKaracteristics ex. animal t\pe 
animal age. 7Ke disease Zas induced EeIore randomi]a-
tion or a transgenic model was used.
8  7Ke similarit\ its not clear orand tKe disease Zas 
induced EeIore randomi]ation.
1  7Ke Easeline cKaracteristics are not similar or not clear 
and tKe disease Zas induced aIter randomi]ation.
3 Selection 
bias
Allocation 
concealment
'escriEe tKe metKod used to conceal 
tKe allocation seTuence in su̦cient 
detail to determine whether interven-
tion allocations could have been 
foreseen before or during enrolment.
<  7Ke allocation Zas adeTuatel\ concealed iI tKe Easeline 
characteristics were similar.
8  7Ke metKods used to allocation are not clear neitKer 
are the similarity of baseline characteristics.
1  1ot reported.
4 Performance 
bias
5andom 
housing
'escriEe all measures used iI an\ to 
house the animals randomly within the 
animal room.
<  7Ke Kousing conditions Zere similar EetZeen groups 
ex. temperature Kumidit\ ligKting In protocols oI 
Iorced exercise tKe sedentar\ animals Zere placed in a 
stationar\ treadmill during tKe same time tKat exercised 
animals.
8  7Ke Kousing conditions Zere similar EetZeen groups 
ex. temperature Kumidit\ ligKting In protocols oI 
Iorced exercise tKe sedentar\ animals remain in tKe cages 
during tKe exercise period.
1  7Ke Kousing conditions Zere not similar EetZeen 
groups ex. temperature Kumidit\ ligKting In protocols 
oI Iorced exercise tKe sedentar\ animals remain in tKe 
cages during tKe exercise period or is not reported.
5 Performance 
bias
Blinding 'escriEe all measures used iI an\ to 
blind trial caregivers and researchers 
Irom NnoZing ZKicK interYention eacK 
animal receiYed. 3roYide an\ 
information relating to whether the 
intended Elinding Zas e̥ectiYe.
7o inYestigate tKe e̥ects oI exercise exposure Elindness is 
not possiEle. 7Ke inYestigators andor tKe caregiYers must 
Ee aZare oI tKe compliance oI tKe animals ZitK tKe 
exercise conditions in order to reduce tKe outcomes Eias. 
7Kus tKis condition is not applicaEle.
6 Detection 
bias
5andom 
outcome 
assessment
'escriEe ZKetKer or not animals Zere 
selected at random for outcome 
assessment, and which methods to 
select the animals, if any, were used.
<  7Ke animals Zere selected at random Ior outcome 
assessment, or the animals were not selected at random 
for outcome assessment, but all the animals were used 
and tKe outcomes is not liNel\ to Ee inÁuenced.
8  7Ke animals Zere not selected at random Ior outcome 
assessment Eut tKe inYestigators pinpoint tKe reasons ZK\.
1  7Ke animals Zere not selected at random Ior outcome 
assessment or its not clear ZK\ tKe inYestigators cKoose a 
specific numEer oI animals or its not reported.
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̂table S2  S<5C/E·s 5oB tool Ior assessing risN oI Eias.
Item bias domain Source of bias Support for judgments Review author’s judgment
7 Detection 
bias
Blinding 'escriEe all measures used iI an\ to 
Elind outcome assessors Irom NnoZing 
which intervention each animal 
receiYed. 3roYide an\ inIormation 
relating to whether the intended 
Elinding Zas e̥ectiYe.
<  7Ke outcome assessment metKods Zere tKe same in 
EotK groups or iI tKe\ Zere not a Yalid reason Zas defined 
ex. to measure tKe e̥ects oI di̥erent amounts oI exercise 
exposure.
8  7Ke outcome assessment metKods Zere tKe same in 
EotK groups Eut its not clear iI a random component Zere 
used.
1  'i̥erences in tKe outcome assessment e. g. di̥erent 
times in sacrificed di̥erences in Elood sample collection 
or iI not reported.
8 Attrition 
bias
Incomplete 
outcome data
'escriEe tKe completeness oI outcome 
data for each main outcome, including 
attrition and exclusions Irom tKe 
anal\sis. State ZKetKer attrition and 
exclusions Zere reported tKe numEers 
in eacK interYention group compared 
ZitK total randomi]ed animals 
reasons Ior attrition or exclusions and 
any re-inclusions in analyses for the 
review.
<  All tKe animals Zere included in tKe anal\sis or iI not 
tKe reasons Ior missing data are Zell explain ex. animals 
tKat did not deYelop tumors.
8  7Ke anal\sis do not include all tKe animals or all tKe 
tumors, but the reasons to do that are not clear.
1  7Ke anal\sis do not include all tKe animals or all tKe 
tumors and no reasons Zere reported.
9 Reporting 
bias
SelectiYe 
outcome 
reporting
State KoZ selectiYe outcome reporting 
Zas examined and ZKat Zas Iound.
<  7Ke stud\ protocol is not registered Eut tKe puElisKed 
report included all expected outcomes.
8  7Ke stud\ protocol is not registered and some results 
are not presented.
1  7Ke stud\ protocol is not registered and tKe presented 
results are not in accordance ZitK all tKe stud\ Tuestions.
10 Other OtKer sources 
of bias
State an\ important concerns aEout 
bias not covered by other domains in 
the tool.
<  7Ke financial support are clearl\ stated no additional 
animals Zere added to replace tKe missing ones
8  7Ke financial support is not clearl\ stated. 7Ke animals 
used were males.
1  1o reIerences is made regarding tKe Iunders 
additional animals Zere added to replace tKe missing 
ones.
Continued.
72
Figueira ACC et al. Exercise-induced Benefits in Breast Cancer Outcomes in Animals. Int J Sports Med 
̂
ta
bl
e 
S3
 4
ua
lit
\ a
na
l\s
is.
St
U
D
Y
SY
RC
LE
’s
 R
ob
 to
ol
RE
SU
Lt
S 
bY
 S
tU
D
Y
Q
1
Q
2
Q
3
Q
4
Q
5
Q
6
Q
7
Q
8
Q
9
Q
10
Se
le
ct
io
n 
bi
as
Pe
rf
or
m
an
ce
 b
ia
s
D
et
ec
ti
on
 b
ia
s
At
tr
it
io
n 
bi
as
Re
po
rt
in
g 
bi
as
O
th
er
 b
ia
s
M
oo
re
, 1
97
3
1
1
1
1
1A
8
1
<
8
1
LR
b  
 11
.1
1 
%
 U
Rb
   
22
.2
2 
%
 H
Rb
   
66
.6
7 
%
th
om
ps
on
, 1
98
8
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
Co
he
n,
 1
98
8
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
La
ne
, 1
99
1
<
1
8
1
1A
<
1
<
<
<
LR
b  
 55
.5
6 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
33
.3
3 
%
Co
he
n,
 1
99
3
<
<
<
<
1A
<
1
<
<
8
LR
b  
 77
.7
8 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
11
.1
1 
%
W
oo
ds
, 1
99
4
<
<
<
<
1A
<
1
<
<
8
LR
b  
 77
.7
8 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
11
.1
1 
%
th
om
ps
on
, 1
99
5
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
th
om
ps
on
, 1
99
5(
1)
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
W
el
sc
h,
 1
99
5
1
<
<
1
1A
<
1
1
<
<
LR
b  
 55
.5
6 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
44
.4
4 
%
Gi
lle
tt
e,
 1
99
7
<
<
<
<
1A
<
1
8
<
<
LR
b  
 77
.7
8 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
11
.1
1 
%
W
es
te
rl
in
d,
 2
00
3
<
<
<
<
1A
<
8
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Zh
u,
 2
00
8
<
<
<
<
1A
<
<
8
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Co
lb
er
t,
 2
00
9
<
<
<
<
1A
<
<
8
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Zh
u,
 2
00
9
<
<
<
<
1A
<
<
8
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Jia
ng
, 2
00
9
<
<
<
<
1A
<
<
1
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
th
om
ps
on
, 2
01
0
<
<
<
<
1A
<
<
<
<
<
LR
b  
 10
0.
0 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
0.
00
 %
M
an
n,
 2
01
0
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
Jo
ne
s,
 2
01
0
<
<
<
<
1A
<
<
<
<
<
LR
b  
 10
0.
0 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
0.
00
 %
M
ur
ph
y,
 2
01
1
<
<
<
<
1A
<
8
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Zh
u,
 2
01
2
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
Jia
ng
, 2
01
3
<
<
<
<
1A
<
8
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
St
ei
ne
r, 
20
13
<
<
<
<
1A
<
1
<
<
8
LR
b  
 77
.7
8 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
11
.1
1 
%
Go
h,
 2
01
3
<
<
<
<
1A
<
1
<
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
11
.1
1 
%
M
al
ic
ka
, 2
01
5
1
<
<
8
1A
<
<
8
<
<
LR
b  
 66
.6
7 
%
 U
Rb
   
22
.2
2 
%
 H
Rb
   
11
.1
1 
%
Av
es
eh
, 2
01
5
<
<
<
8
1A
<
1
<
<
8
LR
b  
 66
.6
7 
%
 U
Rb
   
22
.2
2 
%
 H
Rb
   
11
.1
1 
%
Fa
us
ti
no
-R
oc
ha
, 2
01
6
<
<
<
<
1A
<
<
8
<
<
LR
b  
 88
.8
9 
%
 U
Rb
   
11
.1
1 
%
 H
Rb
   
0.
00
 %
Fa
us
ti
no
-R
oc
ha
, 2
01
6(
1)
<
<
<
<
1A
<
<
<
<
<
LR
b  
 10
0.
0 
%
 U
Rb
   
0.
00
 %
 H
Rb
   
0.
00
 %
Is
an
ej
ad
, 2
01
6
<
8
8
<
1A
<
<
<
<
<
LR
b  
 77
.7
8 
%
 U
Rb
   
22
.2
2 
%
 H
Rb
   
0.
00
 %
/e
ge
nd
 <
   
/o
Z 
ris
N o
I E
ias
 /
5B
 
1 
  +
ig
K 
ris
N o
I E
ias
 +
5B
 
8 
  8
nc
lea
r r
isN
 o
I E
ias
 8
5B
. 
1A
   
1o
t a
pp
lic
aE
le.
5e
su
lts
 E
\ d
im
en
sio
n
 (Q
1,
 Q
2 
&
 Q
3)
 ²
 H
Rb
   
.

 
 U
Rb
   
.

 
 L
Rb
   

.
 
 (
Q
4)
 ï
 H
Rb
   

.
 
 U
Rb
   
.

 
 L
Rb
   

.
 
 (
Q
6 
&
 Q
7)
 ï
 H
Rb
   

.
 
 U
Rb
   
.

 
 L
Rb
   

.
 
 (
Q
8)
 ï
 
H
Rb
   
.

 
 U
Rb
   

.
 
 L
Rb
   

.
 
 (
Q
9)
 ï
 H
Rb
   
.

 
 U
Rb
   
.

 
 L
Rb
   

.
 
 (
Q
10
) ï
 H
Rb
   
.

 
 U
Rb
   

.
 
 L
Rb
   

.
 

73
Figueira ACC et al. Exercise-induced Benefits in Breast Cancer Outcomes in Animals. Int J Sports Med
Review Thieme
Translations:
Database:
PubMed
User query:
Exercise “exercise”[MeSH Terms] OR “exercise”[All Fields]
[(Exercise OR Physical activity) OR (Voluntary running OR treadmill running)] AND [(breast tumor OR breast neoplasms OR mammary cancer) AND
(animals)
“running”[MeSH Terms] OR “running”[All Fields]
“animals”[MeSH Terms:noexp] OR animals[All Fields]
“breast neoplasms”[MeSH Terms] OR (“breast”[All Fields] AND “neoplasms”[All Fields]) OR “breast neoplasms”[All Fields] OR (”breast”[All
Fields] AND “tumor”[All Fields]) OR “breast tumor”[All Fields]
“breast neoplasms”[MeSH Terms] OR (“breast”[All Fields] AND “neoplasms”[All Fields]) OR “breast neoplasms”[All Fields] OR (“mammary”[All
Fields] AND “cancer”[All Fields]) OR “mammary cancer”[All Fields]
“breast neoplasms”[MeSH Terms] OR (“breast”[All Fields] AND “neoplasms”[All Fields]) OR “breast neoplasms”[All Fields] 
“exercise”[MeSH Terms] OR “exercise”[All Fields] OR (’physical”[All Fields] AND “activity”[All Fields]) OR “physical activity”[All Fields]
running
breast
tumor
breast
neoplasms
mammary
cancer
animals
Physical
activity
̂Fig. S1 Example oI electronic searcK material.
74
Figueira ACC et al. Exercise-induced Benefits in Breast Cancer Outcomes in Animals. Int J Sports Med 
Correlation (95% Cl) with study removedStudy name Statistics with study removed
0.00–1.00 –0.50 0.50 1.00
Point
Lower
limit
Upper
limit p-ValueZ-Value
Cohen, Choi and Wang, 1988 –0.202 –0.298 –0.102 0.000–3.931
Cohen, Kendall, Meschter er al, 1993 a –0.199 –0.293 –0.102 0.000–3.971
Cohen, Kendall, Meschter er al, 1993 b –0.204 –0.299 –0.105 0.000–4.004
Colbert, Westerlind, Hursting et al, 2009 a –0.216 –0.305 –0.123 0.000–4.478
Colbert, Westerlind, Hursting et al, 2009 b –0.211 –0.303 –0.115 0.000–4.258
Colbert, Westerlind, Hursting et al, 2009 c –0.212 –0.303 –0.118 0.000–4.338
Faustino-Rocha er al, 2016 (1) –0.204 –0.298 –0.105 0.000–4.018
Gillette, Znu, Thompson er al, 1997 a –0.212 –0.305 –0.114 0.000–4.210
Gillette, Znu, Thompson er al, 1997 b –0.224 –0.309 –0.135 0.000–4.841
Lane, Teer, Strahan et al, 1991 c –0.209 –0.303 –0.110 0.000–4.102
Malicka et al, 2015 a –0.203 –0.302 –0.111 0.000–4.134
Thompson, Ronan, Meeker et al, 1988 –0.217 –0.305 –0.125 0.000–4.539
Thompson, Westerlind, Singh et al, 1995 a –0.207 –0.302 –0.107 0.000–4.038
Jiang, Zhu and Thompson, 2009 –0.195 –0.289 –0.098 0.000–3.890
Jiang, Zhu and Thompson, 2013 –0.194 –0.287 –0.097 0.000–3.894
Lane, Teer, Strahan et al, 1991 a –0.203 –0.298 –0.104 0.000–3.962
Lane, Teer, Strahan et al, 1991 b –0.200 –0.295 –0.101 0.000–3.898
Malicka et al, 2015 b –0.201 –0.295 –0.102 0.000–3.952
Malicka et al, 2015 c –0.202 –0.296 –0.103 0.000–3.979
Mann, Jiang, Thompson et al, 2010 a –0.191 –0.285 –0.094 0.000–3.836
Mann, Jiang, Thompson et al, 2010 b –0.193 –0.287 –0.095 0.000–3.847
Thompson, Westerlind, Singh et al, 1995 b –0.205 –0.300 –0.105 0.000–3.983
Thompson, Westerlind, Singh et al, 1995 c –0.201 –0.297 –0.101 0.000–3.906
Thompson, Westerlind, Singh et al, 1995 d –0.202 –0.298 –0.102 0.000–3.923
Thompson, Westerlind, Snedden et al, 1995(1) a –0.193 –0.287 –0.096 0.000–3.849
Thompson, Westerlind, Snedden et al, 1995(1) b –0.193 –0.286 –0.095 0.000–3.845
Thompson, Westerlind, Snedden et al, 1995(1) c –0.195 –0.290 –0.097 0.000–3.855
Thompson, Wolfe, Mctiernan et al, 2010 a –0.193 –0.288 –0.095 0.000–3.821
Thompson, Wolfe, Mctiernan et al, 2010 b –0.198 –0.294 –0.097 0.000–3.827
Westerlind, McCarty, Strange et al, 2003 –0.203 –0.298 –0.105 0.000–3.992
Zhu, Jiang, Thompson et al, 2009 –0.195 –0.289 –0.097 0.000–3.863
Zhu, Jiang, Thompson et al, 2008 –0.194 –0.288 –0.097 0.000–3.881
Zhu, Jiang, Thompson et al, 2012 a –0.195 –0.288 –0.097 0.000–3.890
Zhu, Jiang, Thompson et al, 2012 b –0.196 –0.289 –0.098 0.000–3.901
Woods, Davis, Pate et al, 1994 a –0.214 –0.305 –0.118 0.000–4.330
Woods, Davis, Pate et al, 1994 b –0.212 –0.305 –0.116 0.000–4.267
–0.202 –0.295 –0.106 0.000–4.084
Moore and Tittle, 1973 –0.193 –0.285 –0.097 0.000–3.904
Study name Statistics with study removed Correlation (95% Cl) with study removed
Cohen, Kendall, Meschter et al, 1993 a
Cohen, Kendall, Meschter et al, 1993 b
Colbert, Westerlind, Hursting et al, 2009
Faustino-Rocha et al, 2016
Goh, Tsai, Bammler et al, 2013
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2013
Malicka et al, 2015 a
Malicka et al, 2015 b
Malicka et al, 2015 c
Mann, Jiang, Thompson et al, 2010 a
Mann, Jiang, Thompson et al, 2010 b
Murphy, Davis, Barrilleaux et al, 2011
Steiner, Davis, Murphy et al, 2013
Thompson, Wolfe, Mctiernan et al, 2010 a
Thompson, Wolfe, Mctiernan et al, 2010 b
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2008
Zhu, Jiang, Thompson et al, 2012 a
Zhu, Jiang, Thompson et al, 2012 b
Z-Value
–5.541
–5.741
–6.224
–5.688
–5.372
–4.941
–4.874
–5.666
–5.533
–5.550
–4.954
–5.003
–5.505
–6.087
–5.177
–4.942
–4.991
–4.898
–5.417
–5.485
–5.514
Upper
limit
–0.457
–0.471
–0.501
–0.470
–0.442
–0.407
–0.400
–0.468
–0.457
–0.458
–0.402
–0.412
–0.454
–0.496
–0.402
–0.401
–0.401
–0.403
–0.448
–0.453
–0.446
Lower
limit
–0.775
–0.778
–0.784
–0.780
–0.770
–0.762
–0.759
–0.779
–0.776
–0.776
–0.755
–0.763
–0.775
–0.786
–0.737
–0.754
–0.751
–0.760
–0.773
–0.774
–0.766
Point
–0.643
–0.650
–0.666
–0.651
–0.634
–0.615
–0.610
–0.650
–0.643
–0.644
–0.607
–0.617
–0.642
–0.666
–0.595
–0.607
–0.605
–0.612
–0.638
–0.641
–0.632
p-Value
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.00–1.00 –0.50 0.50 1.00
a
b
̂Fig. S2 a: Incidence sensitiYit\ anal\sis. b: Multiplicit\ sensitiYit\ anal\sis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Study name Statistics with study removed Correlation (95% Cl) with study removed
p-ValueZ-Value
Upper
limit
Lower
limitPoint
Aveseh er al, 2015 0.002–3.039–0.139–0.570–0.375
Faustino-Rocha et al, 2016 a 0.000–3.872–0.222–0.596–0.427
Faustino-Rocha et al, 2016 b 0.001–3.319–0.170–0.584–0.397
Jiang, Zhu and Thompson, 2013 0.010–2.563–0.084–0.560–0.344
Steiner, Davis, Murphy et al, 2013 0.004–2.900–0.123–0.563–0.363
Westerlind, McCarty, Strange et al, 2003 b 0.011–2.533–0.077–0.542–0.329
Westerlind, McCarty, Strange et al, 2003 c 0.003–2.989–0.134–0.571–0.373
Westerlind, McCarty, Strange et al, 2003 d 0.011–2.552–0.077–0.529–0.321
Westerlind, McCarty, Strange et al, 2003 a 0.003–2.989–0.135–0.572–0.374
Woods, Davis, Pate et al, 1994 b 0.001–3.226–0.160–0.579–0.389
Woods, Davis, Pate et al, 1994 a 0.001–3.198–0.157–0.578–0.387
Zhu, Jiang, Thompson et al, 2008 0.005–2.814–0.097–0.497–0.311
Zhu, Jiang, Thompson et al, 2012 a 0.004–2.864–0.120–0.567–0.364
Zhu, Jiang, Thompson et al, 2012 b 0.004–2.897–0.124–0.569–0.367
0.002–3.083–0.139–0.557–0.366
0.00–1.00 –0.50 0.50 1.00
Study name Correlation (95% Cl) with study removedStatistics with study removed
0.00–1.00 –0.50 0.50 1.00
Lower
limitPoint Z-Value
Upper
limit p-Value
Aveseh et al, 2015 –0.685–0.456 –2.786–0.145 0.005
Cohen, Choi and Wang, 1988 –0.690–0.463 –2.830–0.153 0.005
Colbert, Westerlind, Hursting et al, 2009 –0.686–0.455 –2.750–0.140 0.006
Faustino-Rocha et al, 2016 –0.704–0.501 –2.336–0.224 0.001
Goh, Tsai, Bammler et al, 2013 a –0.671–0.433 –2.604–0.114 0.009
Goh, Tsai, Bammler et al, 2013 b –0.676–0.438 –2.629–0.119 0.009
Isanejad et al, 2016 –0.548–0.322 –2.336–0.054 0.019
Malicka et al, 2015 a –0.697–0.482 –3.072–0.188 0.002
Malicka et al, 2015 b –0.688–0.460 –2.824–0.151 0.005
Malicka et al, 2015 c –0.686–0.458 –2.801–0.147 0.005
Murphy, Davis, Barrilleaux et al, 2011 –0.681–0.448 –2.708–0.132 0.007
Steiner, Davis, Murphy et al, 2013 –0.681–0.448 –2.699–0.131 0.007
Welsch M., Cohen and Welsch C., 1995 –0.681–0.443 –2.618–0.119 0.009
Westerlind, McCarty, Strange et al, 2003 a –0.638–0.397 –2.459–0.085 0.014
Westerlind, McCarty, Strange et al, 2003 b –0.684–0.426 –2.334–0.073 0.020
–0.668–0.443 –2.812–0.143 0.005
c
d
̂Fig. S2 Continued. c: 7umoral mass sensitiYit\ anal\sis. d: 7umoral Yolume sensitiYit\ anal\sis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Study name Biomarkers Statistics with study removed Correlation (95% CI) with study removed
Isanejad et al, 2016 ki67
Point
–0.783 –0.882 –0.617 –6.202 0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
–1.00 –0.50 0.00 0.50 1.00
–6.227
–7.321
–7.573
–7.142
–7.493
–5.883
–6.487
–6.218
–7.830
–7.132
–0.616
–0.680
–0.690
–0.673
–0.627
–0.600
–0.638
–0.614
–0.699
–0.655
–0.880
–0.893
–0.894
–0.892
–0.851
–0.882
–0.887
–0.880
–0.894
–0.881
–0.781
–0.812
–0.816
–0.809
–0.761
–0.777
–0.794
–0.780
–0.819
–0.794
Lower
limit
Upper
limit Z-Value p-Value
CYCLIND1
CYCLIND1
CYCLIND1
E2F-1
p27kip1
p27
p27kip1
E2F-1
p27kip1
Jiang, Zhu and Thompson, 2009 a
Jiang, Zhu and Thompson, 2009 a
Jiang, Zhu and Thompson, 2009 b
Jiang, Zhu and Thompson, 2009 c
Jiang, Zhu and Thompson, 2013
Jiang, Zhu and Thompson, 2013
Zhu, Jiang, thompson et al, 2009
Zhu, Jiang, thompson et al, 2009
Zhu, Jiang, thompson et al, 2009
a
b
c
Correlation (95% CI) with study removedStudy name Biomarkers Statistics with study removed
Lower
limit
Upper
limitPoint Z-Value p-Value
Correlation (95% CI) with study removedStudy name Biomarkers Statistics with study removed
Lower
limit
Upper
limitPoint Z-Value p-Value
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Zhu, Jiang, Thompson et al, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Jiang, Zhu and Thompson, 2009
Faustino-Rocha et al, 2016 a
Faustino-Rocha et al, 2016 b
Isanejad et al, 2016 a
Isanejad et al, 2016 b
Jones, Viglianti, Tashjian et al, 2010
Jones, Viglianti, Tashjian et al, 2010
Jones, Viglianti, Tashjian et al, 2010
Zhu, Jiang, Thompson et al, 2009
Apaf-1
Apaf-1
BAX
BAX
BAX
XIAP
BCL-2
CASP 3
XIAP
BCL-2
BCL-2
PER VESS
VEGF
VEGF
VEGF
VEGF
CD31
CD31
PER VESS
CASP 3
–0.800 –0.878 –0.682 –8.100 0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
–1.00 –0.50 0.00 0.50 1.00
–1.00 –0.50 0.00 0.50 1.00
–9.338
–8.158
–8.576
–8.994
–8.355
–7.930
–7.997
–7.707
–8.395
–7.625
–9.378
–8.726
–0.721
–0.685
–0.662
–0.713
–0.693
–0.669
–0.663
–0.672
–0.661
–0.664
–0.721
–0.690
–0.884
–0.878
–0.853
–0.883
–0.880
–0.872
–0.866
–0.879
–0.856
–0.875
–0.883
–0.872
–0.818
–0.802
–0.775
–0.815
–0.806
–0.791
–0.785
–0.798
–0.777
–0.792
–0.817
–0.798
–0.441 –0.782 0.102 –1.612 0.107
0.274
0.647
0.754
0.469
0.566
0.436
0.738
0.448
–1.094
–0.459
–0.313
–0.724
–0.574
–0.778
–0.334
–0.759
0.309
0.517
0.518
0.451
0.496
0.432
0.525
0.392
–0.809
–0.727
–0.659
–0.784
–0.760
–0.790
–0.677
–0.734
–0.382
–0.173
–0.109
–0.277
–0.222
–0.296
–0.119
–0.256
̂Fig. S3 a: 3roliIeration sensitiYit\ anal\sis. b: Apoptosis sensitiYit\ anal\sis. c: Angiogenesis sensitiYit\ anal\sis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Section/topic # Checklist item Reported on page #
tItLE 
Title  IdentiI\ tKe report as a s\stematic reYieZ meta-anal\sis or EotK. 
AbStRACt 
Structured summar\  3roYide a structured summar\ including as applicaEle EacNground oEMectiYes data 
sources stud\ eligiEilit\ criteria participants and interYentions stud\ appraisal and 
s\ntKesis metKods results limitations conclusions and implications oI Ne\ findings 
systematic review registration number.

INtRODUCtION 
5ationale  'escriEe tKe rationale Ior tKe reYieZ in tKe context oI ZKat is alread\ NnoZn. 
OEMectiYes  3roYide an explicit statement oI Tuestions Eeing addressed ZitK reIerence to 
participants interYentions comparisons outcomes and stud\ design 3ICOS.

MEtHODS 
3rotocol and registration  Indicate iI a reYieZ protocol exists iI and ZKere it can Ee accessed e. g. :eE 
address and iI aYailaEle proYide registration inIormation including registration 
number.

EligiEilit\ criteria  SpeciI\ stud\ cKaracteristics e. g. 3ICOS lengtK oI IolloZ-up and report cKaracter-
istics e. g. \ears considered language puElication status used as criteria Ior 
eligibility, giving rationale.
 
Information sources  'escriEe all inIormation sources e. g. dataEases ZitK dates oI coYerage contact 
ZitK stud\ autKors to identiI\ additional studies in tKe searcK and date last 
searched.
 
SearcK  3resent Iull electronic searcK strateg\ Ior at least one dataEase including an\ limits 
used sucK tKat it could Ee repeated.
̂table 4 ̂Fig. 4
Stud\ selection  State tKe process Ior selecting studies i. e. screening eligiEilit\ included in 
s\stematic reYieZ and iI applicaEle included in tKe meta-anal\sis.
 
'ata collection process  'escriEe metKod oI data extraction Irom reports e. g. piloted Iorms independent-
l\ in duplicate and an\ processes Ior oEtaining and confirming data Irom 
investigators.

'ata items  /ist and define all YariaEles Ior ZKicK data Zere sougKt e. g. 3ICOS Iunding 
sources and an\ assumptions and simplifications made.

5isN oI Eias in indiYidual 
studies
 'escriEe metKods used Ior assessing risN oI Eias oI indiYidual studies including 
specification oI ZKetKer tKis Zas done at tKe stud\ or outcome leYel and KoZ tKis 
information is to be used in any data synthesis.
 ̂table 5
Summar\ measures  State tKe principal summar\ measures e. g. risN ratio di̥erence in means. 
S\ntKesis oI results  'escriEe tKe metKods oI Kandling data and comEining results oI studies iI done 
including measures oI consistenc\ e. g. I Ior eacK meta-anal\sis.

5isN oI Eias across 
studies
 SpeciI\ an\ assessment oI risN oI Eias tKat ma\ ḁect tKe cumulatiYe eYidence e. g. 
puElication Eias selectiYe reporting ZitKin studies.

Additional analyses  'escriEe metKods oI additional anal\ses e. g. sensitiYit\ or suEgroup anal\ses 
meta-regression iI done indicating ZKicK Zere pre-specified.

RESULtS 
Stud\ selection  Give numbers of studies screened, assessed for eligibility, and included in the review, 
ZitK reasons Ior exclusions at eacK stage ideall\ ZitK a ÁoZ diagram.
 ̂Fig. 1
Stud\ cKaracteristics  For eacK stud\ present cKaracteristics Ior ZKicK data Zere extracted e. g. stud\ 
si]e 3ICOS IolloZ-up period and proYide tKe citations.
  ̂table 2
5isN oI Eias ZitKin 
studies
 3resent data on risN oI Eias oI eacK stud\ and iI aYailaEle an\ outcome leYel 
assessment see item .
̂table 6
5esults oI indiYidual 
studies
 For all outcomes considered Eenefits or Karms present Ior eacK stud\ a simple 
summar\ data Ior eacK interYention group E e̥ect estimates and confidence 
interYals ideall\ ZitK a Iorest plot.
̂table 6
S\ntKesis oI results  3resent results oI eacK meta-anal\sis done including confidence interYals and 
measures of consistency.
   
5isN oI Eias across 
studies
 3resent results oI an\ assessment oI risN oI Eias across studies see Item . 
Additional analysis  *iYe results oI additional anal\ses iI done e. g. sensitiYit\ or suEgroup anal\ses 
meta-regression >see Item @.
 ̂Fig. 5a,b,c,d and 
̂6a, b, c
35ISMA  CKecNlist.
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DISCUSSION 
Summar\ oI eYidence  Summari]e tKe main findings including tKe strengtK oI eYidence Ior eacK main 
outcome consider tKeir releYance to Ne\ groups e. g. KealtKcare proYiders users 
and polic\ maNers.
    
/imitations  'iscuss limitations at stud\ and outcome leYel e. g. risN oI Eias and at reYieZ-leYel 
e. g. incomplete retrieYal oI identified researcK reporting Eias.

Conclusions  3roYide a general interpretation oI tKe results in tKe context oI otKer eYidence and 
implications Ior Iuture researcK.

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Abstract 28 
Background: Investigating the mechanisms by which exercise training can positively 29 
influence breast carcinogenesis is one of the main goals in exercise-oncology research. 30 
There is strong evidence that exercise exposure after a diagnosis of breast cancer may 31 
induce major advantages in tumor development by decreasing inflammation and sex 32 
hormone concentrations in addition to favorable changes in insulin resistance. 33 
Nevertheless, the published preclinical data are varied and have never been 34 
quantitatively summarized, and the exercise-moderating variables with the greatest 35 
potential influence on carcinogenesis have not yet been examined. Objective: With 36 
this review we intend to investigate the effectiveness of exercise in modulation of host 37 
systemic biomarkers. Method searches: PubMed, MEDELINE, Web of science and 38 
System for Information on Gray Literature in Europe databases were searched up to 39 
December 2016. We performed 61 correlations in order to analyze 10 exercise 40 
programs that involved 1224 animals in nine studies. Effect sizes were calculated for 41 
three dependent variables (i.e., inflammation and cytokines, glucose homeostasis and 42 
metabolism, and sex hormones). Results: The positive impact of exercise upon host 43 
systemic responses observed with respect to the three dependent variables was of large 44 
magnitude. We also identified the exercise-moderating variables that correlated with 45 
better outcomes, in which we emphasized the vigorous intensity as a determinant. 46 
However, the ideal amount of exercise needed to improve the outcomes was hampered 47 
by the diversity of experimental protocols used in the analyzed studies. Conclusions: 48 
Exercising can significantly improve tumor-related systemic inflammation, glucose 49 
metabolism, and sex hormones levels. 50 
Keywords: Inflammation and cytokines, glucose metabolism, sex hormone, 51 
exercise intensity, preclinical data. 52 
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Introduction 53 
Breast cancer is the most frequently diagnosed and extensively studied cancer among 54 
women 1,2. The increasing number of survivors is due to several factors, including the 55 
adoption of an active lifestyle 3. 56 
Regular physical activity and exercise training (considered exercise in this study) has 57 
been pointed out as one of the non-pharmacological approaches to improve breast 58 
cancer outcomes 4-11. However, the way in which exercise can improve breast cancer 59 
survival remains poorly understood. 60 
A number of mechanisms have been proposed to explain how exercise can potentially 61 
lower disease-specific mortality and recurrence. A considerable amount of data has 62 
established that cancer-induced inflammation, in conjunction with insulin resistance 63 
and high circulating estradiol levels are key determinants in breast cancer progression, 64 
recurrence and death 12-17. Thus, over the past several years, the efficacy of exercise in 65 
altering the circulating levels of specific key biomarkers that are supposed to be 66 
involved in the exercise-cancer relationship has been studied using animal models 18. 67 
Given the possibility of preclinical trials to clarify the biological mechanisms that may 68 
underlie associations between exercise and cancer, and evaluating the behavior of key 69 
biomarkers after exposure to specific amounts of exercise, is important to quantify the 70 
extent of evidences from previously published data. This was the first aim of the 71 
present review. Accordingly, we analyzed circulating biomarkers classified into three 72 
families: (1) inflammation and cytokines, (2) glucose homeostasis and metabolism, 73 
and (3) sex steroid hormones 19. 74 
Additionally, we also examined the exercise designs used in order to determine the 75 
exercise parameters that would contribute to improved outcomes. 76 
Methods 77 
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We followed the recommendations of the PRISMA statement for systematic reviews 78 
and meta-analyses 20. 79 
Information sources and search strategy  80 
In both April and December 2016, we search for published reports in PubMed, 81 
MEDELINE, Web of Science (Web of Knowledge), and SIGLE (System for 82 
Information on Gray Literature in Europe) databases [Eletronic upplementary material 83 
(ESM) figure F1). Relevant MeSH terms and text expressions were used to construct 84 
the search strategy (ESM Table S1). Additionally, the reference lists of included 85 
manuscripts were screened for potential eligible studies. 86 
Study selection criteria 87 
Three authors independently assessed full-text versions (ACCF, RF and JAD) and 88 
disagreements were resolved by consensus. 89 
We included the manuscripts if they fulfilled the next set of inclusion criteria: (1) they 90 
were written in English and performed on animals; (2) they compared the effects of an 91 
active versus a sedentary lifestyle on at least one host systemic biomarkers; and (3) 92 
they examined the effects of exercise following tumor induction. 93 
We excluded manuscripts for several reasons: (1) they examined the cancer-preventive 94 
effects of exercise: (2) they evaluated acute effects of exercise; (3) they only included 95 
combined exposures (e.g., exercise plus chemical therapy); and (4) the reported results 96 
do not allow calculation of effect sizes. 97 
Data extraction and quality assessment 98 
Four reviewers (ACCF, AC, JS and JCL) extracted the baseline characteristics and 99 
outcomes data and contacted the authors for missing data. In order to make it possible 100 
to correlate the eighteen biomarkers found, they were grouped into three families: (1) 101 
inflammation and cytokines, (2) glucose homeostasis and metabolism, and (3) sex 102 
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5
steroid hormones, accordingly with the host-related determinant processes in which 103 
they participate in the context of cancer 19. 104 
Three reviewers (ACCF, RF and JAD) evaluate the Risk of Bias of included studies 105 
using the SYRCLE’s Risk of Bias (RoB) tool (SYstematic Review Centre for 106 
Laboratory animal Experimentation Risk of Bias tool), a Cochrane RoB tool adapted 107 
for animals 21,22. Each article was graded (low, unclear or high risk of bias) in the six 108 
domains (selection, performance, detection, attrition, reporting and other bias) of 109 
SYRCLE’s RoB tool. However, we decided to abolish the question 5 (blinding) of 110 
performing bias dimension. In fact, to investigate the effects of exercise is absolutely 111 
essential that both, investigators and caregivers, be aware of the animals compliance 112 
with the exercise conditions in order to reduce the outcome bias (ESM Table S2). 113 
Disagreements were resolved by consensus and a fourth author (JS) was consulted if 114 
consensus could not be reached. 115 
Data synthesis and analysis 116 
Data were pooled using random-effects model. As the included studies used different 117 
scales to assess the same outcome, we used the correlation coefficient, r, to estimate 118 
the effect size of its value in exercise-cancer associations. When r was unavailable, we 119 
converted the available data (averages, standard deviations, percentages and exact p 120 
values) into r values 23. Presence of heterogeneity was tested using Cochran’s Q and I2 121 
tests, and Cohen’s (1988) criteria for small, medium and large r (r = .10, .30, and .50 122 
respectively) effects were used 24 to estimate the magnitude of the results. In order to 123 
explore potential sources of heterogeneity, and the influence of different factors on the 124 
estimate of effect size we select, relied on theory and previous findings, potential 125 
moderating variables (e.g., voluntary or forced exercise, intensity, distance covered, 126 
duration and frequency) 25, and  we coded them to categorize the analyses (Table 1). 127 
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To test the robustness of the overall weighted effect sizes, a sensitivity analysis was 128 
conducted by extracting the results of one study at a time from the initial meta-129 
analysis. 130 
Determination of bias was made observing the funnel plot and applying Egger’s 131 
regression and Begg’s rank correlation. We used the Comprehensive Meta-Analysis 132 
software version 2.2.057 (CMA, Englewood, New Jersey, USA) to perform all of the 133 
statistical analyses. 134 
Table 1 135 
Results 136 
Study selection and characteristics 137 
At the end of the search, we identified 282 reports (Fig. 1), from which only nine 19,26-138 
33 fulfilled the inclusion criteria and blocked any exclusion criteria.  139 
Fig. 1 140 
A total of ten experimental exercise (Table 2) protocols that were equally divided into 141 
forced exercise (50.0%) 26,27,29-31 and voluntary (50.0%) exercise 19,28,32,33 modalities 142 
were used. In voluntary exercise designs, the free-wheel was used the most when 143 
compared with the motorized-wheel (30.0% versus 20.0%). 144 
Intensity was measured in eight protocols (80.0%). Moderate intensity was the most 145 
frequently used, while vigorous and low intensities were equally distributed over the 146 
remaining two protocols (40.0% versus 20.0% versus 20.0%). 147 
Only 50.0% of the experimental protocols had defined exercise bout durations (long: 148 
60.0%; medium: 20.0%; short: 20.0%). In the remaining 50.0% of the designs, no data 149 
was provided regarding the length of the daily exercise period. 150 
Chemical-induced breast cancer (equal doses and administration routes) was the most 151 
frequently used model (66.7%) 19,26,27,31-33, followed by a transgenic model 28,30 (66.7% 152 
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versus 22,2%). Only one study used the human breast cancer cell inoculation (11.1%) 153 
29.154 
Table 2 155 
In general, a positive balance in the exercise-tumor relationship can be observed in the 156 
analyzed publications regarding the three families of systemic biomarkers. 157 
Exercise prevented tumor-induced systemic inflammation in the majority of the 158 
published studies 19,26,28-33, but negative data concerning circulating levels of IL-6 19,33 159 
and albumin content 31 were reported in three studies. 160 
Positive modulation of glucose metabolism biomarkers by exercise was also observed 161 
in the majority of the studies 19,26,27,32,33. Nevertheless, a negative influence was 162 
referred in one study in which the association of high levels of circulating glucose 163 
with the free-wheel exercise modality was reported 19. 164 
Exercise also prevents the exposure to higher levels of estradiol 19,32,33 although the 165 
opposite is described in one study 26. 166 
Risk of bias and quality of evidence 167 
In 92.59% of the cases the sequence generation, the baseline characteristics and the 168 
allocation concealment were adequate (low risk of bias). Housing conditions were 169 
similar in 88.89% of the cases, and the outcome assessment methods were also 170 
adequate in 72.22%. Incomplete outcome data (the analysis do not include all the 171 
animals) was unclear in only 22.22% of the analyzed studies.  100% (low risk of bias) 172 
of the published reports included all the expected outcomes and clearly stated the 173 
financial support. Overall, the nine studies were judge at low risk of bias (ESM Table 174 
S3). 175 
Effect size of exercise on systemic biomarkers levels 176 
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To quantify the relationship between exercise and the evaluated 18 biomarkers, a total 177 
of 65 correlations were made, using 33 of them to examine the effects of exercise on 178 
the inflammatory process and cytokines levels (Fig. 2a), 21 of them to analyze 179 
exercise effects with respect to glucose homeostasis and metabolism (Fig. 2b), and 11 180 
to determine exercise effects on the sex hormone family (Fig. 2c). 181 
 Fig. 2 a, b, c 182 
The positive impact of exercise on the modulation of all of the selected biomarkers 183 
could be observed. Exercise promotes large benefits on tumor-related systemic 184 
inflammation (r = -.519, p = .011; 95% CI =  -.768; -. 133; n = 413; k = 33), on 185 
exposure to sex hormones (r = -.697, p = .002; 95% CI = -.887; -.308; n = 470; k = 186 
11), and on the regulation of glucose-related factors (r = -.745, p = .000; 95% CI = -187 
.898; -.433; n = 341; k = 21). 188 
We identified high heterogeneity among collected study data 34 with respect to 189 
dependent variables, namely with respect to inflammation and cytokines family 190 
[Q(32) = 4104.799, p = .000 (I2 = 99.220)], glucose homeostasis metabolism [Q(20) = 191 
2934.269, p = .000 (I2 = 99.318)], and sex hormone families [Q(10) = 699.156, p = 192 
.000 (I2 = 98.570)]. Removing on study at a time did not substantially alter our results 193 
in any of the variables. In systemic-induced inflammation the variations in global 194 
effect size (r = -.479, p = .019, 95% CI =  -.738, -.064; r = -.575, p = .001, 95% CI =  -195 
.779 -.260) were low than 10% (ESM figure F2a). Similar results (r = -.698, p = .000, 196 
95% CI =  -.873, -.361; r = -.799, p = .000, 95% CI =  -.909 -.584) can be observed for 197 
glucose-related levels (ESM figure F2b), and for sex hormone levels (ESM figure F2c: 198 
r = -.615, p = .005, 95% CI =  -.839, -.213; r = -.734, p = .001, 95% CI =  -.906 -.353). 199 
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High variability in effect sizes could also be related to different parameters in the 200 
experimental exercise designs. Accordingly, we also tried to identify the strength of 201 
the influence of the different exercise parameters on the exercise-tumor relationship. 202 
Potential moderating factors 203 
To examine how the outcomes with respect to the three dependent variables could be 204 
affected by the exercise designs, we performed separate analyses.  With some 205 
exceptions, exercise-induced moderation could be observed (Table 3). 206 
Table 3  207 
Voluntary exercise versus forced exercise: The benefits of exercise in tumor-related 208 
inflammation, circulating levels of glucose-related factors, and sex hormone 209 
concentrations seem to occur whether or not the exercise type was forced or voluntary. 210 
Inflammation biomarkers (72.5% versus 58.9%) and sex hormones (86.9% versus 211 
86.6%) benefit from both exercise modalities. Additionally, glucose metabolism 212 
shows small beneficial effects when exercise is performed on a treadmill (25.1%), and 213 
larger beneficial effects when performed on motorized (82.7%) or free-wheel 214 
equipment (94.4%). 215 
Intensity: Vigorous exercise intensity appears to be essential in order to positively 216 
alter systemic biomarker concentrations. In spite of all levels of intensity have exerted 217 
positive influence in the three studied biomarker families, the highest scores were 218 
obtained with vigorous followed by moderate intensity (inflammation and cytokines: 219 
58.3% - 43,1%; glucose homeostasis and metabolism: 88.8% - 25,1%; and sex 220 
hormones: 80.5% - 47.9%). 221 
Distance covered: When considering the distance covered, the beneficial effects 222 
observed on biomarkers outcomes did not seem to depend on this variable. 223 
Moderation was found only in glucose homeostasis and metabolism , but the 224 
Page 9 of 35
Scandinavian Journal of Medicine & Science in Sports - PROOF
Scandinavian Journal of Medicine & Science in Sports - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
92
PROOF
10
beneficial effects were significant regardless of the distance that was covered (85.7% 225 
versus 92.4%). 226 
Duration: Short and medium exercise bouts exerted significant effects on circulating 227 
marker concentrations. Short exercise bouts showed a large effect on inflammation 228 
when compared with long exercise bouts (97.9% versus 43.1%), and the same effect 229 
could be observed on sex hormone levels (96.0% versus 47.9%). The biomarkers 230 
associated with glucose metabolism seem to have gained more benefits from medium 231 
length exercise bouts (32.2%). However, it is worth noting that none of the other 232 
members of the biomarker families were examined under medium exercise bouts 233 
conditions. 234 
Frequency: Weekly exercise did not moderate the observed benefits in circulating sex 235 
hormone levels. In tumor-related inflammation, an exercise frequency of 5 or 7 days 236 
has similar and significant effects (67.1% versus 62.0%) with respect to the observed 237 
improvements, while for glucose metabolism a 7-day frequency (90.6%) appeared to 238 
be more beneficial. 239 
We found no evidences of publication bias after observing funnel plots and 240 
considering Egger’s regression and Begg’s rank correlation, with respect to 241 
inflammation and cytokines (p = .16742), glucose homeostasis and metabolism (p = 242 
.24057), and sex hormone families (p = .04655). 243 
Discussion 244 
In this review we first aimed to summarize and quantify the current knowledge about 245 
the effects of exercise on the levels of tumor-related biomarkers of inflammation, 246 
glucose metabolism, and sex hormones. To the best of our knowledge, no meta-247 
analytical study has been done to quantify this association in breast cancer preclinical 248 
models. 249 
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In contrast to some preclinical studies that link the deregulation of some systemic 250 
markers to exercise 19,26,31,33, our meta-analysis showed that engaging in 251 
approximately 85 min per week (useful days) of vigorous forced exercise after cancer 252 
induction, was associated with 61.5% tumor-reduced systemic inflammation 253 
biomarkers, and with 69.7% improvement in steroid hormones circulating levels. 254 
Similar outcomes can be obtained with vigorous motorized-wheel and in free-wheel 255 
modalities but in the latter, it is not possible to point the exercise parameters. 256 
We also found that engaging in voluntary exercise modalities (free-wheel or vigorous 257 
motorized-wheel) is associated with 86.6% improvement in the circulating levels of 258 
glucose metabolism biomarkers. Small beneficial effects can also be achieved by 259 
participating in about 200 minutes of vigorous treadmill exercise per week (useful 260 
days). 261 
Our results also indicated a positive influence of moderate intensity in all biomarkers 262 
outcomes but in a small degree. In fact, participating in approximately 85 min per 263 
week (useful days) of moderate treadmill exercise can also have positive effects on 264 
tumor-related inflammation (43.1%) and in the circulating sex hormone levels 265 
(47.9%). In glucose metabolism, the positive effects of moderate intensity (25.1%) can 266 
also be observed but only to a small degree. 267 
Exercise’s significant impact on inflammation and cytokines family and on the sex 268 
hormone family was achieved with the similar amounts of exercise than those 269 
prescribed in the guidelines for cancer patients regarding vigorous activity (i.e., 75 270 
min vigorous activity per week) 35. 271 
The best results in glucose homeostasis and metabolism family appear to be associated 272 
with voluntary exercise, which indicates that we can not determine the exact amount 273 
of exercise performed that made possible to achieve those results. On the other hand, 274 
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the results obtained when exercise is performed under forced modalities, hardly 275 
reproducible during breast cancer continuum (i.e. 200 minutes of vigorous exercise 276 
every week), even positive, were smaller. 277 
In contrast to what has been reported in several studies 19,32,33, we found that the 278 
distance covered by the animals did not seems to be important for modulating selected 279 
biomarker levels. It seems that exercise intensity is the determining variable that 280 
improved the outcomes. This finding seems to be a strong argument favoring exercise 281 
designs in which the intensity levels can be manipulated. 282 
It is clear that inflammation plays a significant role in the development and 283 
progression of cancer by influencing the host immune response 36-40. Despite 284 
inconsistent results about an inverse relationship between exercise and inflammation 285 
described in the literature 41, the present data from animal studies strongly supports 286 
this inverse relationship. It remains to be clarified as to whether exercise can exert a 287 
direct influence on inflammatory pathways or if the beneficial effects are achieved 288 
thought indirect ways such as the modulation of body composition 42.  Evidence that 289 
improvements in circulating sex hormone levels are associated with exercise, 290 
especially in postmenopausal breast cancer, is more consistent in the literature 43-45. 291 
Accordingly, our data demonstrates a strong and inverse association between exercise 292 
and the modulation of steroid hormone levels. Additionally, there is sufficient current 293 
evidence to justify interventions, such as exercise, that lower insulin levels, as targeted 294 
treatments in breast cancer 46,47. Several studies have demonstrated that elevated 295 
insulin and insulin-like growth factors levels are associated with poor prognosis in 296 
breast cancer patients 4,14,15,39,48-50, and that exercise might have an important action on 297 
regulating these levels. The present data confirmed this finding, however, the fact that 298 
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the best results were obtained with voluntary exercise modalities limited any kind of 299 
information about the exact amount of exercise needed to reach this endpoint. 300 
Another finding in this review lies in the diversity of exercise designs used, which 301 
imposes clear limitations in extending the results obtained by these studies to other 302 
populations and other contexts. 303 
Animal studies provide an important contribution to manipulating exercise variables in 304 
order to establish the ideal amount to modulate the biological pathways involved with 305 
the underlying exercise-cancer relationship mechanisms (e.g., insulin sensitivity, 306 
chronic inflammation, steroid hormone levels, and innate immunity). Nevertheless, the 307 
lack of studies in the present analysis shows that these studies have been underused. 308 
Furthermore, the differences in exercise designs create serious difficulties for 309 
quantitative reviews. Additionally, half of the studies do not clearly define the exercise 310 
model that they want to reproduce in humans. This is a strong limitation with respect 311 
to relating preclinical results to clinical contexts. 312 
Strengths and limitations of this review 313 
As far as we know our meta-analysis is the first one to provide a comprehensive and 314 
quantitative overview in preclinical data related to the effects of exercise in breast 315 
cancer biomarkers. We used current recommendation to judge the risk of bias and 316 
rated the reports with an overall low risk of bias. 317 
We analyzed potential moderators that could have influenced our effect estimates and 318 
we found the amounts of exercise training that better improved cancer-induced 319 
inflammation and sex hormone levels. We also performed a sensitivity analysis to 320 
examine the impact of each study in the overall effect size and we observed small 321 
variations. We do not found publication bias in none of the variable studied. 322 
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There are limitations in this study. First, studies published in languages other than 323 
English were not considered. Additionally, some manuscripts were excluded (n = 3) 324 
because they did not present all the necessary data. 325 
Perspectives 326 
We found considerable improvements in cancer-related inflammation, in the 327 
regulation of glucose-related factors, and in the sex hormone concentrations, among 328 
the animals exposed to exercise. It became clear that performing 85 min per week of 329 
vigorous forced exercise reduced systemic inflammation, and improved sex hormone 330 
levels. It was impossible to pinpoint the exercise amount needed to regulate host 331 
glucose-related factors. Based on the proposed framework, we recommend future 332 
preclinical studies including similar exercise parameters with specific endpoints 333 
evaluation that can be reproduce in humans. 334 
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Figure legends 489 
Fig. 1 Flow chart depicting the selection of studies for the meta-analysis. 490 
Fig. 2a Forest plot of the meta-analysis about exercise effects on systemic levels of 491 
inflammation and cytokines. Correlation: effect size (r) for each study. CI= confidence 492 
interval. a, b: different measures within the same study. 493 
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Abbreviations: SPWEIGHT, spleen weight; IL-6, interleukin-6; TNF-α, tumor 494 
necrosis factor-α; CRP, C reactive protein; IFN-Y, interferon-Y; MCP-1, monocyte 495 
chemoattractant protein; SAP, serum amyloid P; TWEAK, TNF-like weak inducer of 496 
apoptosis. 497 
Fig. 2b Forest plot of the meta-analysis about the influence of exercise on systemic 498 
levels of glucose homeostasis and metabolism biomarkers. Correlation: effect size (r) 499 
for each study in. CI= confidence interval. a, b, c: different measures within the same 500 
study. 501 
Abbreviations: CORT, corticosterone; GLUC, glucose; IGF-1, insulin like growth 502 
factor; INSUL, insulin; LDH, lactate dehydrogenase. 503 
Fig. 2c Forest plot of the meta-analysis addressing the influence of exercise on 504 
systemic levels of sex steroid hormone biomarkers. Correlation: effect size (r) for each 505 
study CI= Confidence Interval. a, b: different measures within the same study. 506 
Abbreviations: ESTR, estradiol; PROG, progesterone. 507 
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ra
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at
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at
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w
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er
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F-
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 t
um
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R
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 r
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C
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 m
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 p
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os
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 m
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 C
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 d
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 d
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ra
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t c
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be
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m
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N
O
TE
: 
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er
ci
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nt
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si
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st
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 c
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ed
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du
ra
tio
n 
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d 
ex
er
ci
se
 f
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qu
en
cy
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s 
m
od
er
at
or
s 
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se
le
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ed
 b
io
m
ar
ke
rs
. N
um
be
r o
f c
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es
 (k
) f
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 c
or
re
la
tio
n 
(r
), 
an
d 
re
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ec
tiv
e 
p-
va
lu
e.
  
a)
Is
 n
ot
 m
od
er
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ed
 b
y 
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xe
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iti
on
.
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C
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m
m
at
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s;
 G
H
M
, g
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eo
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 m
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at
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, m
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, l
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B
); 
N
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H
R
B
); 
U
 =
 U
nc
le
ar
 ri
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 o
f b
ia
s (
U
R
B
). 
N
A
 =
 N
ot
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R
es
ul
ts
 b
y 
di
m
en
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on
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Q
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 Q
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&
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R
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; U
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B
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R
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Q
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Q
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Q
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R
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R
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Q
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Exercise training-induced modulation in microenvironment 
of rat mammary neoplasms 
Journal: International Journal of Sports Medicine 
Manuscript ID IJSM-03-2018-6869-pb 
Manuscript Type: Physiology & Biochemistry 
Key word: Breast tumor, Ki67, Cell proliferation, TUNEL assay, Cell death, Colagem content 
Abstract: 
Despite the importance attributed to exercise training in the breast cancer 
(BC) continuum, the underlying mechanisms modulating tumor behavior 
are unknown. We evaluated the effects of long-term moderate-exercise in 
the developm nt of mammary tumors, and studied the microenvironment 
of infiltrative lesions, the amount of connective tissue, and balance 
between cellular proliferation/death. 
Fifty Sprague-Dawley rats, randomly assigned into four groups: two control 
groups (sedentary and exercised) and two models of BC groups (sedentary 
and exercised) induced by N-methyl-N-nitrosoureia (MNU), were sacrificed 
after 35 weeks of moderate-exercise, and all perceptible tumors were 
removed for histological and immunohistochemistry analysis. 
The median number of infiltrative-lesions per animal was lower in the MNU 
exercised animals (p=0.02). More than one histological pattern was 
identified, and papillary carcinoma was the most frequent in both groups. 
Within infiltrative-lesions, the number of immunopositive cells per µm2 of 
Ki67 was lower in exercised animals (p=0.002). This presents increased 
cell death per µm2 (p=0.019). Tumors from sedentary animals had a 
higher expression of collagen deposition (p=0.027). 
Long-term moderate-exercise has beneficial effects in tumor development 
with a diminished prevalence of malignancy. Within infiltrative-lesions, 
moderate-exercise improves the balance between cell-proliferation and 
cell-death with decreased connective tissue that suggests lower tumor 
aggressiveness. 
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1 
Exercise training-induced modulation in microenvironment of rat mammary 1 
neoplasms 2 
Abstract 3 
Despite the importance attributed to exercise training in the breast cancer (BC) 4 
continuum, the underlying mechanisms modulating tumor behavior are unknown. We 5 
evaluated the effects of long-term moderate-exercise in the development of mammary 6 
tumors, and studied the microenvironment of infiltrative lesions, the amount of 7 
connective tissue, and balance between cellular proliferation/death.  8 
Fifty Sprague-Dawley rats, randomly assigned into four groups: two control groups 9 
(sedentary and exercised) and two models of BC groups (sedentary and exercised) 10 
induced by N-methyl-N-nitrosoureia (MNU), were sacrificed after 35 weeks of 11 
moderate-exercise, and all perceptible tumors were removed for histological and 12 
immunohistochemistry analysis. 13 
The median number of infiltrative-lesions per animal was lower in the MNU exercised 14 
animals (p=0.02). More than one histological pattern was identified, and papillary 15 
carcinoma was the most frequent in both groups. Within infiltrative-lesions, the number 16 
of immunopositive cells per µm2 of Ki67 was lower in exercised animals (p=0.002). 17 
This presents increased cell death per µm2 (p=0.019). Tumors from sedentary animals 18 
had a higher expression of collagen deposition (p=0.027). 19 
Long-term moderate-exercise has beneficial effects in tumor development with a 20 
diminished prevalence of malignancy. Within infiltrative-lesions, moderate-exercise 21 
improves the balance between cell-proliferation and cell-death with decreased 22 
connective tissue that suggests lower tumor aggressiveness. 23 
Keywords: Breast tumor, exercise training, ki67, cell death, TUNEL assay, cell 24 
proliferation, collagen content. 25 
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2 
Introduction 26 
Breast cancer is the second most common cancer in world and the most common in 27 
women [39]. The International Agency for Research on Cancer (IARC) has estimated 28 
that 1.97 million new cases will be diagnosed worldwide in 2020 (25% of all cancers) 29 
[16]. Early detection, improved treatments, and active lifestyles increase breast cancer 30 
survival [38]. Several studies have shown that exposing breast cancer patients to regular 31 
physical exercise benefits prevention, recurrence, and survival but the biological 32 
mechanisms underlying these benefits remain unclear [17, 34]. The role of exercise in 33 
the breast cancer continuum is unclear despite convincing clinical epidemiological data 34 
confirming its efficacy with contrasting results in animal models [9]. In addition, 35 
knowledge about the tumor microenvironment (TME) during exercise is lacking [2]. 36 
The proliferative capacity of a tumor is one of the most important variables that 37 
determines tumors’ progression along with its ability to undergo apoptosis [8, 31]. In 38 
fact, what defines the growth rate of a given cell population is the balance between 39 
cellular proliferation and death. Thus, improve the competency of the apoptotic 40 
machinery in malignancy is an important target in breast cancer. [10]. Furthermore, a 41 
relationship is established between malignant cells and the TME during cancer 42 
progression. This is composed of the extracellular matrix (ECM) and cellular 43 
components. Moreover, it is now well-documented that neoplastic cells are influenced 44 
by the surrounding microenvironment and vice-versa [36]. The crosstalk between 45 
cancer cells and the other TME-associated cells (e.g. fibroblasts and macrophages) may 46 
underlie the tumor’s capability to grow and metastize [22]. 47 
It is unclear how mammary tumors in animals respond to exercise training. The few 48 
research reports in this area show promising results by associating exercise training 49 
exposure with reductions in proliferation-associated proteins together with increased 50 
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3 
expression of apoptosis-associated proteins, but this needs confirmation [25-27, 47]. It 51 
remains unknown if exercise training modulates neoplastic stroma. 52 
Here, we used a well-characterized model of breast cancer induced in rats by N-methyl-53 
N-nitrosourea (MNU) to determine the long-term exercise effects in the54 
microenvironment of neoplastic tissue. Previously, our research team has shown that 55 
exercise training can reduce malignancy [15]. Here, we hypothesized that exercise 56 
training could favorably modulate the TME via the following: (1) reducing their 57 
proliferative capacity; (2) improving their ability to undergo cell death; and (3) 58 
remodeling the TME stroma. 59 
Materials and methods 60 
Animals 61 
Fifty female Sprague-Dawley rats (38 days old; 289±17g body weight) from Harlan 62 
Interfauna Inc. (Barcelona, Spain) were randomly housed in collective cages (4 animals 63 
per cage) and maintained under controlled atmospheric conditions (21-22°C; 60 ± 5% 64 
humidity) in a 12/12 hours light/dark cycle with free access to food (standard laboratory 65 
diet 4RF21® Mucedola, Italy) and water. All the ethical principles of research involving 66 
animals were met [23]. The Portuguese Ethics Committee for Animal Experimentation 67 
(Direção Geral de Alimentação e Veterinária) approved the animal protocol with license 68 
number 008961, and the experimental protocol was performed in accordance to 69 
European Commission Recommendation 2007/5266/CE. 70 
Experimental design 71 
After two weeks of acclimatization, the animals were randomly assigned to one of four 72 
groups: sedentary injected with MNU (MNU+SED, n=15); exercised injected with 73 
MNU (MNU+EX, n=15); sedentary control, injected with sterile saline solution 74 
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4 
(CONT+SED, n=10); and exercised control, injected with sterile saline solution 75 
(CONT+EX, n=10). Animals from the MNU groups were injected intraperitoneally 76 
(i.p.) with 1-methyl-1-nitrosureia (ISOPAC®, Sigma Chemical Co., Madrid, Spain) 77 
given in a dose of 50 mgkg; the control groups received i.p. injection of vehicle (sterile 78 
saline solution 0.9%). Two days after carcinogen injection, animals from the exercised 79 
groups started a treadmill running program (Treadmill Control LE 8710, Harvard 80 
Apparatus, USA) for 35 weeks. The duration and intensity of running were gradually 81 
increased over the first two weeks until it reached 60 m/day, 5 days/week and 20 m/min 82 
of speed (estimated work rate of 70% maximum oxygen consumption) [32]. This was 83 
maintained until the end of the experimental protocol. Sedentary animals were 84 
manipulated daily to establish identical conditions to active animals. 85 
At the end of experimental protocol, animals were euthanized by i.p. injection of 86 
ketamine (75mg/Kg, Imalgen® 1000, Merial SAS, Lyon, France) and xylazine (10 87 
mg/Kg, Rompun® 2%, Bayer Healthcare S. A., Kiel, Germany). In each animal, all 88 
perceptible tumors were removed, counted, weighed, and prepared for histological and 89 
immunohistochemical analysis. 90 
Histological and immunohistochemical analysis 91 
Briefly, samples were fixed with paraformaldehyde, dehydrated in graded ethanol 92 
solutions, cleared in xylene, and embedded in paraffin. Paraffin blocks were then cut 93 
into 5 µm sections with a Leica 2125 rotary microtome (Leica Microsystems Inc.). The 94 
paraffin embedded slides were deparaffinized in xylene and hydrated using a series of 95 
graded ethanol. They were stained with hematoxylin and eosin (H&E) for histological 96 
classification and with Picrosirius Red (PSR) to assess collagen content (CC).  Tumors 97 
were classified according to Russo and Russo [37] and presented different histological 98 
patterns (here designated as lesions). After being identified and quantified, all 99 
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5 
infiltrative lesions were further analyzed via the TUNEL assay and Ki67 100 
immunostaining. 101 
TUNEL assay: A TUNEL test (Terminal deoxynucleotidyl transferase-mediated d-102 
UTP Nick End Labeling) was performed (In Situ Cell Death Detection Kit, Ap, 103 
11684809910 from Roche®, Germany) according to manufacturer’s instruction on 104 
paraffin embedded tissues using the citrate buffer (pH=6.0). Samples were then heat-105 
treated (in a pressure cooker) for 5 minutes for antigen retrieval. Appropriate positive 106 
and negative controls were used throughout. After Fast Red application, the slides were 107 
rinsed in water, counterstained with hematoxylin for 5 minutes, and mounted with 108 
Crystal Mount (aqueous-based). Imaging detected and quantified the cell death per µm2. 109 
Ki67 immunostaining: Rabbit monoclonal [SP6] antibody to Ki67 (rabbit ab16667 110 
from Abcam®, England) was used to quantify cells into cell cycle per µm2. Slides were 111 
immersed in citrate buffer (pH=6.0) and heat-treated (in a pressure cooker) for antigen 112 
retrieval for 15 minutes. This was then cooled down in citrate buffer for 30 minutes. 113 
Slides were rinsed in PBS (pH=7.4) twice between applications of each of the following 114 
reagents. Endogenous peroxidase activity was blocked applying a solution with 115 
methanol, hydrogen peroxide, and PBS-Tween (phosphate-buffered saline) for 30 116 
minutes. Bovine serum albumin (3%) was applied 30 minutes for non-specific blocking. 117 
Primary and secondary (goat anti-rabbit HRP, ab 97069 from Abcam ®, England; HRP-118 
conjugated secondary antibody) antibodies were applied for 120 minutes and 60 119 
minutes, respectively, in a humidified 37°C chamber. After DAB (diaminobenzidine) 120 
application for 7 minutes, the slides were rinsed in water, counterstained with methyl-121 
green for 3 minutes, dehydrated using a series of graded ethanol, cleared in xylene, and 122 
mounted with DPX (Distryene Plasticizer Xylene). Negative controls for primary and 123 
secondary antibodies were used throughout. 124 
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6 
After all of these procedures, slides from each malignant lesion were scanned with a 125 
Virtual Slide System VS110 (Olympus, Japan), and the digital slides were analyzed 126 
using Fiji ImageJ Pro and Image Pro (Media Cybernetics, version 6.0). Several 127 
parameters were assessed from each analyzed section including: (1) the number of 128 
Ki67-positive nuclei per µm2 [5]; (2) the number of TUNEL-positive nuclei per µm2 129 
[11] and; (3) the overall percentage of collagen within the tissue section [24].130 
Statistical analysis 131 
All quantitative variables were expressed as median and percentiles (25th and 75th) due 132 
to their abnormal distribution as previously assessed with the Shapiro-Wilk test. All 133 
categorical variables were expressed as an absolute and/or relative frequency. For 134 
quantitative variables, data comparison between groups was done with a non-parametric 135 
Mann-Whitney test one-tailed; inter-group comparison of categorical variables was 136 
performed with the Chi squared test. The odds ratio (OR) with 95% CIs were also 137 
calculated (Fisher’s exact test) to establish the association between sedentary and 138 
exercise behaviors with the odds of developing an infiltrative lesions. A p value < 0.05 139 
was considered statistically significant. Graph Pad Prism software (version 7.0) was 140 
used for all analysis. 141 
Results 142 
All MNU animals developed tumors at the end of the experimental protocol; no tumors 143 
were detected in the control groups. The number of tumors developed was similar in 144 
both groups [14]. Table 1 shows no significant differences between groups in the 145 
infiltrative tumor’s total weight. Non-infiltrative lesions were slightly higher in the 146 
MNU sedentary animals, but this was not significant. However, the positive impact of 147 
exercise training can be observed in the prevalence of infiltrative lesions per animal—148 
these were significantly lower in the exercised MNU animals (p=0.020). 149 
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7 
The frequency of distribution for the different types of lesions between groups (Fig. 1) 150 
was significantly different  (p=0.0005). Different histological patterns of non-infiltrative 151 
(Fig. 1A) and infiltrative (Fig. 1B) lesions were identified. The most frequent infiltrative 152 
type for both groups, although lower in exercised animals, was the papillary type 153 
followed by the cribriform pattern. No invasive comedocarcinoma pattern was detected 154 
in MNU-exercised animals. This was the most aggressive lesion identified in MNU 155 
sedentary animals. Similar rates of pre-neoplastic lesions (intraductal proliferation) 156 
were found in both MNU groups. 157 
Insert Table 1 158 
Insert Figure 1 159 
Additionally, the computed OR revealed that the odds of appearance of an infiltrative 160 
lesion in sedentary animals are higher (OR=1.27; CI: 0.67 - 2.37) than the odds of this 161 
appearance in exercised animals. The opposite is seen relative to non-infiltrative lesions 162 
(OR=0.79; CI: 0.41, 1.51). These are less likely to appear in MNU sedentary animals. 163 
This means that the probability of a MNU sedentary animal developing an infiltrative 164 
lesion is 27% higher. 165 
Immunohistochemical analysis 166 
The positive influence exerted by long-term (35 wks.) moderate exercise training in 167 
malignant lesions was noted in their density of cell proliferation and cell death. Cell 168 
proliferation was evaluated by Ki67 staining by counting the positive nuclei in all 169 
sections of the scanned slides (Fig. 2A and 2B). An increase in cell proliferation (322 170 
[265.5-442.5]) was observed in sedentary animals comparatively to exercised animals 171 
(194 [98.5-284.5]; Figure 2C). 172 
Insert Fig. 2 173 
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8 
Cell death was assessed by TUNEL staining, and the positive nuclei for DNA 174 
fragmentation were counted using all sections of the scanned slides. Figure 3 shows the 175 
collected data for cellular death fraction—a decrease in positive nuclei (19 [15.75-39.5]) 176 
can be observed in MNU sedentary (Fig. 3A) animals compared to the MNU exercised 177 
animals (Fig. 3B, 38 [27.5-70.5]). Significant differences were observed between MNU 178 
groups (Fig 3C). 179 
Insert Fig. 3 180 
Collagen content analysis 181 
The collagen content was measured as the percentage of pixels containing the red 182 
signaling in tissue images. Exercised animals (Fig. 4B; 6.16  [3.76-9.48]) had a lower 183 
amount of connective tissue in the TME of active animals’ tumors versus sedentary 184 
animals (Fig. 4A, 7.41 [4.97-10.22]) (Fig. 4C). 185 
Insert Fig. 4 186 
Discussion 187 
This study provides strong evidence for the protective effects of exercise training on 188 
tumor development and malignancy accompanied by substantial improvements in the 189 
features of the lesions. In contrast to previous reports that associated a reduction in 190 
tumor burden with exercise training, we found that breast tumors grew at comparable 191 
rates in sedentary and exercising animals [3, 19, 25-27, 33, 35, 40, 43-46, 48, 49]. Other 192 
researchers have reported that the increased rates of mammary tumor growth are 193 
associated with exercise exposure [6, 7, 14, 33]. These contrasting results can be 194 
explained by differences in the protocols. 195 
For example, Zhu et al., Jiang et al., Goh et al., and Welsch et al., found positive results 196 
in tumor size associated with voluntary exercise, but the duration of the experiments 197 
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9 
ranged from 5 to 10 weeks [48, 49] [26, 27] [19] [43]. Only one report has associated 198 
voluntary exercise with a 40.0% decrease in tumor size, but this used a longer protocol 199 
(20 weeks) [40]. In contrast, Cohen et al., and Colbert et al., found the opposite results 200 
in animals subjected to voluntary exercise for a longer period (20 and 21 weeks 201 
respectively) [6] [7]. 202 
If we consider forced exercise designs, then we can verify the same tendency of 203 
exercise-induced reduction in tumor size associated with small duration experiments 204 
(between 2 and 12 weeks) [3, 33, 44, 46]. Exercise-induced tumor growth appears to be 205 
associated with longer experiments (20 and 35 weeks) under forced exercise designs [7, 206 
14]. These differences might be partially explained in voluntary exercise experiments. 207 
There is an inevitable reduction in the amount of exercise performed when tumor 208 
burden increases. Whereas in forced exercise protocols like ours, the heavier and bigger 209 
tumors observed over longer duration experiments might result from the increased 210 
vascularization induced by exercise [15, 28, 29]. 211 
The benefits of regular exercise were also shown in the histology data. The tumor-212 
bearing animals exposed to exercise training presented fewer non-infiltrative lesions 213 
and fewer infiltrative lesions. Exercise training might hamper the progression from 214 
noninvasive to invasive lesions, and this might explain at least partially explain the 215 
significant differences in the prevalence of malignant lesions. These differences toward 216 
a lower aggressiveness in the histological lesions of exercised animals are related to 217 
cancer-reduced systemic inflammation as we described previously [14]. Indeed, the 218 
levels of CRP and IL-6 were higher in sedentary animals. They also had a heavier 219 
spleen weight. This establishes an association between exercise training and decreased 220 
expression in systemic markers of inflammation that might be mediated by 221 
improvements in the host immune response, which is consistent with other results [18]. 222 
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10 
It remains unclear if the same thing happened in the TME of exercised animals once we 223 
no longer measured intratumoral markers of inflammation or immune infiltration. 224 
Obviously, the expression of immune mediators (e.g. natural killer cells and 225 
macrophages) could be activated or suppressed as could the expression of pro-226 
inflammatory cytokines [20]. IL-6 and other factors secreted by the tumor influence the 227 
behavior of TME-associated cells such as macrophages and fibroblasts, and these 228 
factors can lead to alternative activation pathways for these cells [41]. The conversion 229 
of Type 1 macrophages (M1) into Type 2 macrophages (M2), for example, produces IL-230 
10 and TGF-β and alters the differentiation of T cells away from the cytotoxic Th1 231 
response. This can cause the cancer cells to attain stem cell-like features and can 232 
increase the fibrosis content [4]. 233 
The high degree of proliferation in the infiltrative lesions of sedentary animals suggests 234 
an overexpression of pro-inflammatory markers. This could suppress the anti-tumor 235 
immune response and can lead to increased malignancy [20]. Exercise could also impact 236 
absorption of MNU. Indeed, if the dose, route, and age of administration were the same 237 
in both groups, then the differences in the outcomes might depend on variations in the 238 
carcinogenic’s toxicokinetics and toxicodynamics as mediated by exercise training [1]. 239 
Interestingly, other papers do not describe differences in histology unlike our work  [2]. 240 
Thus, is spite of our results being encouraging they can not be compared with others 241 
The reduced malignancy seen here could also be via modulation of malignant tissue 242 
properties. Obviously, uncontrolled cell proliferation and decreased apoptosis are key 243 
features of malignancy [21]. Increased proliferation and suppression of apoptosis are 244 
hallmarks of malignant tumors, and they play a central role in the development and 245 
progression of cancer [13]. Ki67 is a prognostic and predictive marker in breast cancer, 246 
and higher values of this protein are normally associated with poor prognosis [12]. Our 247 
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11 
results show that the infiltrative tumors of the animals exposed to moderate exercise 248 
training have lower Ki67 expression versus sedentary animals. 249 
Our findings indicate that exercise training positively affected the growth fraction of 250 
malignant tissue differently than what has been previously reported by Zhu and 251 
colleagues in an identical work [47]. They found that physical activity had no 252 
significant influence on the immunoexpression of Ki67 in mammary carcinomas 253 
Malicka and co-workers also saw no changes in the expressiveness of Ki67 [33]. On the 254 
contrary and similar to us, Isanejad and co-workers described significantly decreased 255 
expression of Ki67 protein in tumor-bearing animals subjected to interval training [25]. 256 
Other studies have analyzed different markers to evaluate the proliferation of neoplastic 257 
cells in breast tumors in animals. In general, the benefits of exercise training are 258 
associated with decreased levels of cell cycle regulatory proteins [26, 48]. We think that 259 
these conflicting results can be related to the differences in exercise design (i.e., amount 260 
of performed exercise and total experiment duration). 261 
The increased cell survival via blocked programmed cell death is the other face of 262 
tumor development. It is well established that tumor cells can acquire resistance to 263 
apoptosis through different mechanisms including increased anti-apoptotic proteins or 264 
decreased pro-apoptotic proteins [42]. Here, lifelong moderate exercise training also 265 
impacted cell death and induced a pro-apoptotic environment for infiltrative lesions of 266 
the MNU active animals. Similarly to prior work our results show that exposure to 267 
moderate exercise training increases the number of apoptotic cells in exercised animals 268 
[27, 47]. Previous reports have studied markers of apoptosis in animal models of breast 269 
cancer exposed to exercise and found that some anti-apoptotic markers (e.g. Bcl-2, Xiap 270 
– X-linked inhibitor of apoptosis pathway) are decreased, and some pro-apoptotic (e.g.271 
Bax, caspase 3, caspase 8, Apaf-1 – apoptosis peptidase-activating factor-1) markers are 272 
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overexpressed in active animals. These findings suggest that exercise training can 273 
induce apoptosis via a mitochondrial pathway (intrinsic pathway) or via a death-274 
receptor pathway (extrinsic pathway) [26]. It remains unclear what might trigger this 275 
chain of events through different pathways. This is explained, at least in part, by the 276 
response of the host's immune system to tumors with different histological types [22]. 277 
The tumor stroma is another cancer hallmark and is modulated by exercise as assessed 278 
by collagen content. The lower levels of collagen in the exercised animals speaks 279 
suggests less fibrotic stimuli (such as TFG-β) and less activity of cancer-associated 280 
fibroblasts (CAFs). CAFs are known to secrete IL-6 and matrix metalloproteinase 281 
(MMP) that break down the ECM to facilitate cancer cell migration and metastasis [4]. 282 
Therefore, exercise could be an advantage because it could modulate the TME away 283 
from tumorigenesis. Furthermore, the increased deposition of collagen type I and III by 284 
CAFs can alter the ECM microenvironment. This could provide additional oncogenic 285 
signs for cancer cell proliferation [30]. The lower expression of collagen seen in our 286 
exercised animals agrees with the equally low expression of cancer cell proliferation. 287 
Conclusion 288 
The main findings of our work are that long-lasting moderate exercise training can 289 
reduce tumor progression by significantly decreased malignancy, cell proliferation, and 290 
cell death. This leads to an improved tissue microenvironment. There is strong evidence 291 
for decreased collagen deposition. Although the biological mechanism by which these 292 
benefits were achieved are not known, these results are a valuable contribution and 293 
confirm that exercise is an important non-pharmacological approach to reduce the 294 
growth and metastatic potential of mammary neoplasms. 295 
296 
297 
298 
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Figure legends 452 
Fig. 1 XY line graph depicting the frequency distribution of non-infiltrative lesions (A) 453 
and infiltrative lesions (B). 454 
Abbreviations: (A) IDPA – Intraductal papilloma; PACY – Pappilary cystadenoma; 455 
TAD – Tubular adenoma; LAD – Lactating adenoma; FI – Fibroma; FIAD – 456 
Fibroadenoma; PRENP – Preneoplastic. (B) PAPC – Papillary carcinoma; CRIC – 457 
Cribriform carcinoma; COC – Comedo carcinoma. 458 
459 
Fig. 2 Representative light micrographs from malignant lesions of sedentary (A) and 460 
exercised animals (B) stained for ki67. Comparatively to A, it is notorious a lower 461 
density of brown marked nuclei in A. In C it is depicted a boxplot diagram of values 462 
observed in both groups. 463 
464 
Fig. 3 Representative light micrographs from malignant lesions of sedentary (A) and 465 
exercised animals (B) stained for Tunel. Comparatively to A, it is notorious a higher 466 
density of red marked nuclei in A. In C it is depicted a boxplot diagram of values 467 
observed in both groups. 468 
469 
Fig. 4 Representative light micrographs from malignant lesions of sedentary (A) and 470 
exercised animals (B) stained with Pricosirius red. Comparatively to A, it is notorious a 471 
lowers density of red stained area in A, which is indicative of a reduced collagen 472 
content. In C it is depicted a boxplot diagram of values observed in both groups. 473 
474 
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Table 1: Tumor burden and different types of lesions in both MNU groups (expressed as median 
quartiles [25th and 75th percentiles]).  
MNU groups 
Sedentary Exercised 
Tumor weight (g)  4.20 [0.75 – 6.27] 6.45 [0.91 – 12.65] 
Non-infiltrative lesions per animal 3 [1-5] 2 [2-4] 
Infiltrative lesions per animal 4 [2-5]* 2 [1-3] 
Total number of lesions per animal 5.5 [3.25-8.5] 4 [3-5] 
* p = 0.02 vs. Exercised 
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Fig. 1 XY line graph depicting the frequency distribution of non-infiltrative lesions (A) and infiltrative lesions 
(B). 
Abbreviations: (A) IDPA – Intraductal papilloma; PACY – Pappilary cystadenoma; TAD – Tubular adenoma; 
LAD – Lactating adenoma; FI – Fibroma; FIAD – Fibroadenoma; PRENP – Preneoplastic. (B) PAPC – Papillary 
carcinoma; CRIC – Cribriform carcinoma; COC – Comedo carcinoma. 
922x691mm (200 x 200 DPI) 
Page 22 of 25
Georg Thieme Verlag KG. P. O. Box 30 11 20, D-70451 Stuttgart, Germany. http://www.thieme.de/fz/sportsmed/index.html
Manuscript submitted to editorial office
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
147
For Peer Review
Fig. 2 Representative light micrographs from malignant lesions of sedentary (A) and exercised animals (B) 
stained for ki67. Comparatively to A, it is notorious a lower density of brown marked nuclei in A. In C it is 
depicted a boxplot diagram of values observed in both groups. 
922x691mm (72 x 72 DPI) 
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Fig. 3 Representative light micrographs from malignant lesions of sedentary (A) and exercised animals (B) 
stained for Tunel. Comparatively to A, it is notorious a higher density of red marked nuclei in A. In C it is 
depicted a boxplot diagram of values observed in both groups. 
922x691mm (72 x 72 DPI) 
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Fig. 4 Representative light micrographs from malignant lesions of sedentary (A) and exercised animals (B) 
stained with Pricosirius red. Comparatively to A, it is notorious a lowers density of red stained area in A, 
which is indicative of a reduced collagen content. In C it is depicted a boxplot diagram of values observed in 
both groups. 
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4. Study 4
Padrão, AI*; Figueira, ACC*; Faustino-Rocha, AI; Gama, A; Loureiro, MM; 
Neuparth, MJ; Moreira-Gonçalves, D; Vitorino, V; Amado, F; Santos, LL; 
Oliveira, PA; Duarte, JA and Ferreira, R. (2017). Long-term exercise training 
prevents mammary tumorigenesis-induced muscle wasting in rats through the 
regulation of TWEAK signaling. Acta Physiol (Oxf), 219, 803-813. (First 
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Abstract
Aim: Exercise training has been suggested as a non-pharmacological
approach to prevent skeletal muscle wasting and improve muscle function
in cancer cachexia. However, little is known about the molecular mecha-
nisms underlying such beneficial effect. In this study, we aimed to, firstly,
examine the contribution of TWEAK signalling to cancer-induced skeletal
muscle wasting and, secondly, evaluate whether long-term exercise alters
TWEAK signalling and prevents muscle wasting.
Methods: Female Sprague-Dawley rats were randomly assigned to control
and exercise groups. Fifteen animals from each group were exposed to N-
Methyl-N-nitrosourea carcinogen. Animals in exercise groups were submit-
ted to moderate treadmill exercise for 35 weeks. After the experimental
period, animals were killed and gastrocnemius muscles were harvested for
morphological and biochemical analysis.
Results: We verified that exercise training prevented tumour-induced
TWEAK/NF-jB signalling in skeletal muscle with a beneficial impact in
fibre cross-sectional area and metabolism. Indeed, 35 weeks of exercise
training promoted the upregulation of PGC-1a and oxidative phosphoryla-
tion complexes. This exercise-induced muscle remodelling in tumour-bear-
ing animals was associated with less malignant mammary lesions.
Conclusion: Data support the benefits of an active lifestyle for the preven-
tion of muscle wasting secondary to breast cancer, highlighting TWEAK/
NF- jB signalling as a potential therapeutic target for the preservation of
muscle mass.
Keywords gastrocnemius, inflammation, mammary carcinogenesis, NF-jB
signalling, oxidative metabolism.
Cachexia is a multi-factorial syndrome associated with
several chronic diseases including cancer and involves
changes in several metabolic pathways, in many
tissues and organs. In the context of cancer, it was
estimated that cachexia indirectly accounts for the
death of at least 20% of all patients with cancer
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(Fearon et al. 2011, Argiles et al. 2014). Skeletal mus-
cle wasting is a major factor involved in cancer
cachexia that contributes to physical disability, weak-
ness, reduced tolerance to anticancer therapy and
reduced survival. Despite its impact on the patient
outcome, body weight loss is rarely assessed, recog-
nized or even targeted in the cancer setting (Fearon
et al. 2011, Julienne et al. 2012, Argiles et al. 2014).
This could be attributed, in part, to the poor under-
standing of the underlying mechanisms in addition to
the lack of approved therapeutic approaches.
Currently, there is strong evidence pointing to the
unbalance between protein synthesis and degradation
as the main mechanisms responsible for skeletal mus-
cle atrophy in cancer cachexia (Padrao et al. 2013).
Reduced ribosome formation and protein synthesis,
and overexpression of atrogin-1 and muscle RING fin-
ger 1 (MuRF1), muscle-specific E3 ligases involved in
protein ubiquitination, have all been shown to medi-
ate muscle wasting in cancer cachexia (Julienne et al.
2012, Padrao et al. 2013). Pro-inflammatory cytokines
secreted by either the host or tumour were shown to
modulate the activation of the signalling pathways
that upregulate muscle protein degradation (White
et al. 2012, Johns et al. 2014, Onesti & Guttridge
2014). TWEAK is a member of the TNF superfamily
of cytokines that was shown to mediate the overex-
pression of E3 ligases through the activation of NF-jB
pathway in muscle fibres (Dogra et al. 2007, Mittal
et al. 2010a, Bonaldo & Sandri 2013, Onesti & Gut-
tridge 2014). TWEAK also seems to inhibit the activ-
ity of PI3K/Akt signalling pathway, boosting the
catabolic action of this cytokine (Kumar et al. 2012),
which makes this pro-inflammatory cytokine a puta-
tive therapeutic target for the management of cancer
cachexia.
Different therapeutic approaches have been tested for
the management of cancer cachexia-induced muscle
mass loss; however, none was yet approved (Fearon
et al. 2013). Beyond pharmacological strategies, exer-
cise training has been suggested as the gold standard for
increasing muscle function in cancer cachexia (Argiles
et al. 2012, Morley et al. 2014). Endurance training
was reported to reduce cancer-related inflammation,
reactive oxygen species and protein catabolism and to
increase protein synthesis (Gould et al. 2013). So, regu-
lar exercise training appears as an attractive therapeutic
strategy to be included in the management of cancer to
attenuate the adverse effects of cachexia. However, the
molecular mechanisms modulated by exercise in cancer
cachexia are poorly characterized, and even less are the
ones underlying the preventive effect of lifelong exercise
training.
To give new molecular insights on the impact of
endurance training in the prevention of cancer-induced
muscle wasting, we used an animal model of mam-
mary tumorigenesis submitted to 35 weeks of moder-
ate treadmill exercise since infancy. In the
gastrocnemius muscle, we searched for the pathways
modulated by the pro-inflammatory cytokine TWEAK
and related it with tumour–host interplay.
Material and methods
Chemicals
N-Methyl-N-nitrosourea (MNU) was purchased from
Sigma chemical Co (Madrid, Spain). All other reagents
and chemicals used were of highest grade of purity
commercially available. Rabbit polyclonal anti-GDF8
(myostatin; ab996), rabbit polyclonal anti-MURF1
(ab77577), rabbit polyclonal anti-TWEAK (ab37170),
rabbit monoclonal anti-TWEAKr (ab109365), rabbit
polyclonal anti-GAPDH (ab9485), rabbit polyclonal
anti-PGC-1a (ab54481), rabbit monoclonal anti-NF-
jB p105/p50 [E381] (ab32360), rabbit polyclonal
anti-NF-jB p65 (ab16502), mouse monoclonal anti-
NF-jB p100/52 (ab71108), rabbit polyclonal anti-
RelB (ab150305) and mouse monoclonal anti-ATPB
(ab14730) were purchased from Abcam (Cambridge,
UK). MitoProfile! Total OXPHOS Western blotting
kit (ab110413) was also purchased from Abcam. Rab-
bit polyclonal atrogin-1 antibody (AP2041) was
obtained from ECM Biosciences (Versailles, KY,
USA). Rabbit polyclonal antibodies for p-mTOR
(#2971), p-Akt (#4058), mTOR (#2972) and Akt
(#9272) and rabbit monoclonal antibody against p-
4E-BP1 (#2855), p-p70S6K (#9234) and p-IjBa
(Ser32) (#2859) were acquired from Cell Signalling
Technology (Leiden, the Netherlands). Secondary per-
oxidase-conjugated antibodies (anti-mouse IgG and
anti-rabbit IgG) were obtained from GE Healthcare
(Buckinghamshire, UK), and anti-goat IgG (ab7125)
was obtained from Abcam.
Animals
Fifty female Sprague-Dawley rats (aged 38 days) were
obtained from Harlan (Barcelona, Spain) and ran-
domly housed in groups of 4 rats/cage, in a controlled
environment at 22 ! 2°C of temperature and
60 ! 5% of relative humidity with 12/12 h dark–light
inverted cycle, with free access to food (standard diet
4RF21!; Mucedola, Settimo Milanese, Italy) and
water. After 1 week of quarantine, the animals were
randomly divided into four experimental groups:
sedentary control (CONT + SED, n = 10), sedentary
MNU (MNU + SED, n = 15), exercised control
(CONT + EX; n = 10), and exercised MNU
(MNU + EX, n = 15). Animals were observed daily
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12721804
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for health check. During the experimental protocol,
four animals from MNU + SED group and five from
MNU + EX group died and were not included for
data analysis. The following protocol was approved
by the Portuguese Ethics Committee for Animal
Experimentation, Direc!~ao Geral de Alimentac!~ao e
Veterin!aria (licence number 008961) and was per-
formed in accordance with European Directive 2010/
63/EU.
Induction of mammary tumorigenesis and
implementation of exercise training
Mammary tumorigenesis was chemically induced in
rats from MNU groups (MNU + SED and
MNU + EX) by the intraperitoneal administration of
one single dose of the carcinogen MNU (50 mg kg!1)
at 50 days of age. Rats from CONT groups
(CONT + SED and CONT + EX) were i.p. injected
with a single dose of vehicle.
Animals from EX groups started a treadmill train-
ing protocol (Treadmill Control LE 8710; Harvard
Apparatus, Holliston, MA, USA) at 52 days of age. In
the first two weeks, exercise duration and treadmill
speed was gradually increased until reaching 60 min
per day at 20 m per min, 5 days per week, which was
maintained during thirty-five weeks. At the end of the
experimental protocol, animals were killed with keta-
mine/xylazine (Imalgen! and Rompun! respectively).
Blood samples were collected from the inferior vena
cava and centrifuged for 5 min at 5000 g, and serum
was obtained and stored at !80 °C for biochemical
determinations. All noticeable tumours were counted
and removed for histological analysis. Gastrocnemius
was removed, weighted and immediately prepared for
histological and biochemical analysis.
Histological analysis of gastrocnemius muscle and
histological and immunohistochemical analysis of
mammary tumours
Cubic pieces from gastrocnemius muscle and mam-
mary tumours were fixed with buffered paraformalde-
hyde 4% (v/v) by diffusion during 24 h and
subsequently dehydrated with graded ethanol and
included in paraffin blocks. Serial cross sections (5 lm
of thickness) of paraffin blocks were cut by a micro-
tome and mounted on silane-coated slides. The slides
were dewaxed in xylene and hydrated through graded
alcohols finishing in phosphate-buffered saline solu-
tion (pH to 7.2). Gastrocnemius samples were stained
with haematoxylin–eosin, dehydrated with graded
alcohols through xylene and mounted with DPX for
analysis in a photomicroscope (Zeis Phomi 3). Pho-
tographs of gastrocnemius cross sections of all
experimental groups were digitalized and analysed
with the NIH ImageJ (Image Processing and Analysis
in JAVA, USA) software. An average of 1429 " 217
fibres were analysed per group for cross-sectional area
(CSA) quantification.
Deparaffinized sections of mammary tumours were
stained for haematoxylin–eosin and classified accord-
ing to Russo and Russo (Russo & Russo 2000). The
immunohistochemical detection of TWEAK was per-
formed using the standard protocol of Novolink Poly-
mer Detection System (Leica Biosystems, Newcastle,
UK). Sections were incubated with primary antibody
for TWEAK (ab37170; Abcam) at a dilution of 1:50,
overnight at 4 °C.
Blood tests
Serum albumin and lactate dehydrogenase (LDH)
were measured in duplicate on an AutoAnalyzer
(PRESTIGE 24i, Cormay PZ). Serum TWEAK levels
were assayed by immunoblotting as described below.
Gastrocnemius homogenate preparations
Whole gastrocnemius muscle was homogenized in ice-
cold solubilization buffer [50 mM Tris-HCl, 1 mM
EDTA, 1 mM EGTA, 0.1% Triton X-100, 10 mM
PMSF, phosphatase inhibitor cocktail (P0044 and
P5726; Sigma), pH 7.5]. Gastrocnemius homogenate
was aliquoted for subsequent biochemical analysis.
Total protein content was determinate with RC-DC
Protein Assay Kit (Bio-Rad, Hercules, CA, USA).
Citrate synthase activity
Citrate synthase (CS) activity was measured in muscle
homogenate using the method proposed by Coore
et al. (1971). In brief, the CoASH released from the
reaction of acetyl-CoA with oxaloacetate was mea-
sured by its reaction with 5,50-dithiobis-(2-nitroben-
zoic acid) (DTNB) at 412 nm (e = 13.6 mM!1 cm!1).
A Multiskan GO Microplate Spectrophotometer
(Thermo Scientific, Northumberland, UK) was used
for CS activity measurement.
Immunoblotting analysis
Serum samples were diluted (1:20) in Tris-buffered
saline (TBS; 100 mM Tris, 1.5 mM NaCl, pH 8.0),
and 100 lL was slot-blotted into a nitrocellulose
membrane (Whatman; Protan, Sigma-Aldrich, St.
Louis, MO, USA). In parallel, equivalent amounts of
whole gastrocnemius muscle proteins of each group
were electrophoresed on a 12.5% SDS-PAGE as
described by Laemmli (Laemmli 1970). Gels were
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12721 805
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blotted onto a nitrocellulose membrane (Whatman!;
Protan, Sigma-Aldrich) in transfer buffer (25 mM Tris,
192 mM glycine, pH 8.3 and 20% methanol) during
2 h (200 mA). Then, non-specific binding was blocked
with 5% (w/v) dry non-fat milk in TBS-T (100 mM
Tris, 1.5 mM NaCl, pH 8.0 and 0.5% Tween 20).
Membranes were incubated with primary antibody
diluted 1:1000 in 5% defatted bovine serum albumin
in TBS-T (anti-p-p70S6K, anti-p-IjBa, anti-p-Akt,
anti-p-mTOR) or in 5% (w/v) non-fat free milk in
TBS-T (anti-TWEAK, anti-TWEAKr, anti-NF-jB p65,
anti-NF-jB p105/p50, anti-NF-jB p100/p52, anti-
RelB, anti-mTOR, anti-Akt, anti-atrogin-1, anti-
MuRF-1, anti-4E-BP1, anti-ATPB, anti-PGC-1a and
anti-GAPDH) for 2 h at room temperature, washed
and incubated with secondary horseradish peroxidase-
conjugated anti-rabbit or anti-mouse (1:10000; GE
Healthcare). Mitochondrial subunits of oxidative
phosphorylation proteins were semi-quantified with
the MitoProfile! Total OXPHOS Western blotting kit
(1:5000, containing NDUFB8-20 kDa of complex I,
SDHB-30 kDa of complex II, core protein 2–48 kDa
of complex III, subunit I- 40 kDa of complex IV and
alpha subunit-55 kDa of ATP synthase). Immunoreac-
tive bands were detected by enhanced chemilumines-
cence ECL (GE Healthcare) according to the
manufacturer’s procedure, and images were recorded
using X-ray films (Kodak Biomax Light Film; Sigma,
St. Louis, MO, USA). The films were scanned in
Molecular Imager Gel Doc XR+ System (Bio-Rad)
and analysed with QuantityOne software (v 4.6.3 Bio-
Rad). Protein loading control was performed with
Ponceau S staining (Romero-Calvo et al. 2010).
Representative images of the results obtained are
presented at Fig. S1.
Statistical analysis
The results are presented as mean ! SD for each
experimental group. Kolmogorov–Smirnov test was
performed to check the normality of the data.
Kruskal–Wallis test followed by Dunns test was used
for non-normal data (muscle fibres CSA). The statisti-
cal significance of the differences between the experi-
mental groups for the remaining variables was
determined using a two-way ANOVA followed by the
Tukey multiple comparisons post hoc test. The signifi-
cance level was set at P ≤ 0.05. Statistical analysis
was performed with GraphPad Prism Software
(version 6.0; GraphPad Software, La Jolla, CA, USA).
Results
Characterization of rat’s response to MNU
administration and/or endurance training
The administration of MNU induced mammary
lesions in 100% of the animals, which was accompa-
nied by 8.4% of lower body weight (Table 1) without
alterations in food consumption (data not shown). No
histopathological changes in mammary tissue were
observed in control animals (CONT + SED and
CONT + EX groups). In MNU groups, animals’
response to tumour burden was not homogeneous.
Approximately 30% of animals with mammary
tumours presented slight variations that range from
Table 1 Characterization of the animals’ response to MNU-induced muscle wasting and/or endurance training regarding body
weight, gastrocnemius mass, gastrocnemius to body weight, citrate synthase activity in gastrocnemius muscle, and serum albu-
min, lactate dehydrogenase (LDH), TWEAK and myostatin
Experimental group
CONT + SED MNU + SED CONT + EX MNU + EX
Body weight (g) 298.29 ! 13.59 273.20 ! 16.62* 313.74 ! 24.51 267.47 ! 27.77†
Gastrocnemius muscle weight (g) 3.94 ! 0.28 3.50 ! 0.31* 4.15 ! 0.245 3.36 ! 0.62†
Gastrocnemius to body weight (mg g"1) 13.38 ! 0.73 13.08 ! 0.65 13.39 ! 0.49 12.43 ! 1.89
Citrate synthase activity (nmol min"1 mg"1 muscle) 18.07 ! 1.53 17.2 ! 0.95 21.42 ! 4.06 29.25 ! 7.67†‡
Serum Albumin (g L"1) 40.73 ! 1.32 37.59 ! 2.05* 39.56 ! 2.77 37.46 ! 5.46
Serum LDH (U L"1) 328.11 ! 91.84 544.81 ! 307.48 483.05 ! 143.97 472.58 ! 251.34
Serum TWEAK (OD, arbitrary units) 130.87 ! 7.24 290.61 ! 34.39* 188.02 ! 49.80* 167.31 ! 38.93‡
Serum myostatin (OD, arbitrary units) 263.80 ! 9.18 340.00 ! 30.97* 266.27 ! 14.24 329.20 ! 38.16†
OD, Optical density.
Values are expressed as mean ! SD.
*P < 0.05 vs. CONT + SED.
†P < 0.05 vs. CONT + EX.
‡P < 0.05 vs. MNU + SED.
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12721806
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no differences of weight to <5%, and 25% of the ani-
mals evidenced a lower body weight in more than
10%. Such variation among individuals with the same
type of tumour and burden was previously reported
(Fearon et al. 2012). The MNU-related lower body
weight was accompanied by a 11% diminishing of
muscle mass (Table 1). Regarding gastrocnemius mus-
cle, eight animals from MNU + SED group showed
lower muscle mass, >7% (three of them more than
17%). No significant differences of muscle-to-body
weight ratio were observed between groups
(MNU + SED vs. CONT + SED, Table 1). Endurance
training modulated tumour development with lower
incidence of mammary lesions observed in the
MNU + EX than in MNU + SED group (50 vs. 71
lesions respectively), and less malignant lesions. Long-
term exercise training also prevented the lower weight
body gain in 10% of animals, although without
apparent effect on the average of body weight or gas-
trocnemius muscle mass (MNU + SED vs. MNU + EX
groups, Table 1).
MNU administration prompted an inflammatory
response in animals, which was characterized by a sig-
nificant decrease of serum albumin and a significant
increase of the pro-inflammatory cytokine TWEAK
and myostatin. Increased serum levels of lactate dehy-
drogenase (LDH) were also noticed in these animals,
similarly to the reported for patients with breast can-
cer (Liu et al. 2015). The impact of endurance train-
ing was mainly noticed in the serum levels of
TWEAK, which were significantly lower in
MNU + EX compared to MNU + SED (Table 1). To
better clarify the impact of exercise training on
tumour–host interplay that underlies the regulation of
TWEAK levels, immunohistochemistry analysis of
TWEAK was performed in tumour sections. Weak-to-
moderate expression of TWEAK was noticed in the
cytoplasm of epithelial cells in adjacent mammary
glands, especially in those presenting secretory
changes. Sporadically, TWEAK was also expressed by
stromal cells, namely fibroblasts, especially in peri-
neoplastic reactive stroma and by plasma cells. Exer-
cise training had no significant impact on the levels
and pattern of TWEAK immunostaining in mammary
tumours (Fig. S2).
Analysis of gastrocnemius muscle adaptation to
mammary tumours and/or endurance training
Morphometric analysis of gastrocnemius highlighted
significantly decreased values of fibre cross-sectional
area (CSA) in sedentary MNU-treated rats
(895.24 ! 341.92 lm2 vs. 1461.45 ! 904.19 lm2 in
CONT + SED group), which was accompanied by
increased interstitial space (Fig. 1). Exercise training
prevented the fibre CSA decrease induced by mam-
mary tumorigenesis (1273.07 ! 648.31 lm2 vs.
895.24 ! 341.92 lm2 in MNU + SED).
The metabolic adaptation of the gastrocnemius
muscle to mammary tumorigenesis was assessed by
the analysis of metabolic enzymes. MNU + SED ani-
mals showed a significant decrease of citrate synthase
(CS) activity in the gastrocnemius muscle (Table 1).
No significant differences of the ratio ATP synthase/
GAPDH expression were noticed in MNU-treated rats
(Fig. 2c). Treadmill exercise training prevented the
MNU-induced decrease of CS activity (Table 1) and
prompted a shift towards oxidative metabolism given
(a) (b)
Figure 1 Effect of MNU-induced mammary tumorigenesis and/or endurance training on cross-sectional area (CSA) in
gastrocnemius muscle. Values are presented as mean ! SD of results obtained from the analysis of 1429 ! 217 fibres per group
(a). Histological appearance of gastrocnemius stained with haematoxylin and eosin evidences fibres’ CSA in each experimental
group (b). (*P < 0.05 vs. CONT + SED; ¥P < 0.05 vs. CONT + EX; #P < 0.05 vs. MNU + SED).
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by the increase of ATP synthase/GAPDH ratio, mostly
due to the overexpression of ATP synthase subunit b
(Fig. 2a and c). This metabolic effect of long-term
exercise training was further supported by the aug-
mented expression of other subunits from the oxida-
tive phosphorylation complexes I and III in the
gastrocnemius muscle of exercised animals
(CONT + EX and MNU + EX groups, Fig. 3). For
instance, the content of NDUF88 subunit from
OXPHOS complex I increased approximately 40% in
MNU + EX compared to MNU + SED and 26% in
CONT + EX compared to CONT + SED (Fig. 3b).
The content of the subunit UQCRC2 from OXPHOS
complex III increased approximately 45% in
MNU + EX compared to MNU + SED (Fig. 3d). No
expression changes were noticed among experimental
groups for the subunits SDH8 and MTCD1 from
OXPHOS complexes II and IV respectively. Alto-
gether, data highlight an increase of skeletal muscle
oxidative capacity stimulated by long-term endurance
training, with concomitant increase of PGC-1a
(Fig. 2d), a key player in the regulation of mitochon-
dria biogenesis (Vitorino et al. 2015).
Analysis of the anabolic/catabolic balance in
gastrocnemius muscle in response to mammary
tumours and/or endurance training
To assess the molecular mechanisms modulated by
mammary tumorigenesis in skeletal muscle and the
regulatory role of long-term exercise training, we eval-
uated the expression of the main mediators involved
in the signalling pathway activated by the pro-inflam-
matory cytokine TWEAK. The expression of TWEAK
in gastrocnemius muscle was related to the serum
levels of this pro-inflammatory cytokine. Indeed, a sig-
nificant increase of this pro-inflammatory cytokine
and of its receptor Fn14 was noticed in the gastrocne-
mius of MNU + SED animals (Fig. 4a and b). These
higher levels of TWEAK were related to the activation
of NF-jB pathway, through the phosphorylation of
IjBa (Fig. 4c) and overexpression of p50, RelB and
p100/p52 subunits (Fig. 4d, f and g). No alterations in
the expression of p65 subunit were noticed (Fig. 4e).
Endurance training prevented the MNU-related
increase of TWEAK but not of Fn14 receptor. The
levels of phosphorylated IjBa and NF-jB subunit p50
also decreased in exercised tumour-bearing rats. Curi-
ously, in healthy animals, exercise training promoted
a significant increase of RelB and p52 subunits (Fig. 4f
and g).
The expression of the E3 ligases MAFbx/atrogin-1
and MuRF1 was also evaluated by Western blotting.
Data evidenced a statistically significant increase of
atrogin-1 in the gastrocnemius muscle of MNU-trea-
ted animals (Fig. 5a). Regarding to MuRF-1, its
expression was not altered in any of the groups
excepting for MNU + EX where it was upregulated
(Fig. 5b).
To assess the impact of tumour–host interplay in
the anabolic activity of gastrocnemius muscle, we
assessed the expression of the kinases Akt and mTOR,
and the downstream p-4E-BP1 and p-p70S6K by Wes-
tern blotting. Mammary tumours induced the decrease
of total Akt but not of its phosphorylated form
(Fig. 5c and d). An opposite trend was noticed for the
phosphorylated form of mTOR, which increased in
MNU-treated animals (Fig. 5f), although no
Figure 2 Effect of MNU-induced mam-
mary tumorigenesis and/or endurance
training on the muscle expression of
ATPB (a), GAPDH (b), ATPB/ GAPDH
ratio (c) and PGC-1a (d). Representative
immunoblots are presented above the
corresponding graphs. Values are
expressed as mean ! SD. (*P < 0.05 vs.
CONT + SED; #P < 0.05 vs.
MNU + SED).
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differences were observed for total mTOR (Fig. 5g).
Nevertheless, the levels of phosphorylated 4E-BP1
decreased and no differences were observed for phospho-
rylated p70S6K content. Exercise training induced the
increase of phosphorylated Akt and so of phospho-Akt/
total Akt ratio as well as of phosphorylated and total
mTOR in MNU-treated animals (Fig. 5c–h). However,
these differences were not translated in the levels of
phosphorylated p70S6K and 4E-BP1 (Fig. 5i and j).
Discussion
The present study highlights the protective role of
long-term moderate exercise training against cancer-
related muscle wasting through the modulation of
tumour–host interplay in the MNU animal model.
This model of mammary tumorigenesis mimics human
breast cancer in terms of the tumour’s histopathology,
origination from mammary ductal epithelial cells, and
altered expression of TGFb, oestrogen receptor and
cyclin D1 (Perse et al. 2009, Soares-Maia et al. 2013).
MNU-induced mammary cancer is also characterized
by chronic inflammation (Soares-Maia et al. 2013).
The long time-course of tumour response with the first
tumours appearing after 10 weeks of carcinogen
administration makes this animal model appropriate
to study the impact of long-term exercise training on
cancer-induced muscle wasting.
MNU administration to female rats at the age of
50 days resulted in histological signs of mammary car-
cinoma similarly to the observed in human breast can-
cer, the most incident and prevalent type of cancer in
women worldwide (Jemal et al. 2011). MNU-induced
mammary tumorigenesis was paralleled by 8% lower
body weight (Table 1), a value that in humans is seen
as a sign of mild-to-moderate cachexia according to
the cachexia score (CASCO) (Argiles et al. 2011).
This lower body weight was paralleled by a 11%
diminishing of gastrocnemius mass (Table 1) and
39% less fibre CSA (Fig. 1), which are suggestive of
altered muscle properties such as weakness and fatigue
(Argiles et al. 2011, Shum et al. 2012). The low
serum levels of albumin and high content of the pro-
inflammatory and catabolic cytokines TWEAK and
myostatin in MNU animals (Table 1) support the
catabolic profile noticed in this group. Indeed, sys-
temic inflammation is thought to be a major mediator
of cancer cachexia (Fearon et al. 2012).
Exercise training has been prescribed as a tool to
counteract systemic inflammation and apparently
(a)
(b) (c)
(d)
(f)
(e)
Figure 3 Effect of MNU-induced mammary tumorigenesis and/or endurance training on the levels of OXPHOS subunits in gas-
trocnemius muscle from animals of all experimental groups. A representative immunoblot is presented (a). Semi-quantitative
analysis of Complex I, CI-NDUFB8 (b); complex II, CII-SDHB (c); complex III, CIII-UQCRC2 (d); complex IV, CIV-MTCO1
(e) and complex V, CV-ATP5A (f). Values are expressed as mean ! SD. (*P < 0.05 vs. CONT + SED; ¥P < 0.05 vs.
CONT + EX; #P < 0.05 vs. MNU + SED).
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represents a safe and effective strategy for the preven-
tion/attenuation of cancer cachexia (Lira et al. 2014).
In the present study, we verified that 35 weeks of
treadmill exercise modulated the levels of the pro-
inflammatory cytokine TWEAK, as recently reported
(Padrao et al. 2015). TWEAK is a typical TNF super-
family member expressed by immune cells, with leuco-
cytes as the major source. This cytokine was also
observed in tumour specimens, some apparently pro-
duced by tumour cells themselves, with soluble
TWEAK detected in the conditioned media of some
tumour cell lines (Burkly 2014). TWEAK acts on cells
via binding to the TNF receptor superfamily member
fibroblast growth factor-inducible 14 (Fn14) (Willis
et al. 2008), and TWEAK/Fn14 has protumorigenic
activity associated with proliferation, invasion, angio-
genesis and inflammation (Michaelson et al. 2005).
TWEAK/Fn14 signalling regulates breast cancer cell
invasive capacity in multiple biological contexts
(Willis et al. 2008) and was previously correlated with
higher tumour grade (Burkly 2014) and cachexia
(Johnston et al. 2015). Our data highlight the preven-
tive effect of chronic exercise training in mammary
tumorigenesis-related increase of soluble TWEAK,
with impact in tumour grade and body wasting.
Indeed, less mammary lesions and less signs of malig-
nancy (such as invasive carcinomas) were observed in
exercised MNU-treated animals (Faustino-Rocha et al.
2016). Once no significant alterations in the tumour
expression of TWEAK were noticed, we might suspect
that the downregulation of soluble TWEAK reflects
the host response to the interplay between tumour
burden and exercise training.
Thirty-five weeks of exercise training prevented, to
some extension, mammary tumorigenesis-induced
muscle wasting by lowering the serum and muscle
levels of TWEAK but not the muscle content of its
receptor Fn14. TWEAK/Fn14 has been identified as a
(a) (b)
(d) (e)
(f) (g)
(c)
Figure 4 Effect of MNU-induced mammary tumorigenesis and/or endurance training on the muscle expression of TWEAK (a),
Fn14 (b), p-IjBa (c), NF-kB p50 (d) and p65 (e), RelB (f) and NF-kB p100/p52 (g) subunits evaluated by Western blotting in
whole gastrocnemius muscle from animals of all experimental groups. Representative immunoblots are presented above the cor-
responding graphs. Values are expressed as mean ! SD. (*P < 0.05 vs. CONT + SED; #P < 0.05 vs. MNU + SED).
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critical regulator of skeletal muscle mass (Kumar et al.
2012), through the activation of NF-jB with the ensu-
ing overexpression of ubiquitin–proteasome system
(UPS) components (Guttridge 2004, Sato et al. 2014),
and the inhibition of the PI3K/Akt signalling pathway
(Dogra et al. 2007). Our data support the association
between tumour-induced TWEAK/NF-jB signalling in
the gastrocnemius muscle, with the involvement of the
canonical and alternative NF-jB pathways. Despite
the activation of Akt and mTOR, the reduced levels
of p4E-BP1 in MNU-treated rats suggest decreased
protein synthesis. So, mTOR does not seem to be
involved in the mTORC1-4E-BP signalling in the
skeletal muscle of rats with mammary tumours but
can possibly be associated with mTORC2 signalling
that regulates cellular processes as glucose uptake via
not only Akt but also SGK and PKC kinases (Albert
& Hall 2015). These findings might be explained by
an overlap between the mechanisms of action of
TWEAK and other cytokines. One of the features of
TWEAK that is not shared with other cytokines is its
effect on NF-jB signalling (Kumar et al. 2004, Bhat-
nagar & Kumar 2012). Exercise training prevented
tumour-induced TWEAK/NF-jB signalling, particu-
larly the canonical pathway, but without apparent
effect on UPS system. The levels of phosphorylated
Akt and mTOR also increased in the muscle of
trained MNU rats although with no impact on the
activity of its downstream targets p70S6K and 4E-
BP1. Even so, exercise training prevented the decrease
in MNU-related muscle fibre CSA (Fig. 1). Besides
being involved in the regulation of protein synthesis,
mTOR also modulates autophagy (Fritzen et al. 2016)
and mitochondrial biogenesis in skeletal muscle
(Albert & Hall 2015). Studies with TWEAK-KO mice
also support the involvement of TWEAK in the regu-
lation of metabolism through the activation of the
canonical NF-jB signalling and the consequent repres-
sion of PGC-1a expression (Mittal et al. 2010b, Sato
et al. 2013, Hindi et al. 2014). By preventing
TWEAK/NF-jB signalling, long-term exercise training
inhibits the suppression of PGC-1a, which regulates
mitochondrial biogenesis, promoting an oxidative
metabolism and fast-to-slow type fibre transition (Sato
et al. 2013). Indeed, in the gastrocnemius muscle,
exercise training increased the levels of PGC-1a,
which might justify, at least in part, the muscle
remodelling towards an oxidative phenotype (Figs 2
and 3). This metabolic adaptation has been related to
enhanced muscle’s ability to extract and utilize oxygen
(a) (b) (c)
(d) (e) (f)
(g) (h) (i) (j)
Figure 5 Effect of MNU-induced mammary tumorigenesis and/or endurance training on the muscle expression of MAFbx/atro-
gin-1 (a), MuRF-1 (b), p-Akt (c), total Akt (d), p-Akt-to-total Akt ratio (e), p-mTOR (f), total mTOR (g), p-mTOR-to-total
mTOR (h), p-4E-BP1 (i) and p-p70S6K (j) evaluated by Western blotting in whole gastrocnemius muscle from animals of all
experimental groups. Representative immunoblots are presented above the corresponding graphs. Values are expressed as
mean ! SD (*P < 0.05 vs. CONT + SED; ¥P < 0.05 vs. CONT + EX; #P < 0.05 vs. MNU + SED).
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from arterial blood (Rivera-Brown & Frontera 2012),
and to improved aerobic performance (Hindi et al.
2014).
In conclusion, the present study provides molecular
evidences that the interaction between endurance
training and mammary tumorigenesis is mediated by
TWEAK/NF-jB signalling. Long-term endurance
training modulates the serum and muscle levels of
TWEAK that despite not being related with its tumour
levels seem to be associated with tumour grade. By
preventing tumour-induced TWEAK/NF-jB signalling
in skeletal muscle, endurance training impacts its
metabolic status. Data support the benefits of an
active lifestyle for the prevention of breast cancer-
related side effects, highlighting the TWEAK signalling
as a potential therapeutic target for the preservation
of muscle performance in wasting conditions.
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The present chapter is divided into two sections that respectively provide 
a discussion of the various methodological approaches and a general 
discussion of the results. 
1. DISCUSSION OF METHODS
The mechanisms by which RPA/REX can improve the prognoses of 
patients with breast cancer have been subject to several studies that have 
identified numerous candidate mechanisms [3, 130]. However, the amount of 
RPA/REX that should be performed to favorably affect the modulation of those 
mechanisms remains unclear, mainly due to the approaches used to evaluate 
the exercise level performed. Nevertheless, it is generally accepted that 150–
300 min/week of moderate exercise or 75min/week of vigorous exercise are 
required, with requisite attention to the patient’s symptomatology [75, 137, 333, 
389]. 
As the intermediate step between in vitro cell cultures and clinical assays 
in humans, animal models have often been used to study cancer. However, 
RPA/REX protocols have presented such diverse data that their results run the 
gamut from positive to negative [20]. To elucidate such divergence we sought to 
summarize and quantify the strength of published preclinical data regarding the 
different mechanisms within the relationship of RPA/REX with breast cancer. 
Second we aimed to scrutinize the features of exercise training designs that 
have better correlated with tumor outcomes. To that end, we conducted two 
systematic reviews involving meta-analyses, in which we analyzed the effects of 
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exercise from either a local perspective focused on the tumor burden (Study 1) 
or a systemic perspective focused on the host organic repercussions (Study 2). 
For target tumor burden, we examined several variables—tumor incidence, 
tumor multiplicity, tumor growth and TME, including cellular proliferation, cellular 
apoptosis, and angiogenesis—that permit measuring the effects of RPA/REX in 
tumorigenesis (i.e. incidence and multiplicity) and in tumor progression (i.e. 
tumor weight and tumor volume), as well as to verify the action of RPA/REX in 
TME hallmarks. Unfortunately, regarding TME collecting data was not an option 
but an unavoidable collection due to the lack of studies on the topic. For the 
systemic perspective, the targeted biomarkers were markers of inflammation, 
sex hormones, and glucose-related factors; analyzing those variables relied on 
the theoretical background about cancer-associated biomarkers mostly 
presented in Chapter 1. We also defined the RPA/REX variables (i.e. type of 
exercise performed, voluntary vs. forced; intensity, duration; frequency, and 
distance covered) that could moderate the interplay of exercise and breast 
cancer, as well as performed grouped analysis considering each of them.  
In response to the heterogeneity of the collected data, we used a random 
effects model in both meta-analyses and performed a sensitivity analysis. Both 
meta-analyses were conducted according to the guidelines of the PRISMA 
statement (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) [262], and the quality of the analyzed studies was assessed using the 
Systematic Review Center for Laboratory animal Experimentation Risk of Bias 
tool (SYRCLE’s RoB), adapted for animal studies [174]. 
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Since most investigations in humans have ascertained the appropriate 
activity level by using subjective measures, which obscures knowledge of the 
amount (e.g. intensity, frequency and duration) of RPA/REX that confers optimal 
benefits, and because ethical principles do not permit the study of certain trends 
in humans, research on the topic using animal models to mimic disease in 
humans seems to be essential. Conceived to complement epidemiological 
studies and human clinical trials, animal studies can help to elucidate the 
cellular and molecular mechanisms by which RPA/REX exerts its beneficial 
effects, identify amounts of RPA/EXT that achieve better outcomes, and provide 
information about cancer initiation, progression, and metastization [361]. To 
furnish new insights into the field of research, the experimental work presented 
in this thesis was conducted in animals. We evaluated the effects of long-term 
(i.e. 35 weeks) moderate (i.e. 20m/min for 60 min every useful days) treadmill 
running on MNU-induced mammary cancer. 
Published studies with animals (e.g. rodents) typically involve voluntary 
exercise via access to a free-spinning or motorized wheel, forced exercise on 
treadmills or swimming [20]. Although all methods have advantages and 
disadvantages, voluntary exercise has the advantage of relying on the animal’s 
willingness, of apparently decreasing stress, and of allegedly imitating daily 
physical activity in humans. However, voluntary exercise in rodents promotes 
intermittent features (e.g., small bouts of intense activity, several times per day, 
every day) that cannot be unfeasible replicated in humans in some, if not all, 
stages of disease [168]. When tumor burden increases, a decline in animal 
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voluntary activity level is almost inevitable. Moreover, voluntary exercise does 
not allow inference about the adjusted training load for greater benefits, 
because it is not always possible to control the amount of exercise performed 
and sometimes impossible to control intensity (i. e. with a free-spinning wheel). 
With motorized wheels, it is possible to define intensity although the animals’ 
willingness cannot be altered [361]. By contrast, forced exercise allows 
researchers to make inferences in a dose-responsive manner, yet it can induce 
stress on animals and influence the results of variables under consideration 
[195].  
In the research reported here, we used forced exercise in order to allow 
the maintenance of the same levels of exercise in all animals and at once 
uphold guidelines for cancer patients [333]. To the best of our knowledge, the 
exercise design used, equivalent to 23 years [336], was the longest-lasting one 
ever made, which allowed the study of the effects of long-term exposure to 
exercise on cancer outcomes [383]. In addition, the option of a chemical model 
of breast cancer, even considering the major disadvantage of limited potential 
for metastization [383], yielded the well-documented advantages of chemically 
induced models, especially the ones that act directly (e.g. MNU) [168]. Such 
major advantages include the ability to investigate stage-specific effects, well-
defined parallels between animal models and human disease, and insights into 
the cellular and molecular mechanisms that underlie tumor development [361]. 
Last, the model was considered to be a better alternative to cell-line derived 
models and a more economical option than genetically engineered ones [139].  
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Several methodological choices were made in order to conduct an 
objective evaluation of the impact of exercise on the progression of mammary 
neoplasms and muscle wasting. The histological type of the developed tumors 
was classified according to Russo and Russo’s taxonomy (see Chapter 1) [318] 
by analyzing slides stained with hematoxylin and eosin (H&E). To characterize 
the infiltrative lesions, we measured cellular proliferation, cell death and 
collagen content. Cellular death was assessed with the terminal 
deoxynucleotidyl transferase-mediated dUTP in situ nick-end labeling (TUNEL) 
test, an increasingly common staining method used to detect apoptotic cells in 
tissue sections [91]. However, the fact that the TUNEL assay usually marks the 
apoptotic nucleus and necrotic cells [358, 378] could have problematized 
examining tumors whose histological character includes necrotic zones, 
particularly comedocarcinomas. Even with that limitation and considering that 
only one comedo-type tumor was detected, the protocol translated the 
amplitude of cellular death within the tumors [91].  
Regarding the growth fraction of malignant tumor tissue, the number of 
cells stained by ki-67 antibody was considered. Uncontrolled proliferation is a 
hallmark of malignancy and may be assessed by a variety of methods, among 
which the immunohistochemical assessment of Ki67 antigen [99], recognized as 
a powerful prognosis marker in patients with breast cancer, is widely used [93, 
236, 266, 391]. In addition, considering that collagen signature may be a 
promising cancer marker, since the content and distribution of collagen in 
cancer tissue, due to remodeling of the ECM during the malignant process, 
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differ from those aspects in corresponding normal tissue [173], tissue sections 
were stained with Picrosirius red to visualize collagen content [203, 354]. 
However, we did not analyze the collagen alignment, which is considered to be 
a tumor-associated collagen signature in breast cancer, and a particularly 
powerful one for tumor progression [72, 304]. 
Regarding muscle wasting, the choice to analyze gastrocnemius was 
based on its physiological characteristics as fast muscle, accompanied by what 
is known about the preferential target of cancer stimuli [65]. All methodological 
choices in that regard were made in an attempt to measure the impact of REX 
on circulating levels of relevant markers (i.e. mediators of cancer-induced 
muscle wasting) produced by both host and tumors and with both anabolic and 
catabolic actions.  
Statistical procedures in both meta-analyses were performed with 
Comprehensive Meta-Analysis version 2.2.057 (BioStat Inc., Englewood, NJ, 
USA). All other statistical procedures were performed with GraphPad Prism 
version 6.0 and 7.0 (GraphPad Software, La Jolla, CA, USA). The choice to use 
parametric and nonparametric tests was based on the normal versus abnormal 
data distribution. 
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2. DISCUSSION OF RESULTS
In Study 1, a strong association was shown between RPA/REX and 
breast tumor outcomes. In contrast to some preclinical research associating the 
development and progression of mammary tumors with exercise [69, 70, 116, 
140, 241, 351, 363, 390], our results after meta-analytic procedures showed the 
beneficial effects of RPA/REX on tumorigenesis. Cellular proliferation and 
apoptosis presented largely favorable changes amid exposure to RPA/REX, 
and tumor weight and tumor volume were shown to benefit moderately from 
RPA/REX. The sole variable that demonstrated small benefits was incidence. 
The meta-analytic procedures allowed us to identify the strength and the 
direction of the previously published findings and thereby confirm the positive 
ones [22, 69-71, 116, 146, 184, 188, 189, 221, 241, 242, 264, 269, 351, 364-
366, 382, 385, 390, 396-398]. The findings of Study 3 also supported those 
results, for we observed evidence of a reduction in the number of tumors 
developed by MNU-exercised animals and in the number of tumors per animal. 
Our results also corroborate previous findings regarding multiplicity [70, 146, 
188, 189, 241, 242, 269, 366, 396-398]. 
Moderate benefits of RPA/REX were found concerning tumor weight and 
tumor volume in meta-analysis 1, which support the results of most cited 
research on that variable [22, 146, 184, 188, 189, 241, 269, 351, 382, 385, 390, 
397, 398]. However, we also found that the tumors grew at comparable rates in 
exercised and sedentary MNU animals (Study 3), arguably due to the length of 
the experimental design. Indeed, our study lasted longer than any of the other 
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previous study on the topic, which inevitably meant increased in tumor burden. 
Meta-analytic procedures in Study 1 also revealed the strong influence of 
RPA/REX on the modulation of the TME in terms of cellular proliferation and 
death. RPA/REX largely improved the dysregulation between proliferation and 
apoptosis, which supports some previous findings [188, 189, 253, 269, 312, 
361, 362, 384, 396, 398] as well as the results of Study 3 that clearly showed a 
reduction in intratumoral cellular proliferation accompanied by the increased 
expression of cellular death in MNU-exercised animals. Furthermore, the 
balance between cell proliferation and cell death in those animals was coupled 
with a significant reduction in their infiltrative lesions. Such results might have 
stemmed from improvements in the systemic markers of inflammation that we 
observed to be deregulated in Study 4. Indeed, we detected a significant 
reduction in the systemic expression of TWEAK in MNU-exercised animals, 
which corroborates knowledge that the TWEAK–Fn14 system demonstrates 
protumorigenic activity associated with proliferation, invasion, angiogenesis, 
and inflammation [258]. Such low malignancy—in fact, the lowest—revealed by 
the mammary tumors of MNU-exercised animals is probably due to 
improvements in host immune response reported by other studies [202, 248, 
256, 313]. However, though promising, the results cannot be compared to 
findings from previous research, which lack data concerning the possible 
association between exercise and the lower aggressiveness in the histological 
patterns of mammary tumors [20]. Additionally, we also believe that the lower 
inflammatory condition revealed by the MNU-exercised animals induced 
Discussion of results 
175
differences observed in Study 3 regarding the collagen content of the TME. The 
lower levels of collagen content of MNU-exercised animals (Study 3) speak in 
favor of a less fibrotic stimuli that can be associated with a lower activity of so-
called “activated” fibroblasts inhibited by the reduction in systemic inflammation 
(Study 4) as has been previously reported [206]. 
In Study 1, we identified that the animal models for breast cancer used in 
the different studies were diverse, which could account for the comparatively 
slight differences obtained for incidence. Different tumor models might result in 
different tumor phenotypes and, consequently, in different behaviors when 
exposed to exercise [142, 172, 196]. Insufficient evidence of a positive 
association between RPA/REX and tumoral angiogenesis was also observed in 
Study 1. Notably, only six studies have involved analyzing TME (Study 1), which 
is a clear limitation to robust conclusions and to securely extrapolating the 
results to clinical contexts. Nevertheless, by showcase the importance of 
cellular proliferation [355] and apoptosis [49, 92, 106] as key features in tumor 
progression, the results of Study 1 and 3 strongly support the recommendation 
of RPA/REX in response to breast cancer. Regarding angiogenesis, we 
suspected that RPA/REX might act to normalize tumor vasculature by reducing 
tumor vessels permeability, which highlight an opportunity for chemotherapeutic 
delivery [239]. However, in Study 1, in attempting to identify the ideal amount of 
exercise to inform better results in tumor outcomes, we encountered 
considerable diversity in exercise protocols, which partly undermined our 
objectives. Yet, we also detected that exercise intensity seems to be a major 
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determinant of reducing tumor development and progression. Exercise training 
of moderate-to-vigorous intensity in bouts of 30–45 min, which upholds 
international guidelines [217, 311, 333], seemed to positively affect all the 
variables under study (Study 1). Also in Study 1 and unlike what is generally 
accepted regarding the duration of exercise bouts, longer exercise episodes 
(>45 min) had adverse effects on tumor incidence, tumor weight and tumoral 
angiogenesis. The exercise episodes used in our experimental research (60 
min) fell into that range; however we did not find significant differences in tumor 
incidence or tumor weight (Study 3), although we did not study angiogenetic 
markers. Regarding moderate intensity, the effects observed in Meta-analysis 1 
aligned with the outcomes of Study 3. Considering those results, future studies 
should preferentially choose exercise designs in which intensity can be 
measured along with exercise bouts in order to yield information that can enable 
advances in the field. 
Findings in Study 2 consistently showed that REX is powerfully 
correlated with improvements in cancer-associated systemic biomarkers, which 
somewhat contradicts published research [116, 287, 366, 398]. Meta-analytic 
procedures enabled us to convincingly report that, for animals, engaging in 
approximately 85 min of vigorous treadmill exercise every week on useful days, 
reduced tumor-induced inflammation by 61.5%, and improved the circulating 
levels of sex hormones by 69.7%. Moreover, our results (Study 2) also showed 
that engaging in approximately 85 min of moderate treadmill exercise every 
week on useful days can also have positive, though in this case moderate, 
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effects upon cancer-related inflammation (43.1%) and the circulating levels of 
sex hormones (47.9%). The results in those two variables were achieved under 
conditions of exercise similar to ones internationally recommended for cancer 
patients [217, 311, 333]. 
Inflammation is another hallmark in the development and progression of 
cancer [83, 155, 156]. Regardless of inconsistent results concerning an inverse 
relationship between exercise and inflammation [55, 95, 114, 202, 291], our 
data from animals strongly supported that relationship, in accordance with the 
findings in other studies [116, 146, 148, 184, 256, 269, 287, 313, 335, 366, 397, 
398]. As mentioned, they also sustained improvements in systemic 
inflammation observed in MNU-exercised animals in Study 4. Indeed, systemic 
inflammation is thought to be a major mediator of cancer-induced muscle 
wasting [122], and compelling evidence indicates that exercise activates a 
network of transcription factors that promote metabolic reprogramming in 
skeletal muscle. TWEAK inhibition appears to be a strategy to prevent the loss 
of skeletal muscle mass [322]. Our results also seem to suggest that REX is 
important for regulating the expression of mediators of skeletal muscle wasting. 
In fact, the impact of REX was primarily observed in the significant enlargement 
of the cross sectional area of muscle fibers and in the significant reduction in 
the serum and muscle levels of TWEAK in the gastrocnemius of MNU-exercised 
animals. The inhibition of TWEAK levels prompted a decreased in the 
expression of atrogenes and the inevitable suppression of NF–κb signaling. As 
previously reported in other studies, TWEAK induces MuRF1 upregulation via 
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NF–κb and thereby causes MyHC loss [261]. The inhibition of NF–κb is 
sufficient to decrease significantly tumor-induced muscle loss by inhibiting the 
upregulation of MuRF1 and MAFBx [38, 51, 215, 265].  
The benefits of RPA/REX for the circulating levels of sex hormones are 
more consistently reported in previous research, particularly among 
postmenopausal women [132, 172, 280], and in preclinical data [366, 397, 398]. 
In contribution, our data from Meta-analysis 2 clearly indicated a strong 
association between exercise and the circulating levels of sex hormones. In 
glucose-related factors small benefits (25.1%) were also observed. In fact, the 
best results in glucose-related factors under treadmill exercise modality were 
achieved with aproximately 200 min/week of vigorous exercise, which hardly 
seems to be reproducible during breast cancer in humans. We also found that 
the best results in glucose-related markers (Study 2) were associated with 
voluntary exercise, which makes it impossible to determine the exact amount of 
exercise needed to achieve those benefits. Although much evidence supports a 
connection between RPA/REX and biomarkers related to glucose metabolism 
[149, 226], our results, though confirming that evidence, did not allows us to 
pinpoint the amount of REX required to alter glucose-related biomarker levels. 
Nevertheless, in Study 4, we did find local improvement in the metabolic profile 
of the gastrocnemius. Indeed, the increased expression of PGC-1α, citrate 
synthase, and other subunits of oxidative metabolism in that muscle of 
exercised animals appear to indicate a fiber shift toward the oxidative 
phenotype (fast-to-slow shift), which also reveals improvements in mitochondrial 
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activity, as reported in others studies [64, 167, 323]. That metabolic adaptation 
has been related to the enhanced ability of muscles to extract and use oxygen 
from arterial blood [310], as well as to improved aerobic performance [167]. 
Shown again in Study 2, albeit to a degree considerably slighter relatively 
than in Study 1, the diversity among experimental designs clearly limited the 
extension of results to other populations. Both studies revealed that the 
distance covered by the animals throughout the experiments did not seem to 
affect the outcomes, which contrasts what has been reported by other 
researchers [146, 366, 382, 397, 398]. Surprisingly, covering short or long 
distances resulted in similar outcomes. In that sense, what seems to be 
important is not how far we go, but instead in which intensity do we get there.  
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CHAPTER IV 
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1. CONCLUSIONS
Our results provided support for the following conclusions: 
1. As preclinical data indicated, exercise is associated with reduced tumor
burden in animals.
2. Regular exercise promotes beneficial changes in the levels of
proliferation and apoptotic biomarkers in animals’ TMEs.
3. In exercise programs, moderate-to vigorous intensity seems to be the
most determinant variable in the modulation of tumor behavior.
4. Performing 85 min/week of vigorous forced exercise reduced systemic
inflammation levels and improved circulating sex hormone levels in
animals.
5. From preclinical data, it is impossible to identify the amount of exercise
training needed to favorably regulate glucose-related factors.
6. Long-term moderate exercise training did not induce improvements in
tumor growth.
7. Long-term moderate exercise training reduced tumor proliferation and the
amount of infiltrative lesions in animals, in the latter of which long-term
moderate exercise training promoted a more favorable TME by
enhancing the rate of cell death and a decreasing collagen deposition.
8. Moderate exercise training prevented tumorigenesis by modulating of
TWEAK–NF-κB signaling.
9. In mammary tumor-bearing animals, long-term moderate training
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improved the metabolic status and prevented the skeletal muscle wasting 
of the gastrocnemius, likely by modulating the serum and skeletal muscle 
levels of TWEAK. 
10. Evidence of the association between exercise and the positive
modulation of angiogenic events in TMEs remains insufficient.
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2. PRACTICAL IMPLICATIONS
Considering all of the findings collected in this thesis, first with preclinical 
contexts in mind, the research as presented sufficient data to inform exercise 
designs. By taking into account a methodological approach mimicking the 
exercise training conditions that can be performed by humans with breast 
cancer, the research allows the extrapolation of its results to clinical contexts. 
However, much work remains to be done to convincingly support evidence-
based exercise training for breast cancer, especially as it pertains to TMEs. 
Taking the clinical contexts into consideration, despite the diversity of 
results reported in the literature, evidence of the benefits of exercising after 
being diagnosed with breast cancer does exist. In light of our results, regular 
exercise training could serve to regulate the mechanisms by which tumors 
become more aggressive. Furthermore, exposure to programs of regular 
exercise training could diminish cancer-induced muscle wasting by modulating 
several associating factors. In particular, host response to the stimuli of cancer 
could be improved under the action of regular exercise training. Exercise 
training is important and should be performed throughout the course of breast 
cancer, although always by considering a symptom-based approach tailored to 
each patient. Moreover, considering our results, exercise training programs for 
patients with breast cancer should prescribe activities that allow them to 
achieve moderate-and-vigorous-intensity levels in their training plans. 
Altogether, we believe that breast cancer treatment teams need to be 
multidisciplinary and always include a specialist in exercise prescription.  
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